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Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung disease, that is 
characterized by persistent airflow limitation that is usually progressive and associated 
with an enhanced chronic inflammatory response in the airways and the lung to noxious 
particles or gases.1 The prevalence of COPD in adults aged ≥ 40 years is estimated at 
9-10%.2 COPD is an important cause of morbidity and mortality. In 2002, COPD was 
the fifth leading cause of death world-wide and it is estimated to become the fourth 
leading cause of death in 2030.3 The main symptoms of the disease are chronic and 
progressive breathlessness (dyspnea), cough and sputum production. However, COPD is 
not only a disease in the lung, often extra pulmonary manifestations are present and the 
prevalence of comorbid conditions is high.4 Common extra pulmonary manifestation and 
comorbidities are skeletal muscle dysfunction, pulmonary hypertension, osteoporosis, 
depression and anxiety.4 Therapeutic interventions for COPD include smoking cessation, 
pharmacologic therapy, rehabilitation, oxygen therapy, ventilatory support and surgical 
treatments.1,5 Furthermore, the latest guidelines of the Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) underline the importance of regular physical activity 
for all patients with COPD in the management of stable COPD.1,5,6 
Physical activity
Physical activity is defined as any bodily movement produced by skeletal muscles that 
requires energy expenditure.7 Physical activity reflects what a patient actually does and 
is thereby different from functional capacity which indicates what a patient is capable of 
doing. Therefore, physical activity also has a behavioural component. Physical exercise is 
a subcategory of physical activity that is planned, structured, repetitive, and purposeful, 
the objective being to improve or maintain one or more components of physical fitness.7 
Regular physical activity has important health benefits. There is strong evidence that 
regular physical activity leads to reduced rates of all-cause mortality and reduced rates 
of various diseases like coronary heart disease, stroke, type 2 diabetes and depression.8 
Furthermore, it can lead to increased cardio-respiratory and muscular fitness, healthier 
body mass and composition, improved bone health, increased functional health and 
improved cognitive function.8 However, worldwide approximately a third of the adults 
are physically inactive.9 Partly due to the development of new technologies, that caused 
a decrease in the need of occupational physical activity.9 Physical inactivity was identified 
by the World Health Organization as the fourth leading risk factor for death in 2004, 
leading to 3.2 million preventable deaths.10
Physical activity and COPD
The prevalence of physical inactivity in COPD patients is even higher than in healthy 
individuals. Lower levels of physical activity compared to healthy controls have been 
reported already in the earlier stages of the disease and furthermore also compared to 
other patient groups like diabetes mellitus and rheumatoid arthritis.11,12 COPD patients 
frequently report dyspnea induced by everyday tasks and consequently reduce or avoid 
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physical activities and therefore may enter a downward spiral of symptom-induced 
immobility leading to deconditioning which in turn aggravates dyspnea even more.13 
Besides the earlier mentioned general health benefits, especially in COPD increasing 
physical activity has shown to decrease dyspnea severity and improve muscle function 
and quality of life.14,15 Furthermore, physical activity was found to be the strongest 
predictor of all-cause mortality in COPD patients.16 As physical activity is modifiable it 
is an important treatment target in this patient group. Until now, most evidence of the 
effects of increasing physical activity in COPD is based on structured exercise programs 
embedded in pulmonary rehabilitation settings. However, it is shown that these programs 
do not guarantee an improvement in physical activity levels.17,18 Furthermore, little is 
known about the effects of these programs on physical activity in daily life some time 
after they have been completed. Understanding why COPD patients are physically active 
or sedentary could contribute to the development and optimizing of physical activity 
enhancement programs with long lasting effects. These programs could target the factors 
that are associated with physical activity or inactivity.
Predictors of physical activity
In general adult populations, female gender, higher age, higher body weight, lower level 
of education, health problems, lower self-efficacy, history of low physical activity and 
weather conditions were shown to be associated with low physical activity.19-21 In COPD 
patients the potential predictors of physical activity are hardly investigated systematically 
so far. Furthermore, the literature is in general limited and inconsistent and only few studies 
have investigated both potential physical as well as psychosocial predictors. It would be 
helpful to identify and investigate the potential physical and psychosocial predictors of 
physical activity especially in COPD patients. The majority of studies on physical activity 
in COPD are based on a quantitative research approach. In contrast, the patient’s own 
perceptions and thoughts on physical activity are hardly investigated. Exploring the 
reasons why COPD patients are physically active or sedentary and the opportunities and 
barriers they experience, could provide additional information and starting points to 
stimulate physical activity in these patients. 
Physical activity recommendations
As regular physical activity has many health benefits the question arises how much 
physical activity is ‘regular’ and should consequently be advised to a COPD patient. 
Approximately 40 years ago the first physical activity recommendation was published 
reporting the recommended minimal amount of physical activity to promote or maintain 
health.22 The currently often utilized physical activity recommendation are the guidelines 
of the American College of Sports Medicine (ACSM). Those guidelines recommend that 
adults should engage in moderate-intensity aerobic physical activity for a minimum 
of 30 minutes for 5 days each week or vigorous-intensity aerobic physical activity for a 
minimum of 20 minutes for 3 days each week, or an equivalent combination of both.23,24 
Besides aerobic exercises, adults should also perform resistance, neuromotor and 
flexibility exercises. In general, the physical activity recommendations are mainly based 
on healthy adults, while the recommendations for adults with a chronic illness like COPD 
are less clear. For elderly adults the ACSM recommends to adjust the intensity to the 
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adult’s aerobic fitness level25 that might be appropriate for COPD patients. The physical 
activity recommendations are hardly investigated in COPD patients and the suitability of 
the recommendations in this patient group is therefore still unclear.
Physical activity and lung hyperinflation 
An important predictor of physical activity in COPD patients is lung hyperinflation.26 Lung 
hyperinflation is an important clinical feature in COPD patients with emphysema and is a 
result of increased airway resistance, reduced lung recoil and shortened available expiratory 
time.27 Lung hyperinflation is more strongly related to patient-centered outcomes like 
dyspnea or health related quality of life than forced expiratory volume in 1 second (FEV1).
27 
In the past decade, lung volume reduction techniques by bronchoscope are increasingly 
investigated. Endobronchial devices are implanted in emphysematous parts of the lung 
to reduce hyperinflation. These techniques are less invasive compared to lung volume 
reduction surgery, and show promising results in improving lung hyperinflation, quality 
of life and exercise capacity.28-31 This treatment may improve the mechanical properties of 
the remaining lung and the efficiency of the inspiratory muscles. Consequently, this may 
lead to a reduction of dyspnea during exertion and improve functional capacity of the 
body. Theoretically, after lung volume reduction a COPD patient’s physical activity level 
could improve, however, so far daily physical activity was never measured before and 
after lung volume reduction. Furthermore, it is not known what size of improvement in 
lung hyperinflation can be regarded as being clinically important for the patient.
Aims of the thesis
In summary, physical activity has many health benefits and is an important treatment 
target in COPD patients. Unfortunately, the physical activity level has shown to be low in 
this patient group, even in the earlier stages of the disease. It is unclear what determines 
whether a patient is physically active or sedentary. The first aim of this thesis is to gain 
more insight in all aspects of physical activity and its predictors in COPD patients in all 
severity stages of the disease, investigating both potential physical and psychosocial 
factors. A second aim is to investigate whether the current general guidelines for the 
recommended minimum amount of physical activity for adults to promote and maintain 
health are suitable for COPD patients. A final aim is to investigate more in depth lung 
hyperinflation, an important determinant of physical activity in COPD patients, and to 
study whether a decrease in lung hyperinflation is associated with an increase in physical 
activity.
Outline of the thesis
In chapter 2 a review of the literature on potential physical and psychosocial factors that 
affect the physical activity level in COPD patients is presented. The role of these potential 
physical and psychosocial predictors of physical activity is investigated in a study that 
is presented in chapter 3. In chapter 4 the results of a study on the predictors of physical 
activity, investigated with a qualitative approach, are presented. This study focuses on 
the patient’s own perceptions on physical activity. The results of a study on the use of 
current physical activity recommendations in COPD patients are presented in chapter 5. 
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In chapter 6 the results of a pilot study aimed at investigating the potential beneficial 
effects of bronchoscopic lung volume reduction on the physical activity level in patients 
with severe emphysema are presented. Chapter 7 describes the results of a study on 
the determination of the minimal important difference (MID) of Residual Volume. The 
established MID could be useful when interpreting the significance of the results of 
clinical trials or power calculations. The established MID was used in the study presented 
in chapter 6. Chapter 8 consists of a summary and a general discussion.
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ABSTRACT
The many health benefits of regular physical activity underline the importance of this 
topic, especially in this period of time when the prevalence of a sedentary lifestyle in 
the population is increasing. Physical activity levels are especially low in patients with 
chronic obstructive pulmonary disease (COPD). Regular physical activity and an active 
lifestyle has shown to be positively associated with outcomes such as exercise capacity 
and health-related quality of life, and therefore could be beneficial for the individual 
COPD patient. An adequate level of physical activity needs to be integrated into daily life, 
and stimulation of physical activity when absent is important. This article aims to discuss 
into more detail the possible role of regular physical activity for a number of well-known 
outcome parameters in COPD.
Keywords: COPD • health benefits • physical activity • physical activity stimulation




Chronic obstructive pulmonary disease (COPD) is a disease characterized by a usually 
progressive airflow limitation that is not fully reversible, and has potential significant 
extrapulmonary effects.1 The symptoms of this debilitating disease may have huge 
impact on a patient’s daily life.
Physical activity is defined as any bodily movement produced by skeletal muscles that 
results in energy expenditure. Exercise, on the other hand, is physical activity done 
on purpose, and carried out in a more structured manner with the aim of improving 
cardiorespiratory or muscular fitness.2 It is important to distinguish physical activity from 
physical fitness, functional or exercise capacity. The latter three indicate what a person 
is capable of doing while physical activity reflects what someone actually does. The 
measurement of physical activity is therefore different from the measurement of physical 
fitness, functional or exercise capacity. Physical activity can be measured by direct 
observation, assessment of energy expenditure (e.g., doubly labeled water technique), 
diaries, questionnaires and performance-based motion sensors (e.g., pedometers and 
accelerometers).3 The first two are time consuming and expensive and are therefore used 
less frequently. Performance-based motion sensors objectively quantify the amount 
of daily physical activity performed and is therefore more accurate as compared with 
questionnaires and diaries, which depend on a person’s memory and interpretation. 
Regular physical activity improves body composition, autonomic tone, coronary blood 
flow, psychological wellbeing, glucose homeostasis and insulin sensitivity, enhances 
lipid lipoprotein profiles and endothelial function, reduces blood pressure and systemic 
inflammation, decreases blood coagulation and augment cardiac function.4 Physical 
inactivity is therefore a modifiable risk factor for cardiovascular disease and a variety 
of other diseases such as diabetes mellitus, cancer, hypertension and dementia.4,5 The 
recommended minimum amount of physical activity for adults to promote and maintain 
physical health is 30 minutes of moderately intense aerobic physical activity at least 5 days 
a week or 20 minutes of vigorously intense aerobic physical activity at least 3 days a week, 
or an equivalent combination. Every adult should also perform muscular strength and 
endurance exercises at least 2 days each week.6 For elderly adults (age ≥65 or ≥50 with 
clinically significant chronic conditions and/or functional limitations) it is necessary to 
adjust the recommended intensity of aerobic activity to the elderly adult’s aerobic fitness. 
Moreover, activities that maintain or increase flexibility are recommended next to balance 
exercises for elderly adults at risk to fall.7 The latter would be adequate for the majority 
of COPD patients. To our knowledge, there are no COPD-specific recommendations 
for an adequate physical activity level. Most guidelines on the management of COPD 
mention the importance of increasing the level of physical activity, however, this is often 
related to treatment with pulmonary rehabilitation. The American Thoracic Society/
European Respiratory Society statement on pulmonary rehabilitation provides practice 
guidelines for exercise training during pulmonary rehabilitation and emphasizes the 
need for the transference of exercise adherence to the home setting.8 Unfortunately, the 
recommended amount of physical activity in daily life is not specified in these guidelines. 
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Several studies have shown that the level of physical activity in COPD patients is low, 
especially compared with that of healthy controls. A selection of these studies is shown 
in table 1. Moreover, a recent study from Sweden9 has reported that the number of COPD 
patients who do not reach the recommended amount of physical activity according to 
the earlier stated guidelines7 was significantly higher than in patients with rheumatoid 
arthritis (RA), diabetes mellitus (DM) and healthy subjects (COPD 84%, RA 74%, DM 72% 
and healthy 60%, respectively). This indicates that the level of physical activity in COPD 
patients is also lower than in other diseases.
From the literature we can conclude that being physically active has many health benefits 
in general, and that many COPD patients lack an adequate level of physical activity. 
Consequently, a reduced level of physical activity may contribute to a lower physical 
fitness and wellbeing. The aim of this article is to discuss in more detail the possible role 
of regular physical activity in a number of well-known outcome parameters in COPD.
Study (year) Population n
Mean         
FEV1 %pred Outcomes Ref.
Walking time    
(min per day)
Sitting time       
(min per day)Accelerometer (DynaPort ) 12-h day*
Pitta et al. (2005) Controls 25 111 81 306 [16]
COPD patients 50 43 44 374
Pitta et al. (2009) COPD patients (Brazil) 40 46 56 296 [77]
COPD patients (Austria) 40 48 40 388
Camillo et al. (2008) COPD patients 31 46 57 [45]
Pitta et al. (2006) COPD patients 23 39 57 338 [25]
Accelerometer (SenseWear) ± 24-h day Steps per day PAL
Troosters et al. (2010) Controls 30 114 9372 [14]
COPD patients 70 54 5584
Watz et al. (2008) COPD patients 170 56 5882 1.50 [42]
Watz et al. (2009) Chronic bronchitis 29 99 ± 9000 ± 1.70 [36]
Accelerometer (SenseWear) 12-h day* Daytime steps
Pitta et al. (2008) COPD patients 40 41 4178 [22]
Camillo et al. (2008) COPD patients 31 46 4603 [45]
Pedometer (type) Steps per day
Schonhofer et al. (1997)
(Fitty 3)
Controls 25 NA 8590 [11]
COPD patients 25 47 3781
McGlone et al. (2006)
(Omron HJ003)
COPD patients 124 46 3716 [10]
TABLE 1. Daily physical activity level in chronic obstructive pulmonary disease.
*Duration measurement included 12 consecutive hours starting at waking up time.
FEV
1
: forced expiratory volume in 1 s; n: number of patients or controls; %pred: percentage predicted; NA: 
not available; PAL: physical activity level score (total energy expenditure/basal metabolic rate-24 h).
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The role of physical activity in specific COPD characteristics
Lung function
Several cross-sectional studies have shown a significant relationship between physical 
activity and the forced expiratory volume in 1 second (FEV1; correlation coefficients [r] 
ranges between 0.20 and 0.63),10-20 while others did not.21-24 Different studies categorized 
the lifestyle of COPD patients as ‘active’ or ‘inactive’ based on their level of physical activity. 
Higher FEV1 values were found in patients who reached the recommended amount of 
physical activity7 (a minimum of 30 minutes of walking every day) compared with those 
who did not25 and in patients who reported moderate or high levels of physical activity 
compared with patients who reported low levels of physical activity, defined as time spent 
walking during leisure time.26 By contrast, when patients were divided into groups based 
on their median physical activity level27 or based on the level of energy expenditure in 
physical activity,28 no difference in FEV1 between groups was observed. However, these 
contradictory results may be explained by the differences in categorization used in these 
studies. 
Surprisingly, one longitudinal study in the general population demonstrated that 
lower physical activity (among other variables) increased the 10-year decline in FEV1 
in active smokers. However, physical activity was not associated with lung function 
decline in young adults (<40 years of age) nor in subjects with mild COPD.29 The same 
study showed that subjects who decreased their level of physical activity during follow-
up had an accelerated lung function decline and were more likely to develop COPD, 
while subjects who increased their level of physical activity showed a reduction in lung 
function decline and COPD risk compared with subjects with unchanged physical activity 
levels. In addition, people with moderate-to-high levels of physical activity had a reduced 
risk of COPD compared with the group that reported low physical activity (odds ratio 
[OR]:0.8).29 In line with these results, another study with a mean follow-up duration of 
3.7 years showed that performing activities with a metabolic equivalent of task (MET) 
score of five or more (equal to, for example, riding on a bicycle at average speed), or more 
stair climbing was associated with a lower percent reduction in FEV1 in both men and 
women.30 MET expresses the intensity of physical activities and is based on the ratio of a 
person’s working metabolic rate relative to their resting metabolic rate.2
In conclusion, cross-sectional data suggest that a lower level of physical activity is 
associated with a lower FEV1. Furthermore, longitudinal studies suggest that physical 
activity reduces FEV1 decline and thus disease progression.
Exacerbations and hospital admissions due to COPD
Worsening of respiratory symptoms can be indicative of a COPD exacerbation, which is the 
main cause of hospital admissions due to COPD. Exacerbations can lead to poorer health-
related quality of life,31 and severe exacerbations requiring hospitalization have shown to 
be associated with all-cause mortality in COPD patients.32 Physical activity seems to play a 
role in the risk of hospitalization due to an exacerbation. COPD patients with low energy 
expenditure in physical activity were more likely to have a COPD-related admission in 
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the previous year.28 Furthermore, patients reporting a very low level of physical activity 
had a higher risk of hospital admission due to COPD than those reporting low, moderate 
or high levels of physical activity, after adjusting for confounders.33 A very low level of 
physical activity was defined as reporting mainly sitting during work, no activity during 
work and no jogging or cycling. Moreover, patients who reported a physical activity level 
which included minimal 2 hours per week of walking or cycling had a 30-40% reduced 
risk of a hospital admission because of COPD.33 In line with those results, less than 2 
hours of physical activity per week showed to be a significant predictor (OR: 0.60) of 
hospitalizations in patients with severe COPD.34 
After an exacerbation, the level of physical activity in COPD patients appears to decrease. 
A measurement of physical activity by an accelerometer 1 month after discharge from 
hospitalization due to a COPD exacerbation, showed that the walking time increased 
significantly when compared with day 2 or 7 after hospitalization. However, the level of 
physical activity 1 month after discharge was still markedly low compared with earlier 
observed daily physical activity levels of stable COPD patients.35 Also, patients who were 
more often readmitted to the hospital for a subsequent acute exacerbation in the year 
following discharge had a significantly lower walking time 1 month after discharge than 
patients who were not readmitted (median 12 min/day vs 30 min/day).35 
Dyspnea
The most prevalent symptom in COPD patients is shortness of breath, or dyspnea. 
Dyspnea often occurs during exertion, which can cause a patient to avoid these activities 
and could result in a decrease in physical activity. For example, COPD patients who 
reported being too breathless to leave the house had a physical activity level (PAL) score 
of 1.26, which is just above the PAL score of a chair- or bed-bound patient.36 The PAL 
score expresses the daily physical activity level of a person over a 24-hour period as a 
number, and is based on the ratio of total energy expenditure and basal metabolic rate. 
Until now, limited research has focused on the association between physical activity 
and dyspnea, and moreover these few studies show inconsistent results. Some studies 
have demonstrated a poor-to-moderate association (r ranges: 0.26-0.46),12,17,19,21 while 
other studies did not.15,23,27 When the lifestyle of COPD patients was categorized into 
inactive and active, patients with an active lifestyle usually reported less dyspnea than 
the patients with an inactive lifestyle. Patients who reached the minimum recommended 
amount of physical activity reported less shortness of breath than patients who did not.25 
In line with this, a higher proportion of subjects with a higher level of dyspnea were 
reported to be in the group with low energy expenditure,28 and patients who reported 
lower levels of physical activity (based on walking time and distance) had more dyspnea 
than those with moderate or high levels of physical activity.26 By contrast, in a study that 
divided two groups according to the median level of physical activity, the above median 
active group did not have a higher dyspnea score.27 In addition, one study evaluated a 
6-month pulmonary rehabilitation program, in which increases in walking time in daily 
life, measured by a triaxial accelerometer, were significantly related to reductions in the 
dyspnea score, as well as with a higher number of completed rehabilitation sessions.37 




As stated earlier physical fitness or exercise capacity differs from physical activity, and is 
therefore measured in a different way. Exercise capacity can be measured by a maximum 
capacity test (e.g., an incremental [cycle] ergometer test) or a submaximal test (e.g., a 
6-minute walk test [6MWT]). Several studies showed a moderate or strong correlation 
between physical activity and exercise capacity measured by the 6MWT (r ranges: 0.42-
0.76).12,15,16,19,21,23,38 Significant correlations between physical activity and maximum 
reached workload (Wmax) and peak oxygen uptake (peak VO2) were also found (r ranges: 
0.33-0.63).16,19-21 Only two studies did not find a significant correlation.24,27 Apparently, 
there seems to be a strong association between physical activity and exercise capacity. 
However, one study showed that the 6MWD was predictive of walking time in daily life 
only in patients with a 6-minute walk distance (6MWD) below 400 meter.16 This indicates 
that in COPD patients with a higher exercise capacity the physical activity level is more 
variable. Two studies categorized patients into groups based on their level of physical 
activity. A study that compared COPD patients who reached the recommended amount 
of physical activity with patients who did not reach this level, showed that the relative 
inactive group had a significantly worse distance on the 6MWT (76 vs 66 %predicted), a 
lower peak VO2 (71 vs 49 %predicted) and lower Wmax (69 vs. 40 %predicted).
25 By contrast, 
when patients were divided by the median number of pedometer counts, the groups did 
not differ in exercise capacity measured by the 6MWT.27 
Muscle function
Maintaining adequate muscle function (force and endurance) in the larger musculoskeletal 
groups such as the quadriceps muscles is important in performing daily activities like 
walking and remaining independent. Quadriceps weakness is found to be a significant 
predictor of mortality in COPD patients.39 Two studies have shown a moderate correlation 
between physical activity and quadriceps function (r: 0.45 and 0.60)16,20 while two others 
did not.40,41 In both pairs, one study measured muscle endurance and one maximal 
muscle force. A group of patients who reached the recommended amount of physical 
activity also did not show significant difference in quadriceps peak torque compared with 
inactive patients.25 Little is known about the relationship between physical activity and 
handgrip force in COPD patients and the results published so far are inconsistent.16,42 
Comorbidity
The prevalence of comorbidity in COPD is high and COPD patients have been shown to 
be at increased risk of various diseases compared with an age matched non-COPD cohort 
(healthy or patients with other diseases than COPD).43 In 200 COPD patients, after reviewing 
their medical chart, an average of 3.7 chronic medical conditions (including COPD) were 
reported, and only 6% of these patients did not have another chronic medical condition 
apart from COPD.44 Comorbidities in COPD that occur frequently include osteoporosis, 
myocardial infarction, angina, fractures and glaucoma.43 Interestingly, COPD patients who 
reported lower levels of physical activity had comorbidities more often than those with 
moderate or high levels of physical activity.26 Furthermore, in COPD patients, a reduced 
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level of physical activity correlated with left cardiac dysfunction,42 hearth rate variability 
reduction,45 self-reported diabetes, cataracts,28 comorbid joint problems and a history of 
joint problems.23 
Highly prevalent in COPD patients is the metabolic syndrome, a cluster of metabolic 
risk factors such as hypertension, obesity and impaired glucose tolerance.46,47 Metabolic 
syndrome is associated with an increased risk of both type 2 diabetes and cardiovascular 
disease.48 Moreover, COPD and chronic bronchitis patients with metabolic syndrome 
showed significantly reduced levels of physical activity in comparison with those without 
metabolic syndrome.46 One review showed that exercise training has mildly or moderately 
favorable effects on many metabolic and cardiovascular risk factors that constitute or 
are related to the metabolic syndrome and thus can play a role in its prevention and 
treatment, although more research has to be conducted with metabolic syndrome as the 
main outcome.49 
COPD is associated with increased levels of systemic inflammatory markers.50 Higher 
levels of systemic inflammation (high-sensitivity C-reactive protein [hs-CRP], IL-6 and 
fibrinogen) have been shown to be associated with reduced physical activity in patients 
with COPD.46 Moreover, physical activity was an independent predictor of hs-CRP, IL-6 
and fibrinogen level.46 The authors of a review on the anti-inflammatory effect of exercise 
in general, suggest that myokines may be involved in mediating the health-beneficial 
effects of exercise and therefore may play an important role in the protection against 
diseases associated with a low-grade systemic inflammation.51 Unfortunately, there are 
only a few studies that have focused on the effect of exercise training on inflammatory 
markers in COPD, and these studies did not show changes in inflammatory markers (e.g., 
TNF-α and IL-6) due to exercise training.52 These data suggested that although exercise 
training did not result in anti-inflammatory effects in COPD patients, it also did not have 
a pro-inflammatory effect.52 
Obesity, assessed by a body mass index (BMI) of 30 or higher, is highly prevalent in 
patients with COPD, especially in those with Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) stages I and II.53 A study in a general population, aimed at examining 
determinants of sedentary lifestyles in the European Union, showed that obese people 
significantly more often had a sedentary lifestyle compared with people with normal 
weight (BMI: 20-25 kg/m2).54 However, this relation was not found in COPD patients. A 
few studies found no association between BMI and physical activity.10,16,23,27 In line with 
these results, different studies that classified patients into groups based on their level 
of physical activity, found that BMI was not significantly different between active and 
inactive COPD patients.25,26,28
Mortality
A follow-up study with a mean duration of 12 years among 2386 COPD patients showed 
that after adjusting for all relevant confounders, subjects who reported low, moderate or 
high physical activity had a lower risk of all-cause mortality, and death from respiratory 
causes or cardiovascular causes, than the group with very low physical activity, defined as 
                                                                                                 Consequences of physical inactivity in COPD (review)
27
2
mainly sitting during work, no activity during work and no jogging or cycling.33 The same 
was also found in the general population; minimal adherence to earlier stated guidelines 
of physical activity was associated with a significant 20-30% reduction in risk of all-cause 
mortality.55 
Health-related quality of life
Health-related quality of life (HRQL) is increasingly recognized as an important patient-
centered outcome, which may be affected by a chronic disease like COPD. A significant 
positive correlation between physical activity and (one domain of ) HRQL was frequently 
reported (r ranges: 0.20-0.42),10,17,19,21,23,56 although one study found different results for 
the different domains of HRQL,15 and one study did not find an association.57 Studies that 
classified patients into groups based on physical activity showed conflicting results. A 
study which divided the patients into low, moderate and high energy expenditure in 
physical activity showed that lower levels of HRQL (physical and mental components) 
were independently associated with a low energy expenditure (OR physical component: 
0.93; OR mental component: 0.96).28 By contrast, there were no significant differences in 
HRQL between patients who reached the recommended amount of physical activity and 
patients who did not,25 nor between those with above compared with below median 
physical activity.27 However, outcomes of these studies are incomparable since different 
questionnaires were used to measure HRQL. Frequently used HRQL questionnaires are St. 
Georges Respiratory Questionnaire, Short Form 36 Health Survey and Chronic Respiratory 
Questionnaire. A recent study with a 5-year follow-up showed that the COPD patients who 
maintained a low physical activity level or decreased their physical activity level during 
follow-up, showed a significant decline in HRQL, while those maintaining a high level 
of physical activity or increasing their physical activity level showed an improvement in 
HRQL.26 
Psychological parameters
Psychological characteristics such as depressive symptoms and anxiety are highly 
prevalent in COPD patients. One review showed that the prevalence of depression 
ranges between 7% and 79%, and the prevalence of anxiety between 10% and 100%.58 
The large variations can be explained by the differences in samples of COPD patients or 
the measures used for assessing psychiatric morbidity (e.g., different questionnaires and 
clinical interviews).58 Furthermore, patients with severe airway obstruction (GOLD stages 
III and IV) were 2.5-times more likely to have depression than controls, while patients 
with mild or moderate COPD (GOLD stage II) showed no increased risk for depression.59 
Moreover, depressive symptoms in COPD patients is strongly associated with worse 
HRQL.60 Two studies found no association between physical activity and the presence 
of depression.23,42 To our knowledge, no studies investigated the association between 
physical activity and anxiety in COPD patients. Self-efficacy in physical activity, the belief 
that you are capable of performing a physical activity, has been shown to correlate 
positively with physical activity (r: 0.27 and 0.43).12,15 
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Can we improve physical activity in COPD? 
Because regular physical activity has many health benefits in general but especially in 
COPD patients, it is important to improve the level of physical activity in COPD patients. 
Most evidence on effects of increasing physical activity in COPD is based on structured 
exercise programs embedded in pulmonary rehabilitation settings, which are most 
often offered to patients with more severe COPD. Pulmonary rehabilitation usually 
consists of multiple disciplines, of which exercise is an important component. Pulmonary 
rehabilitation programs with a short duration (until 12 weeks), have shown different 
results regarding its effects on physical activity. A 3-week pulmonary rehabilitation 
program showed that the increased level of physical activity was related to the increasing 
intensity of the training sessions and the authors suggested that there was no change 
in personal lifestyle toward longer periods of walking.57 Two studies with a slightly 
longer rehabilitation program (6-12 weeks) also found that there was not a significant 
increase in level of physical activity after rehabilitation.27,61 By contrast, 3 studies found 
a significant increase in physical activity after pulmonary rehabilitation with about the 
same duration.18,62,63 A pulmonary rehabilitation program with a duration of 6 months 
showed that the mean walking time did not improve significantly after 3 months, but 
actually did after 6 months.37 Unfortunately, to our knowledge, no study examined the 
level of physical activity some time after finishing the pulmonary rehabilitation program. 
Consequently, an indication whether the patients have incorporated a more active 
lifestyle afterwards is lacking. 
The effects of a structured exercise intervention or pulmonary rehabilitation are 
significant64-68 and emphasize the importance of exercise or regular physical activity in 
COPD. However, a structured after-care program is often lacking and, furthermore, the 
disadvantages of a structured exercise program are that they are often time-consuming, 
expensive and require a lot of organization and, therefore, patients often drop out. It is 
also important that patients integrate physical activity in daily life and adopt a physical 
active lifestyle. Therefore, another way to improve physical activity is by enhancing daily 
physical activities such as walking, bicycling, gardening, and thereby promoting an 
active lifestyle. The primary focus of such a lifestyle strategy is not to improve functional 
capacity like in pulmonary rehabilitation, but to establish new physical activity routines in 
daily life, which could give better maintenance of the results in the long term. One study 
in an older general population compared the long-term effects of a structured exercise 
group to a home-based lifestyle intervention. After 1 year following the intervention, 
the lifestyle intervention group maintained their increase in physical activity while the 
structured exercise group no longer had higher levels of physical activity compared with 
the control group (without intervention).69 Obviously, education and/or counseling is an 
important component of lifestyle physical activity enhancement. A successful example in 
COPD patients is a counseling program that used pedometers to monitor and motivate 
COPD patients to increase their physical activity in daily life. A total of 12 weeks after 
this program, the outclinic COPD patients who received exercise counseling showed a 
significant increase in the number of steps per day as compared with those who received 
usual care.70 Furthermore, after 12 weeks, the counseling group showed a significant 
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improvement in arm and leg strength, HRQL and changes in intrinsic motivation score 
to be physically active.70 The same counseling strategy was added to COPD patients 
who already followed a rehabilitation program. Both the experimental (pulmonary 
rehabilitation plus exercise counseling) and control group (only pulmonary rehabilitation 
program) showed an increase in the number of steps per day, with the experimental 
group showing the largest increase.71 Comparable, another study looked at the effects 
of a daily self-monitored walking training at home after a 7-week supervised pulmonary 
rehabilitation program. The integration of the daily walking training at home already 
started during rehabilitation. The improvements in exercise capacity after rehabilitation 
were maintained at 6 months and although slightly declined, were still significantly better 
at 1-year follow-up compared with baseline.72 These results show that a lifestyle physical 
activity strategy and pulmonary rehabilitation or structured exercise programs can be 
complementary. 
In the reconvalescence phase of a COPD exacerbation it may also be worthwhile to 
enhance physical activity. For example, one interesting study looked at the positive 
effects of a specialized walking program for COPD patients admitted to the hospital for 
an exacerbation.73 During their hospital admission, patients walked six times per day and 
during the 6 months afterwards patients were stimulated to walk three times per day. 
All patients kept a diary with walking distances and time spent on walking at home. In 
these 6 months the patients recorded a mean daily walking distance of 2308 meter, on 
an average of 157 walking days. The training group increased their exercise performance 
and quality of life while the control group, which did not receive any structured training, 
did not (directly after the hospitalization, after 6 and 18 months).74 These results show 
that the stimulation of walking, an important component of daily physical activity, has 
benefits even in COPD patients shortly after a hospitalization due to an exacerbation.
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CONCLUSION AND DISCUSSION
While physical activity has many health benefits in general, the level of physical activity 
in COPD patients appears to be low, compared with a healthy population but also with 
other patient groups, and is therefore an important modifiable risk factor in COPD 
patients. Although there are general guidelines for the recommended minimum amount 
of physical activity for adults to promote and maintain health, it seems worthwhile to 
investigate whether these guidelines are also suitable for COPD patients.
Significant correlations were found between physical activity and important disease 
outcomes of COPD like FEV1, dyspnea, exercise capacity, muscle function, comorbidities, 
systemic inflammation and HRQL. However, it should be recognized that the literature 
is limited and inconsistent, and that most correlations are only moderate. Furthermore, 
a few other cross-sectional studies separated active COPD patients from inactive COPD 
patients, which could give interesting insight into the determinants and consequences 
of an inactive lifestyle. Although not consistent, an inactive lifestyle was associated with 
lower FEV1, higher levels of dyspnea, higher number of COPD admissions, worse exercise 
capacity and worse domains of HRQL. These results are obtained from cross-sectional 
data and therefore definite conclusions regarding a possible cause-effect relationship are 
difficult to draw. 
To our surprise, no significant associations were found between physical activity and BMI 
in contrast with findings in the general population. This could be explained by the lower 
prevalence of obesity that has been found in GOLD stage IV patients75 and in patients 
with emphysema.76 Apparently, the disease severity and phenotype of COPD are far more 
important than BMI in this perspective. An association between physical activity and 
psychological factors, such as depression was also not found. We anticipate that other 
factors like motivation to be physically active play an important role for the physical 
activity level of COPD patients, however studies on this relationship are lacking.
The prevalence of comorbidites in COPD is high and comorbidities might play a 
determining role in the reduced level of physical activity. For example, common 
conditions like arthrosis and osteoporotic fractures reduce the COPD patient’s ability to 
be physically active. Physical activity also has favorable effects on many metabolic and 
cardiovascular risk factors, which might have important implications for the prevention 
as well as management of many common comorbidities in COPD. Therefore, the existence 
of comorbidities needs to be taken into account when investigating physical activity in 
COPD, but also when developing physical activity enhancement programs for COPD 
patients.
The different methods used to classify COPD patients into active versus inactive makes 
it difficult to compare the results. The methods used to measure (accelerometer, 
pedometer, questionnaire and interview) and to express the variations in physical activity 
(e.g., minimal recommended physical activity level, energy expenditure and time spent 
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walking during leisure time) are extremely different. Furthermore, the question arises 
which level of physical activity can be considered as an active lifestyle that could lead to 
health benefits. 
Clearly, more research is necessary to investigate the determinants and consequences 
of an inactive lifestyle in COPD patients, as well as more insight into the best way to 
stimulate the physical activity level in this group of patients. Figure 1 shows a theoretical 
framework of the role and consequences of physical inactivity in COPD, embedded into 
background factors.
The effects of an increase in physical activity are often obtained from research on structured 
exercise or pulmonary rehabilitation programs. These programs have shown significant 
improvements for important patient-centered outcome parameters, and the effects of 
stimulating physical activity during the hospitalization and pulmonary rehabilitation after 
an acute exacerbation are promising. However, owing to the multidisciplinary structure 
of pulmonary rehabilitation programs, it is difficult to identify the isolated role of exercise, 
and it is well-known that the long-term effects of pulmonary rehabilitation in general are 
modest. Programs that focused particularly on the enhancement of physical activity in 
daily life, to change a patient’s lifestyle, also show good results.
Both pulmonary rehabilitation and lifestyle physical activity enhancement seem to 
increase physical activity at least immediately after the program ends. Unfortunately, 
there are no long-term data regarding physical activity after pulmonary rehabilitation 
or lifestyle physical activity enhancement. In the authors’ opinion, it is important that 
especially sedentary COPD patients incorporate the desired increase in physical activity 
into daily life and maintain this behavior. Because most physical activity and pulmonary 
rehabilitation programs do not have a structured aftercare program, much attention 
should be paid to this aspect already during the program. Education, counseling, 
preparing the patients towards the end of the program, transfer to first-line healthcare 
providers and involving family members and colleagues at work might all contribute to a 
successful maintenance of physical activity after discharge. 
We conclude that regular physical activity is positively associated with important health 
outcome parameters of COPD and that it may successfully be improved by structured 
exercise and lifestyle physical activity enhancement programs. Exacerbations and dyspnea 
are probably important threats against maintaining an adequate physical activity level in 
more severe COPD patients. We believe that stimulation of embedding low- or moderate-
intensity physical activity in daily life is important for the long-term effects of specialized 
physical activity programs. Finally, the stimulation of physical activity should already start 
in the early stages of COPD, if appropriate also using high-intensity physical activity to 
prevent a sedentary lifestyle later in life. 


















































































































































































































































































































































In the past decade, physical activity has increasingly been noticed as an important outcome 
variable in COPD and the literature on the role of physical activity in COPD patients is 
growing. The development of performance-based motion sensors (e.g., pedometers and 
accelerometers) which are able to objectively measure the actual performed level of 
physical activity has given an important boost. Accelerometers are more technologically 
advanced devices, which detect body acceleration and are able to determine the quantity 
and intensity of movements. An extensive review on physical activity monitoring in COPD 
can be found in the reference list.3 The results of this new research area are promising and 
indeed suggest that a higher physical activity level is healthy for most COPD patients. 
However, results are still inconsistent, which may be caused by small study samples or 
cross-sectional study designs. Moreover, a lot of different instruments are being used to 
measure physical activity, which complicates the comparison of results. Furthermore, the 
literature on the relationship between physical activity and psychological parameters is 
still limited.
The available literature shows that the physical activity level in COPD is generally low. 
Structured exercise programs show good results, but it is important that COPD patients 
integrate physical activity in their daily life and adopt an active lifestyle. More insight is 
necessary on the determinants of this physical activity level in order to develop more 
efficient programs to stimulate physical activity structurally in COPD patients. In our 
opinion, studies are needed that explore the strategies to enhance physical activity. 
Furthermore, the optimal embedment for these programs in the healthcare system 
needs to be established. Until now, much research has focused on the more severe COPD 
patients, however it is also useful to measure and already stimulate, if necessary, the level 
of physical activity of patients with mild and moderate COPD. This information can lead 
to the development of more structured physical activity enhancement programs that are 
suitable for COPD patients in all severity stages of their disease.
FIVE-YEAR VIEW
We are convinced that the interest in physical activity in COPD will persist and the 
knowledge about the role of physical activity in COPD will grow. We expect that the 
developments in ICT might have a huge influence on this field. The development and 
refinement of the performance-based motion sensors will continue. For example, 
accelerometers at this moment are mostly used in research settings but are becoming 
increasingly easier to use, and thus more applicable at home. Therefore, those instruments 
could be useful tools in the individually tailored stimulation of physical activity in COPD 
patients next to their measuring ability. This could also be useful in the fast developing 
field of home telemonitoring. The combination of these devices and computers/internet 
will provide the ability to give patients feedback on their physical activity level at their 
homes in a less time consuming and expensive manner. In 5 years, we expect that even 
more patients will be familiar with computer and internet use and therefore that these 
methods will become more easily applicable.
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KEY ISSUES
•	 Regular physical activity has important health benefits in general.
•	 The level of physical activity in COPD is low compared with matched controls but also 
with other patient groups.
•	 Physical activity is positively associated with FEV1, dyspnea, exercise capacity, muscle 
function, comorbidities, systemic inflammation, health-related quality of life and 
hospital admissions in COPD patients.
•	 Because of the many health benefits of physical activity in general and especially 
for COPD patients, it is important to improve the level of physical activity in COPD 
patients. 
•	 More research is necessary on the modifiable predictors of a sedentary lifestyle in 
COPD patients.
•	 Structured exercise programs and pulmonary rehabilitation have shown important 
results for important outcome parameters in COPD, but the literature on the effect of 
the level of physical activity is limited and not convincing.
•	 Lifestyle physical activity enhancement should focus more on behavioral change in 
physical activity routines in daily life, and could result in better long-term outcomes. 
Such a strategy can exist next to but also complementary to structured exercise 
programs or pulmonary rehabilitation.
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ABSTRACT
Background: The physical activity level in patients with Chronic Obstructive Pulmonary 
Disease (COPD) is low, and as a modifiable factor, physical activity is a potential treatment 
target. Clinical characteristics only incompletely reflect the physical activity level and 
potential psychosocial predictors are hardly investigated. Aim of this study was to assess 
physical activity and sitting time in COPD patients and to investigate their potential 
physical and psychosocial determinants.
Methods and results: We included 113 COPD patients. Physical activity, measured with an 
accelerometer (24hours/day), showed a mean locomotion and shuffling time per day of 
6.8% (range:0.7-20.4). Reduced levels of physical activity were most prevalent in GOLD 
stage III-IV. Predictors of physical activity were higher self-efficacy, functional exercise 
capacity and lower lung hyperinflation. In GOLD stage I-II, higher self-efficacy and the 
spring/summer season were predictors, whereas in GOLD III-IV, worse lung hyperinflation, 
dyspnea severity, leg muscle function and oxygen use were. Predictors of sitting time in 
the total group were more positive perception on treatment control, less autonomous 
motivation to exercise, not using sleep medication and oxygen use.
Conclusion: In conclusion, both physical and psychosocial factors affected physical activity 
in COPD. The determinants of physical activity in the early stages of COPD were more 
generic, in contrast to the physical and disease-specific determinants in more severe 
stages. The determinants of sitting time were different from those of physical activity.
Keywords: COPD • lung hyperinflation • physical activity • sedentary lifestyle • 
         self-efficacy




Physical inactivity has shown to be a predictor of mortality in patients with Chronic 
Obstructive Pulmonary Disease (COPD).1 Unfortunately, many COPD patients have a 
sedentary lifestyle.2 Physical activity is a modifiable factor and is therefore an interesting 
and potential treatment goal in COPD. Increasing physical activity in these patients 
might be beneficial, since it may break the observed vicious circle of dyspnea-induced 
immobility, and subsequent deconditioning.3 Furthermore, increasing physical activity 
has shown to decrease dyspnea severity and improve muscle function and quality of life.4 
The variation in physical activity between COPD patients is high2 and to be able to reduce 
physical inactivity, it would be useful to explore the determinants of physical activity.   
Physical inactivity could be caused by generic as well as COPD-specific factors. In general 
adult populations female gender, higher age, higher body weight, lower education, health 
problems and lower self-efficacy are shown to be associated with physical inactivity.5,6 
Furthermore, season and weather conditions are known to affect physical activity.7 
COPD-specific factors that could affect the physical activity level are for example: lung 
function, lung hyperinflation, dyspnea severity, body composition, exercise capacity 
and muscle function. In several studies significant associations between these physical 
parameters and physical activity were observed, except for body composition, but results 
were inconsistent.8,9 Since, COPD is a disease with high prevalence of comorbidity,10 
comorbidities could also affect physical activity. For example, joint problems and self-
reported diabetes were shown to be related to reduced physical activity in COPD patients.8 
Additionally, the use of long term oxygen therapy (LTOT), and its subsequent limitation 
in mobility, could influence physical activity. However, the relation between LTOT and 
physical activity is not clear.11,12 
Besides physical factors, psychosocial factors could explain the variation in physical 
activity in COPD patients. Unfortunately, psychosocial factors are less frequently 
investigated. Potential psychosocial determinants of physical activity could be social 
support, motivation to be physically active, depression, illness perception, self-efficacy 
and sleep quality. Studies found a significant association between physical activity and 
self-efficacy in physical activity and no association with depression.8 
In the past decade, knowledge on the determinants of physical activity in COPD patients 
has importantly increased. However, a lot of studies underlying our knowledge had small 
sample sizes or specific COPD populations, and only a few studies investigated potential 
physical and psychosocial determinants. Therefore, it would be interesting to investigate 
whether the above described physical and psychosocial determinants contribute to 
physical activity in COPD patients with a broad range of disease severity.
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The aims of this study are to assess 1) the level and variation of physical activity and sitting 
time in COPD patients; 2) the independent predictors of physical activity and sitting time, 
including physical and psychosocial variables; and 3) the association between physical 
activity and quality of life.
METHODS
Study population
Patients with mild to very severe COPD were recruited at outpatient clinics of general 
hospitals and from general practitioners. Patients were included if their FEV1/FVC ratio 
post bronchodilator was below 0.7. Patients were excluded if they had a serious active 
disease that needed medical treatment (e.g. recent myocardial infarction, carcinoma) or 
treatment for a COPD exacerbation in the past 2 months. The study was approved by the 
local ethics committee and all patients provided informed consent.
Measurements
Physical activity
Physical activity was measured with a triaxial accelerometer, DynaPort (McRoberts, The 
Netherlands). Patients were instructed to wear the accelerometer day and night, for one 
week (24/7). The DynaPort has shown to be an accurate instrument for evaluating gait 
and postures in COPD patients.13 
Biographical factors
Data on medication use, LTOT, number of exacerbations in the past year, smoking status, 
living situation and education level were reported. Seasons were split in two: spring and 
summer (April-September) versus autumn and winter (October-March). Comorbidity was 
assessed by the Cumulative Illness Rating Scale for Geriatrics (CIRS-G).14 
Physical determinants
Pulmonary function Forced expiratory volume in 1 second (FEV1) and forced vital capacity 
(FVC) were measured using a spirometer (PFT, Masterscreen, Masterscope; Viasys) 
and residual volume (RV), total lung capacity and intrathoracic gas volume by body 
plethysmograpy (PFT; Viasys), both according to the ERS/ATS guidelines.15,16 
Dyspnea severity was registered by the modified Medical Research Council dyspnea index 
(mMRC).17
Exercise capacity Maximal exercise capacity was measured by a symptom limited 
incremental cycle ergometer test (Bicycle ergometer: Jaeger ER 900L; Oxycon Pro, 
CareFusion) in line with the ATS/ACCP statement.18 Functional exercise capacity by a 
6-minute-walk-distance test (6MWD) according to the ATS guidelines.19 
Leg muscle function was measured by a 30-seconds chair stand test.20 
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Body composition Fat free mass was measured by bioelectrical impedance (Bodystat-1500) 
and calculated with COPD and gender specific equations.21 Body Mass Index (BMI) was 
calculated.
The BODE index, a multidimensional index combining BMI, FEV1, mMRC and 6MWD was 
calculated.22
Psychosocial determinants
The influence of social support on physical activity was measured by the Dutch version 
of the social support for exercise behaviours scale questionnaire (SSQ).23 Motivation 
to exercise by the Exercise Self-Regulation Questionnaire (SRQ-E).24 Depression by the 
Beck Depression Inventory (BDI).25 Illness perception by the revised version of the Illness 
Perception Questionnaire (IPQ-R).26 Self-efficacy by the Dutch version of the Perceived 
Physical Ability Subscale questionnaire (LIVAS).27 Sleep quality and disturbances by the 
Pittsburgh Sleep Quality Index (PSQI).28
Quality of life and health status
Quality of life was measured by a disease-specific questionnaire, the Saint Georges 
Respiratory Questionnaire (SGRQ)29 and by a generic questionnaire, the RAND-36.30 
Health status by the Clinical COPD Questionnaire (CCQ).31
Statistical analyses
Patients were included in the analyses if they had worn the accelerometer for at least 
4 full days, in accordance with literature.32 A day was considered a valid measurement 
day if the device was worn for at least 94% of the day.33 If patients did not wear the 
accelerometer during the night only, this time was recorded as lying. Physical activity 
outcomes were compared between GOLD stages and calculated quartiles of the BODE 
index using ANOVA or Kruskall-Wallis tests with Holm-Bonferroni adjustment. The sum 
of %locomotion and %shuffling during 24 hours was analyzed as outcome parameter for 
physical activity and %sitting during 24 hours for sitting time. Shuffling was defined as 
all movement from standing to standing that could not be classified as walking because 
of lower intensity or because the number of steps is less than 3. Pearson or Spearman 
correlation coefficients were calculated to test univariate associations between potential 
determinants and %locomotion&shuffling or %sitting, and between quality of life and 
physical activity. Differences between groups were tested using an independent sample 
T-test or a Mann-Whitney-U-test as appropriate for continuous variables. Stepwise 
backward linear regression analysis was performed to identify the independent 
predictors of %locomotion&shuffling or %sitting, with adjustment for age, gender and 
height. Variables were selected into the stepwise backward model if the p-value was <0.2 
in univariate analysis. Table E1 shows the results of the univariate tests and variables that 
were included in the backward linear regression analyses. P-values <0.05 were considered 
statistically significant. Statistical analyses were performed using PASW statistics 18.
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GOLD I (n=30) GOLD II (n=30) GOLD III (n=32) GOLD IV (n=21) p-value
GOLD assessment, A/B/C/D¶ 29/1/0/0 24/4/0/2 0/0/16/16 0/0/3/18
Gender, female 8 (27%) 8 (27%) 10 (31%) 11 (52%) 0.174
Age, year 68.2 ± 8.9 64.4 ± 6.1 67.2 ± 8.2 57.8 ± 8.7 <0.000
Smoking status, current (%) 15 (50%) 9 (30%) 3 (9%) 3 (14%) 0.001
LTOT, yes 0 (0%) 0 (0%) 3 (9%) 11 (52%) <0.001
BMI, kg/m2 24.8 ± 2.1 26.3 ± 4.3 24.1 ± 3.3 25.3 ± 6.1 0.221
FFM, index 17.0 ± 1.9 17.5 ± 2.5 16.3 ± 1.7 16.2 ± 3.0 0.110
FEV1*, % predicted 94 (82- 119) 64 (50- 79) 38 (30-49) 23 (14-29) <0.001
RV, % predicted 122.6 ± 31.3 147.0 ± 36.4 190.7 ± 60.1 247.3 ± 61.6 <0.001
ITGV%TLC, % 59.1 ± 5.5 63.2 ± 6.9 73.1 ± 6.8 78.6 ± 4.5 <0.001
Peak VO2, ml/min/kg 22.4 ± 4.8 19.7 ± 4.0 14.6 ± 3.7 12.0 ± 4.0 <0.001
Peak Workload, watt 135 ± 46 117 ± 34 63 ± 29 35 ± 22 <0.001
6MWD, meter 512 (358- 646) 521 (344- 641) 387 (60-600) 351 (175 - 576) <0.001
mMRC dyspnea, score 1.0 (1-5) 2.0 (1-5) 2.5 (1-5) 4.0 (2-5) <0.001
BODE index, score 0 (0-3) 1 (0-5) 3 (2-8) 6 (3-8) <0.001
CIRS-G, total score 2.5 (0-10) 3.5 (0-6) 3.0 (0-9) 2.0 (0-8) 0.445
CCQ, total score 0.7 (0.2 - 4.6) 1.6 (0-4.6) 1.9 (0.1-4.4) 2.5 (0.6-4.4) <0.001
Self-efficacy, LIVAS total score 33.5 ± 7.7 28.7 ± 8.4 26.8 ± 6.8 27.5 ± 5.6 0.004
SSQ, family positive score 12 (10-24) 14 (10-40) 12 (10-29) 18 (10-39) 0.031
SSQ, family negative score 3 (3-9) 3 (3-7) 3 (3-7) 3 (3-7) 0.456
SSQ, friends positive score 5 (5-16) 5 (5-20) 5 (5-13) 5 (5-16) 0.219
BDI, total score 3.0 (0-25) 5.5 (0-30) 6.0 (1-17) 9.0 (1-22) 0.071
TABLE 1. Patient characteristics per GOLD stage (n=113)
Data are presented as n, mean ± SD or median (range). Differences between groups were tested with ANOVA, Kruskal-
wallis or Chi-Square. ¶Combined COPD assessment with use of the mMRC scale (GOLD 2011). *Post bronchodilator. 
LTOT: long term oxygen therapy, BMI: body mass index, FFM: fat free mass, FEV1: forced expiratory volume in 1 second, 
RV: residual volume, ITGV: intra thoracic gas volume, TLC: total lung capacity, VO2: oxygen uptake, 6MWD: 6-minute 
walk distance, mMRC: modified medical research council, CIRS-G: cumulative illness rating scale for geriatrics, CCQ: 
clinical COPD questionnaire, SSQ: social support for exercise behaviour scale questionnaire, BDI: Beck depression 
inventory.
RESULTS
One hundred and fifteen COPD patients, that were on optimal medication, were included 
in the cross-sectional study and 113 patients (33% female, mean age 65 years and median 
FEV1 52% predicted) wore the accelerometer for at least 4 full days and were included in 
the analyses. Patient characteristics per GOLD stage are shown in table 1.
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FIGURE 1. Distribution of types of activity and steps per GOLD stage or BODE-index quartile.
a) distribution types of activity, mean percentage relative time per 24 hour per GOLD stage. b) distribution 
types of activity, mean percentage relative time per 24 hour per BODE-index quartile. c) steps per day per 
GOLD stage. d) steps per day per BODE-index quartile. BODE quartiles: 1= BODE score 0, 2= BODE score 
1&2, 3=BODE score 3&4, 4=BODE score 5-8. *significant difference between groups; p<0.05.
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Figure 1 shows the physical activity variables per GOLD stage and BODE quartile. 
Locomotion and shuffling time and steps per day did not differ between GOLD stage I and 
II, all other GOLD stages significantly differed, with lower physical activity in more severe 
COPD (table 2). All BODE quartiles significantly differed in locomotion and shuffling time, 
and only BODE quartile I and II did not differ in steps per day (table E1). Furthermore, 
the ranges in physical activity outcomes were large within GOLD stage or BODE quartile. 
Sitting time during the day was not significantly different between GOLD stages or BODE 
quartiles.
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a) Total population (R2 0.56)
Variable B Std. Error p-value
Self-efficacy (LIVAS score) 0.096 0.034 0.006
6MWD (meter) 0.015 0.003 <0.001
RV (liter) -0.612 0.200 0.003
b) GOLD I & II (R2 0.25)
Variable B Std. Error p-value
Self-efficacy (LIVAS score) 0.161 0.051 0.003
Season (0=spring/summer) -1.895 0.745 0.014
c) GOLD III & IV (R2 0.66)
Variable B Std. Error p-value
RV (liter) -0.538 0.170 0.003
Dyspnea (mMRC score) -0.763 0.273 0.008
Chair stand test (number) 0.414 0.097 <0.001
LTOT (0=no) -1.529 0.558 0.009
GOLD I (n=30) GOLD II (n=30) GOLD III (n=32) GOLD IV (n=21) p-value































































TABLE 2. Physical activity per GOLD stage (n=113)
Data are presented as median (range). g= average body acceleration. Differences between groups were tested with 
ANOVA or #Kruskal Wallis with Holm-Bonferroni adjustment. 1There was no difference between GOLD stage I and II, all 
other GOLD stages were significantly different from each other. 2GOLD stage II was significantly different compared 
to GOLD stage III and IV.
TABLE 3. Stepwise backward linear regression analyses with percentage 
locomotion & shuffling as dependent variable
Analyses were adjusted for age, gender and height. 
6MWD: 6-minute walk distance, RV: residual volume, mMRC: modified 
medical research council index, LTOT: long term oxygen therapy.
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Determinants of physical activity (%locomotion and shuffling 24-hours)
Total group
Higher physical activity was significantly associated with higher functional and maximal 
exercise capacity, less airway obstruction, static lung hyperinflation and dyspnea severity, 
better leg muscle function, lower number of exacerbations, better illness perception 
scores (various IPQ-R subscales), lower depression score, higher self-efficacy in physical 
ability and more autonomous motivation to exercise. Physical activity was significantly 
lower in LTOT users and during autumn/winter (table E2). 
Higher self-efficacy, higher 6MWD and lower RV were significant independent predictors 
of higher physical activity (R2=0.56; table 3a). The number of steps per day was associated 
with the same independent predictors.
Mild to moderate COPD (GOLD I and II)
Higher physical activity was significantly associated with higher 6MWD, and physical 
activity was significantly lower in autumn/winter (table E1). 
Higher self-efficacy and physical activity measured in spring or summer were significant 
independent predictors of higher physical activity (R2=0.25; table 3b).
Severe to very severe COPD (GOLD III and IV)
Higher physical activity was significantly associated with higher functional and maximal 
exercise capacity, less airway obstruction, static lung hyperinflation and dyspnea severity, 
better leg muscle function, better subscale score ‘consequences’ of the Illness perception 
questionnaire and lower depression score. Additionally, physical activity was significantly 
lower in LTOT users (table E1). 
Lower RV, less dyspnea severity, better leg muscle function and not using LTOT were 
significant independent predictors of higher physical activity (R2=0.66; table 3c).
Physical activity and Quality of life and health status
Physical activity was significantly associated with all subscales and total score of the SGRQ 
and CCQ (table E3). All subscales of the RAND-36 except for the subscales mental health 
and bodily pain were significantly associated with physical activity.
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a) Total population (R2 0.26)
Variable B Std. Error p-value
LTOT (0=no) 8.143 2.360 0.001
Treatment control (IPQ-R score) 0.627 0.239 0.010
Introjected regulation (SRQ-E score) 1.381 0.560 0.015
Use sleep medication (0=no) -4.511 2.264 0.049
b) GOLD I & II (R2 0.230)
Variable B Std. Error p-value
Introjected regulation (SRQ-E score) 1.722 0.792 0.035
Number of exacerbations (number) 3.312 1.476 0.030
c) GOLD III & IV (R2 0.164)
Variable B Std. Error p-value
LTOT (0=no) 8.449 3.120 0.009
Determinants of sitting time (%sitting 24-hours)
Total group
Higher sitting time was significantly associated with higher number of exacerbations 
in the past year, lower functional exercise capacity and less autonomous motivation for 
exercise (SRQ-E subscales; external regulation and introjected regulation). Sitting time 
was significantly higher in LTOT users, in patients who do not use sleep medication and in 
patients living together with others (table E1). 
More positive perception on treatment control (IPQ-R), higher introjected regulation in 
exercise (‘taking on other’s values’-SRQ-E), not using sleep medication and use of LTOT 
were significant independent predictors of higher sitting time (R2=0.26; table 4a).
Mild to moderate COPD (GOLD I and II)
Higher sitting time was significantly associated with higher fat free mass and more 
positive perception on treatment control (IPQ-R). 
Higher introjected regulation and higher number of exacerbations in the past year were 
significant independent predictors of higher sitting time (R2=0.23; table 4b).
Severe to very severe COPD (GOLD III and IV)
Higher sitting time was significantly associated with external regulation in exercise (‘no 
choice others make me do it’-SRQ-E) and was significantly higher in LTOT users. 
Using LTOT was a significant independent predictor of higher sitting time (R2=0.16; table 
4c).
Analyses were adjusted for age, gender and height. 
LTOT: long term oxygen therapy, IPQ-R: illness perception questionnaire-
revised, SRQ-E: exercise self-regulation questionnaire.
TABLE 4. Stepwise backward linear regression with percentage 
sitting as dependent variable




Our study showed that reduced levels of physical activity were most prevalent in severe 
or very severe COPD patients, and that the variation in physical activity was high, even 
within GOLD stages or BODE quartiles. Physical activity was significantly associated with 
both physical and psychosocial factors. Self-efficacy, functional exercise capacity and 
static lung hyperinflation were identified as important determinants of physical activity. 
The determinants of physical activity in mild to moderate COPD were mainly generic, in 
contrast to the disease-specific determinants in (very) severe COPD. Physical activity was 
positively associated with almost all domains of quality of life and health status. Sitting 
time did not differ between GOLD stages or BODE quartiles and the determinants of 
sitting time differed from those of physical activity.
The largest difference in physical activity was present between GOLD stage II and III 
patients. This is in line with two studies, that furthermore demonstrated comparable 
number of steps/day in the GOLD stages.33,34 The same studies also showed that the 
physical activity level of patients with GOLD stage I was not significantly different from 
matched controls, whereas patients with GOLD stage II did not differ in some physical 
activity outcomes.33,34 This suggest that at approximate 50% of FEV1 %predicted, patients 
start to become limited by their ventilator capacity. Furthermore, we found a high 
variation in physical activity within GOLD stages, which confirms that severity of airway 
obstruction alone does not explain the variation in physical activity. The BODE-index 
(containing besides lung function also exercise capacity, dyspnea and body mass index) 
was slightly stronger correlated with physical activity, however the variation was still high 
within quartiles, confirming that other factors also play a role.
Self-efficacy in physical ability, static lung hyperinflation and functional exercise capacity 
were determinants of physical activity. In line with our results, 2 studies found a positive 
association between self-efficacy and physical activity.35,36 Self-efficacy has shown to 
be a strong predictor of exercise adherence,37,38 and therefore might be an interesting 
treatment target for physical activity enhancement programs. 
RV, contrary to FEV1 was an independent predictor of physical activity. This is in line with 
the finding that lung hyperinflation is stronger associated with patient-centered outcomes 
than FEV1,
39 suggesting that lung hyperinflation is importantly affecting physical activity. 
The finding that the 6MWD is a strong determinant of physical activity in COPD is consistent 
with results from many previous studies.8 Interestingly, cycle ergometry outcomes in our 
study were significantly associated with physical activity but not identified as independent 
determinants. This supports the suggestion that the 6MWD gives a better reflection 
of the physical conditions needed to perform physical activity than a cycle ergometer 
test. Another study also found that 6MWD and lung hyperinflation were independent 
determinants of physical activity, while cycle ergometry outcomes were not.9 
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The determinants of physical activity were different between GOLD stages. In mild to 
moderate COPD patients, self-efficacy and season were identified as determinants. 
Probably, COPD patients in an early stage are less restricted by their disease and more 
influenced by general factors. These results suggest that improving self-efficacy in 
physical ability might be an attractive treatment target in an early stage of COPD. 
Furthermore, the influence of weather type on physical activity should be reduced, for 
example by discussing with the patient back-up activities in case of bad weather. Perhaps, 
COPD-specific physical activity enhancement is not necessary in the early disease stages, 
but to prevent physical inactivity in later stages, sedentary lifestyles should already be 
addressed. In (very) severe COPD patients, higher RV, higher dyspnea severity, worse leg 
muscle function and LTOT use were identified as determinants of low physical activity. 
These are more physical disease-specific factors. Apparently, symptoms are the main 
limiting factor for physical activity in more severe COPD.
A number of variables that we expected to be associated with physical activity were not, 
e.g. social support, sleep quality, comorbidity and body composition. Social support 
has been shown to improve exercise behaviour.40 In our study, COPD patients reported 
low social support scores and therefore might hardly experience social support in that 
perspective. Involving significant others in the enhancement of physical activity could be 
important. Poor sleep quality could lead to fatigue during the day and consequently lower 
physical activity. However, although 29% of our patients were identified as poor sleepers 
(assessed by PSQI score> 528) we found no association between sleep quality and physical 
activity. Contrary to other studies, we found no association between comorbidity and 
physical activity. An explanation could be that other studies used specific disease groups 
and not a composite index-score like we did. In our sample the numbers of patients in 
specific disease groups were too small to analyse separately. In line with previous studies 
in COPD we found no association between physical activity and fat free mass or BMI.8 
Apparently, in COPD patients body composition does not affect physical activity, in 
contrast to the general elderly population.5 
Unexpectedly, sitting time during the day did not differ significantly between GOLD 
stages and BODE quartiles. However, patients with GOLD stage III-IV sat approximately 40 
minutes per day longer than patients with GOLD stage I-II. This could be clinically relevant 
as sitting time has found to be associated with an increased risk of mortality, even 
independent of leisure time physical activity.41 Our study demonstrated that the explained 
variances of the regression models with sitting time as dependent variable were much 
lower than those of physical activity models, indicating poorer predictive properties. This 
finding is consistent with one study in COPD patients and one in a general population.42,43 
The determinants of sitting time were more positive perception on treatment control, less 
autonomous motivation for physical activity, not using sleep medication and use of LTOT. 
The use of LTOT is clearly interfering with the mobility of the patients. Less autonomous 
motivation for physical activity could indicate a passive attitude towards the disease and 
physical activity, while the association between more positive perception on treatment 
control and higher sitting time is not clear. Opposite to what we expected, use of sleep 
medication was associated with lower sitting time. However, the patients that used sleep 
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medications also had a higher lying time compared to the patients who did not use sleep 
medication. Apparently, this subset of patients might lay down rather than sit down 
during the day when feeling tired.
A strength of the study is that we investigated COPD patients from all severity stages 
of the disease, using an extensive list of both physical and psychosocial measurements. 
Unfortunately, we did not measure inflammation, which was also shown to affect physical 
activity.44 Furthermore, our study lacked a control group and it would be interesting to 
investigate if determinants of physical activity differ between healthy subjects and 
COPD patients. Another strength of the study was measuring physical activity with a 
well-validated triaxial accelerometer.13 However, this device is not able to measure non-
ambulatory activities, like cycling or swimming. This may have led to underestimation of 
physical activity. We choose to use the percentage of activity or sitting during 24 hours, 
to include all physical activity and sitting time during the day. Unfortunately, there is no 
consensus yet on physical activity measurement duration of the day in COPD research, 
which makes it difficult to compare outcomes.
In conclusion, both physical and psychosocial factors affected physical activity in COPD 
patients. Decreased physical activity was strongest in more severe stages of the disease, in 
which the patients were mainly limited by physical disease-specific factors. In less severe 
COPD patients the determinants of physical activity were more generic and less COPD-
specific. Our results could be useful for identifying starting points in the enhancement of 
physical activity in COPD patients with a sedentary lifestyle in all severity stages of the 
disease.
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BODE I (n=37) BODE II (n=32) BODE III (n=22) BODE IV (n=22) p-value
Steps, per day 7906 6689 3940 1827 <0.001#1
(3556-18433) (3557-14281)  (1082-8944) (236- 6737)
Locomotion & shuffling time, % per day 9.1 7.6 5.1 2.6 <0.0012
(4.9-20.4) (4.4-15.3) (1.2-8.8) (0.7-8.1)
Standing time, % per day 13.3 12.4 12.8 11.1 0.301
(6.0-24.1) (5.5-19.7) (4.1-30.8) (3.7-22.4)
Sitting time, % per day 36.4 35.7 39.4 40.8 0.513
(22.6-49.1) (21.0-50.6) (13.3-64.4) (18.8-55.8)
Lying time, % per day 40.3 39.3 40.9 45.9 0.183#
(31.1-55.5) (29.5-59.6)  (30.3-73.2) (35.0-67.6)
Physical Activity Level (PAL) 1.73 1.67 1.55 1.45 <0.0012
(1.51-2.04) (1.45-1.98) (1.35-1.84) (1.32-1.57)
Movement intensity locomotion, g 0.202 0.191 0.178 0.169 <0.001#3
(0.151-0.302) (0.133-0.286) (0.130-0.257) (0.131-0.221)
SUPPLEMENTARY DATA
TABLE E1. Physical activity per BODE quartile (n=113)
Data are presented as median (range). g= average body acceleration.
Differences between groups were tested with ANOVA or #Kruskal-wallis with Holm-Bonferroni adjustment. 
1There was no difference between BODE quartile I and II, all other BODE quartiles were significantly different from 
each other. 2All BODE quartiles were significantly different.  3BODE quartile II was significantly different compared to 
BODE quartile III and IV.
Legend table 2a:
All values are Spearman’s rho, except for #Pearson correlation coefficient.*p<0.20, **p<0.05, ***p<0.001, the 
variables indicated with these symbols were included in the regression analyses. ¶post bronchodilator. FEV1: forced 
expiratory volume in 1 second; FVC: forced vital capacity; RV: residual volume, ITGV: intra thoracic gas volume; BMI: 
body mass index; FFM: fat free mass; VO2: oxygen uptake; 6MWD: six-minute walk distance; CIRS-G: cumulative illness 
rating scale for geriatrics; mMRC: modified medical research ; IPQ-R: illness perception questionnaire-revised; BDI: 
beck depression inventory; LIVAS: dutch version of the perceived physical ability subscale questionnaire; SRQ-E: self-
regulation questionnaire- exercise; PSQI: Pittsburgh sleep quality index.
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Total group (n=113) GOLD I + II (n= 60) GOLD III + IV (n= 53)
%locomotion 
& shuffling
%locomotion   
& shuffling
%locomotion 
& shuffling%sitting %sitting %sitting
Physical factors Correlation coefficient Correlation coefficient Correlation coefficient
Age, year # 0.183* 0.098 0.015 0.180* 0.209* 0.092
Height, cm # 0.094 0.067 -0.004 0.146 -0.024 0.056
Packyears, year 0.023 -0.001 -0.146 -0.077 0.000 0.074
Exacerbations, number -0.312** 0.261** -0.038 0.227* -0.245* 0.195*
FEV1¶, liter 0.621*** -0.141* 0.029 0.130 0.478*** -0.057
FEV1/FVC¶, % # 0.578*** -0.156* 0.003 -0.063 0.458** -0.053
RV, liter # -0.520*** 0.078 -0.090 -0.090 -0.426** 0.024
ITGV/TLC, % # -0.576*** 0.162* -0.066 -0.054 -0.456** 0.176
BMI, kg/m2 # 0.026 0.086 -0.049 0.263** -0.077 0.013
FFM, index # 0.156* 0.054 -0.007 0.294** 0.071 -0.061
Peak VO2max, ml/min/kg # 0.503*** -0.047 0.046 0.084 0.511*** -0.073
Peak Workload, watt # 0.569*** -0.098 0.056 0.124 0.624*** -0.134
6MWD, meter 0.744*** -0.233** 0.438*** -0.123 0.735*** -0.219*
CIRS-G, total score 0.013 -0.097 0.115 -0.005 -0.053 -0.151
mMRC, score -0.609*** 0.105 -0.081 0.008 -0.603*** -0.076
Chair stand, number # 0.404*** -0.173* 0.200* -0.119 0.528*** -0.170
Psychosocial factors
IPQ-R, consequences # -0.464*** 0.067 -0.190* 0.166 0.296** -0.118
IPQ-R, Treatment control # 0.153* 0.176* 0.005 0.275** 0.139 0.154
IPQ-R, Illness coherence # -0.168* -0.036 0.024 -0.103 0.003 -0.064
IPQ-R, emotional representations -0.233** 0.024 -0.076 0.198* -0.226* -0.156
Depression, BDI total score -0.229** 0.009 -0.076 0.059 -0.278** -0.090
Self-efficacy, LIVAS total score # 0.324*** -0.082 0.202* -0.021 0.237* -0.071
SRQ-E, RAI index # 0.210** -0.124* 0.130 -0.036 0.191* -0.151
SRQ-E, external regulation -0.227** 0.245** -0.018 0.132 -0.316** 0.302**
SRQ-E, introjected regulation -0.197** 0,198** -0.043 0.207* -0.283** 0.219*
SRQ-E, identified regulation 0.046 0.109 0.273** 0.061 -0.097 0.137
SRQ-E, intrinsic motivation 0.094 -0.046 0.163 -0.077 -0.023 0.022
Social support, family positive -0.075 0.045 0.035 -0.072 -0.126 0.041
Social support, familiy negative 0.012 -0.030 0.040 -0.052 -0.044 -0.027
Social support, friends positive 0.070 -0.005 0.050 -0.008 -0.028 0.062
Sleep quality, PSQI total score 0.023 -0.047 -0.067 -0.072 0.034 0.002
TABLE E2a. Univariate associations between potential predictor variables and percentage 
locomotion & shuffling or percentage sitting
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CCQ Correlation coefficient p-value
Symptom -0.257 0.006
Functional state -0.476 <0.001
Mental state -0.298 0.001
Total score # -0.418 <0.001
SGRQ
Symptoms # -0.255 0.007
Activity # -0.558 <0.001
Impacts -0.479 <0.001
Total score # -0.503 <0.001
RAND-36
Physical functioning 0.578 <0.001
Social functioning 0.281 0.003
Role physical 0.478 <0.001
Role emotional 0.235 0.012
Mental health 0.060 0.530
Vitality # 0.247 0.008
Bodily pain 0.008 0.934
Health perceptions # 0.285 0.002
TABLE E3. Univariate association between quality of life 
or health status and percentage locomotion & shuffling 
in the total group (n=113)
All Spearman’s rho, except for #Pearson correlation coefficient. 
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ABSTRACT
Background: The level of physical activity in COPD patients is low, however qualitative 
data on why some patients are active and others are sedentary are scarce. Aim of this 
study was to investigate the personal reasons why COPD patients are physically active 
or sedentary using qualitative research methods, and to assess the relationship between 
those reasons and the actual measured level of physical activity.
Methods: We included 115 patients with mild to very severe COPD (68% male, mean age 
65 years, FEV1 57.5%predicted). Patients underwent a semi-structured interview.
Results: The most frequently reported reason to be physically active was health benefits, 
followed by enjoyment, continuous active lifestyle in the past and functional reasons. 
The most frequently reported reason to be sedentary was weather, followed by health 
problems and lack of intrinsic motivation. Mean steps per day ranged between 236 
and 18433 steps (tri-axial accelerometer). A high physical activity level was related to 
enjoyment and self-efficacy in physical activity. A low physical activity level was related 
to weather influencing health, financial constraints, health and shame. 
Conclusions: In conclusion, we identified important facilitators and barriers to be physically 
active, which is very useful for the enhancement of physical activity in sedentary COPD 
patients. 
Keywords: COPD • interview • physical activity • sedentary lifestyle • self-efficacy




Regular physical activity has many health benefits for the general population including 
patients with Chronic Obstructive Pulmonary Disease (COPD).1 Although COPD is a 
chronic progressive disease, regular physical activity has shown to improve exercise 
capacity and muscle function, and to decrease feelings of fatigue and dyspnea.2 These 
benefits increase the independence of the patients and improve their quality of life. 
Furthermore, physical activity has shown to be an independent predictor of mortality 
in COPD.3,4 Despite the observed beneficial health effects of regular physical activity in 
COPD, the physical activity level appears to be low.5
As it is important to increase the physical activity level in COPD patients, it is necessary 
to unravel its determinants. Several studies found significant associations between 
physical activity and lung function, dyspnea severity, exercise capacity, muscle function, 
comorbid conditions, systemic inflammation, self-efficacy in physical activity and health-
related quality of life.6 We may conclude that the main focus is on physical determinants, 
leaving the potential large role of psychosocial or behavioural determinants neglected. 
Furthermore, it also has been shown that improving these features, e.g. by following a 
pulmonary rehabilitation program, does not automatically lead to a higher physical 
activity level.7
To be able to increase the physical activity level of COPD patients it would be very helpful 
to gain more insight in the patients’ own thoughts and ideas on physical activity. Exploring 
the reasons why COPD patients are physically active or sedentary and the opportunities 
and barriers they experience, could provide additional information and starting points to 
stimulate physical activity in these patients. A good method to investigate the reasons 
to be physically active or sedentary is by performing qualitative research (e.g. by means 
of an interview), because this will provide detailed insight in behavioural aspects related 
to physical activity. Frequently reported reasons to be physically active in the general 
elderly population are: health concerns, socialization, facilities, physician encouragement 
and purposeful activity, whereas frequently reported reasons to be sedentary are: lack 
of time, fear of injury, tiredness, lack of discipline, inadequate motivation, boredom, 
intimidation (afraid to slow others down), poor health, physical environment, lack of 
knowledge and understanding the relationship between physical activity and health.8-10 
However, to be able to increase the physical activity level particularly in COPD patients 
we assume it is necessary to identify COPD-specific reasons to be physically active or 
sedentary. To our knowledge, the personal reasons to be physically active or sedentary 
are hardly studied yet using qualitative research methods in COPD patients. Furthermore, 
it would be interesting to investigate how these personal reasons relate to the patient’s 
physical activity level. We suggest this could lead to a tailor made strategy to enhance 
daily physical activity in COPD patients.
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The aim of this study is to gain insight in the personal reasons why COPD patients are 
physically active or sedentary using qualitative research methods. Additional aim is to 
assess the relationship between those reasons and the actual measured physical activity 
level of these patients.
METHODS
Patients with mild to very severe COPD were asked by their general practitioner or lung 
physician at outpatient clinics of general hospitals in the northern part of the Netherlands 
to participate in this study. Patients were included in this cross-sectional study if they 
had COPD according to the GOLD criteria.11 Comorbidity was allowed but patients were 
excluded if they had serious active disease that needed medical treatment (e.g. recent 
myocardial infarct, carcinoma), or if they were treated for a COPD exacerbation in the past 
2 months. All patients provided informed consent and the study was approved by the 
local ethics committee.
Interview
All patients were interviewed at home by one trained interviewer (JH) and the duration 
of the interview was approximately one hour. The interviews were semi-structured; a 
framework of themes related to physical activity guided the interviewer. The framework 
of themes was based on literature and finalised after discussion with medical experts 
and 2 COPD patients. The themes were: history of physical activity, experiences with 
physical activity, reasons to be physically active or sedentary, cognitions about physical 
activity and opportunities and barriers to become physically active. Interview questions 
were open and the framework guided the interviewer but unanticipated themes were 
allowed. During the interview the interviewer made notes and those were written down 
extensively directly after the interview. 
Analyses
Answers to the questions raised during the interview were coded into categories using 
the inductive content analysis approach. The aim of this qualitative research technique 
is to attain a condensed and broad description of the phenomenon and the outcome of 
the analysis are categories describing the phenomenon.12 The approach includes open 
coding, creating categories and abstraction.12 Each interview transcript was red several 
times, and afterwards keywords in the text were labelled with codes and grouped into 
similar concepts, after that categories were formed. To increase consensus, the coding 
process was separately performed by 2 persons (JH and MG) and afterwards compared 
and discussed. Disagreements were resolved through discussion with the other authors. 
We combined the qualitative analysis with a quantitative analysis to be able to assess 
the relationship between the personal reasons and the actual measured physical activity 
level. 
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Sex, male (%) 78 (68)
Age, years 65 ± 8.7
GOLD, I/II/III/IV 30/31/33/21
FEV1, % predicted 57.5 ± 27.8
Employed, yes (%) 13 (11.3)
BMI, kg/m2 25.1 ± 4.0
6MWD, meter 437 ± 118
mMRC, score 2.4 ± 1.2
Physical activity (n=113)
Steps, per day 5552 (236-18433)
Lying & sitting, % 79.8 ± 7.2
To assess the relation between the obtained categories and the actual physical activity 
level, a k-means cluster analysis was performed using PASW statistics 18 (SPSS Inc., 
Chicago, IL, USA). Cluster analysis is a descriptive statistical method that attempts to 
identify relatively homogeneous groups of patients based on patient characteristics.
Physical activity
Physical activity was measured with a triaxial accelerometer: DynaPort (McRoberts, The 
Netherlands). The DynaPort is a small device that is worn around the waist. Patients were 
instructed to wear the DynaPort continuously for one week, except during showering 
and swimming. The DynaPort is able, int. al. to detect types of (in)activity and to measure 
steps. The DynaPort has shown to be an accurate instrument to measure postures and 
gait in older adults and COPD patients.13,14 
Other measurements
Lung function (forced expiratory volume in 1 second and forced vital capacity) was 
measured by trained lung function technicians with a spirometer (PFT, Masterscreen, 
Masterscope; Viasys) according to the ERS/ATS guidelines.15 Dyspnea severity was 
determined by the modified medical research council dyspnea index.16 Exercise capacity 
was measured with the 6-minute-walk distance test.17
RESULTS
A total of 115 COPD patients were included and interviewed and performed all other 
measurements. Patient characteristics are shown in table 1. Patients were predominantly 
male (68%), with mild to very severe COPD and with a median number of steps per day of 
5552. Twenty-eight percent of these patients claim they should be more physically active, 
47% claim to be sufficiently active and 25% claim they are not able to be more physically 
active due to health problems. 
TABLE 1. Patient characteristics (n=115)
Data are presented as n (%), mean ± SD or number/n/n/n. GOLD: 
Global Initiative for Chronic Obstructive Lung Disease, FEV1: forced 
expiratory volume in 1 second, 6MWD: 6-minute walk distance, 
BMI: body mass index, mMRC: modified medical research council 
dyspnea index.
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Based on the coding analysis, several categories were distinguished (figure 1). Topics of 
the categories were: reasons to be physically active, reasons to be sedentary, history of 
physical activity, subjective experience on physical activity, barriers to become physically 
active and the influence of social support and stress on physical activity. The reasons to 
be physically active could be categorized into 4 categories. The most frequently reported 
reason to be physically active was health benefits (reported by 65% of the patients), 
followed by enjoyment (44%), continuous active lifestyle in the past (28%) and functional 
reasons (26%). An example of a reported functional reason is that physical activity is 
necessary for certain daily life activities, like transportation or gardening. The reasons to 
be sedentary could be categorized into 3 categories and there were 18 answers that did 
not fit into a category. The most frequently reported reason to be sedentary was poor 
weather (48%), followed by health problems (43%) and lack of intrinsic motivation (11% 
In addition 20% of the patients reported to have no reason to be sedentary.
Reasons to be physically active
Health benefits 65.2%
Enjoyment 43.5%
Continuous active lifestyle in the past 27.8%
Functional 26.1%
Number of reasons reported, (n 1/2/3/4) 47/57/5/6
Reasons to be sedentary
Poor weather 47.8%
Health problems 42.6%
Lack of intrinsic motivation 11.3%
Miscellaneous answers 15.7%
None 20.0%
Number of reasons reported, (n 0/1/2/3) 23/54/35/3




High self-efficacy in DPA 85.2%
History of physical activity
Gymnastics at school 87.8%
Sports after age 30 48.7%




Positive and negative 3.5%
None, not applicable 46.9%




Barriers to become physically active
Weather 74.8%
Health 67.8%
Weather health specific 53.0%
Financial constraints 32.2%
Not able to pay money 20.2%
Not willing to pay money 12.3%
Sleep 9.6%
Physical activity facilities in neighbourhood 7.0%




Positive influence on physical activity 18.3%
Negative influence on physical activity 13.0%
None, not applicable 67.8%
FIGURE 1. Categories distinguished from the interview answers, using an inductive content analysis 
approach (n=115)
Data are presented as percentage patients that reported a specific reason. Or in case of ‘number of 
reasons reported’ as the number of patients that reported that number of reasons n/n/n/n.
                                                                                                           Qualitative analysis on physical activity in COPD
67
4
On average, patients reported 1.7 (range 1-4) reasons to be physically active and 1.2 (range 
0-3) reasons to be sedentary. Positive social support for physical activity was reported by 
almost 50% of the study population, this included social support from spouse, exercise 
group/partner, clinician, family and friends. Only a small group of patients (19%) feel that 
the experienced social support positively influences their physical activity level.
Figure 2 shows that there is a large variability in physical activity preferences. 
Approximately one-third of the patients prefer going to a health club or performing a 
sport activity, while 25% of the patients prefer lifestyle activities, like walking or gardening. 
Over 40% prefers a combination of both types of physical activity. Additionally, 40% of the 
patients prefer being physically active together with others, 30% alone and 30% prefer a 
combination of both. The patients who prefer sports or the health club prefer more often 
being physically active together and the patients who prefer lifestyle activities prefer 
more often to be physically active alone.
113 patients wore the accelerometer for at least 4 complete days and were included 
in the k-means cluster analysis. The cluster analysis formed 2 clusters, one cluster with 
a high physical activity level (n=52) and one cluster with a low physical activity level 
(n=61). Table 2 shows the results of the cluster analysis. A high physical activity level 
was related to being physically active because of enjoyment and high self-efficacy in 
physical activity. A low physical activity level was related to being sedentary because 
of poor weather influencing health, financial constraints, health problems and shame 
to be physically active. The cluster with a high physical activity level was characterized 
by higher lung function and exercise capacity and less dyspnea severity compared with 
the cluster with low physical activity level. Gender and age did not differ significantly 
between clusters.




FIGURE 2. Physical activity type preferences
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DISCUSSION
The identification of personal perspectives about physical activity is important because 
it increases our knowledge on the facilitators and barriers of physical activity in COPD 
patients. Our results show that the most frequently reported reason to be physically 
active was health benefits, followed by enjoyment, continuous active lifestyle in the past 
and functional reasons. The most frequently reported reason to be sedentary was poor 
weather, followed by health problems and lack of intrinsic motivation. 
Additionally, we could identify several factors that were related to the actual measured 
physical activity level. A high physical activity level was related to the following 2 
facilitators: enjoyment and self-efficacy in physical activity. A low physical activity level 
was related to the following 4 barriers: weather influencing health, financial constraints, 
health problems and shame.
Facilitators
An identified facilitator of physical activity was enjoyment. This is in line with a review 
that also showed that perceived exercise enjoyment and satisfaction predict higher levels 
Cluster 1 (n=52)  
High physical activity
Cluster 2 (n=61) 
Low physical activityVariable p-value
Steps per day, steps 8807.4 3331.9 <0.001
Gender, (0=male) 0.27 0.38 0.227
Age, years 65.6 64.4 0.502
FEV1, % predicted 71.6 45.5 <0.001
mMRC dyspnea, score (1-5) 1.8 2.9 0.000
6MWD, meter 511.5 373.9 <0.001
Answers on the interview
Reasons to be physically active 
Enjoyment 0.56 0.33 0.014
Self-efficacy in physical activity (1= high self-efficacy) 0.94 0.79 0.018
Reasons to be sedentary
Weather, health specific 0.38 0.66 0.004
Financial constraints 0.12 0.49 <0.001
Health  0.52 0.80 0.001
Shame 0.00 0.08 0.035
TABLE 2. K-means cluster analysis (n=113)
The cluster analysis shows the interview variables that were significantly different between the clusters. Reasons to 
be physically active or sedentary were coded as 0= not present, 1= present. Therefore, a higher score indicates that 
the specific reason was more present in that cluster. FEV1= forced expiratory volume in 1 second; mMRC= modified 
medical research council dyspnea index; 6MWD= 6-minute walk distance.
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of physical activity and adherence to exercise in 2 general adult populations.18 Another 
identified facilitator was high self-efficacy in physical activity. Self-efficacy is someone’s 
belief in his/her capabilities to successfully execute a specific type of behaviour, in this 
case physical activity. High self-efficacy was found to be more present in mild to moderate 
COPD patients than (very) severe COPD patients and more in males than in females. It is 
known that self-efficacy is a strong and consistent predictor of exercise adherence and that 
it is essential for the process of behavioural change.9,19,20 Furthermore, 2 studies in COPD 
patients showed that physical activity was positively associated with self-efficacy.21,22 This 
emphasises the importance of enjoyment of physical activity and self-efficacy in physical 
activity for adherence to a physically active lifestyle. 
Barriers
An identified barrier in being physically active was weather type, 75% of the patients 
reported poor weather as a barrier to become physically active. Mostly, patients reported 
disease-related complaints caused by different weather types, like more dyspnea with 
high humidity in the air. This is in line with studies in general but also COPD populations, 
showing that weather affects exercise adherence and physical activity levels.23-25 A second 
barrier was health problems. Health as a barrier was mainly due to COPD-related complaints 
like dyspnea, but also other comorbidities were reported to affect physical activity, like 
joint problems. Health as a barrier was more frequently reported in (very) severe COPD 
patients. Health was also the most frequently reported reason to be physically active. 
Despite health-related limitations many patients also understand the benefits of regular 
physical activity for their health. These results are in line with those found in an elderly 
population.8 A third barrier was financial constraints. Financial constraints were reported 
by almost a third of all patients. Financial constraints included patients that were not able 
to pay for physical activity or were not willing to. In general elderly populations, financial 
constraints are not among the most frequently reported reasons to be sedentary.8-10 
However, in our COPD population it appears to be an important factor. A last barrier was 
shame. The reasons to feel ashamed, limiting these patients in physical activity, were use 
of a walking aid with sometimes an oxygen cylinder or having to exercise with healthy 
people. Patients that reported this barrier all had very severe COPD and were mainly 
female. Partly, this is similar to a frequently mentioned reason in the general elderly 
population: intimidation; afraid to slow other people down during physical activities.8
Behavioural change theories
Several theories exist on behavioural change and may explain adherence to physical 
activity. Adherence to physical activity seems to be promoted by the presence of 
individual needs, personal level of fitness, readiness for behavioural change, self-efficacy 
and social support.26 In line, we found that individual needs, personal level of fitness and 
self-efficacy were related to physical activity in COPD patients. Importance of individual 
needs was reflected by our finding that enjoyment in physical activity is important, as 
was the high variability in individual preferred type of activity. Readiness for change 
in behaviour was not a theme of the interview. In contrast with those theories, the 
influence of social support on physical activity was not clear in our population. Although 
a large group of patients report positive social support on physical activity, they do not 
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feel that the experienced social support influences their actual physical activity level. 
Furthermore, we identified some disease specific barriers in physical activity in COPD 
patients that are not specifically present in the behavioural change theories; health, 
financial constraints, weather and shame. Additionally, lack of time, a frequently reported 
reason to be sedentary in the general elderly population, was only reported by 3 patients 
in our sample. Consequently, lack of time appears not to be an issue in our COPD patients. 
Remarkably, tiredness or poor sleep quality and fear of movement were not reported 
frequently as reasons to be sedentary.
Strengths and weaknesses of the study
This study is unique because of the large heterogeneous population of COPD patients 
we have studied and its qualitative design. Our population included 115 COPD patients 
in all severity stages of the disease and therefore allows conclusions about the full range 
of COPD patients. The use of qualitative research methods allows us to gain more insight 
in the personal thoughts and ideas on physical activity, especially when no suitable 
questionnaire is available. A disadvantage of the current study is that due to the relatively 
high number of patients, the interviews were not audio-taped and transcribed verbatim. 
Furthermore, we also measured physical activity in a performance based manner which 
gave us the possibility to compare the personal answers to the actual measured physical 
activity level.
 
Practical implications of the study
To be able to use our results in daily practice and to develop and optimize physical 
activity enhancement strategies in COPD, the practical implications of our results will be 
discussed in the next section. Three important implications useful for the enhancement 
of physical activity can be distinguished, namely reducing barriers and increasing insight 
in health benefits, tailoring type of activity and improvement of self-efficacy.
Reducing barriers and increasing insight in health benefits COPD patients pose a challenge, 
because they feel limited by their health problems to increase their physical activity level, 
but in the same time are aware of potential benefits of regular physical activity. Frequently, 
the balance is in favour of feelings of limitation because health as a barrier was related 
to low physical activity and because benefit awareness was not related to high physical 
activity. This implicates that we first should try to dissolve false perceptions on barriers 
for physical activity, and after that increase insight in the many potential health benefits 
of regular physical activity. In our opinion, removing barriers is not only an educational 
process, but should also be achieved with real-life physical activity experiences, for 
example with help of a physical therapist.
Tailoring type of activity The large variability in types of preferred physical activity between 
COPD patients suggests that one standardised physical activity program will not be 
suitable. Patients should not be forced to participate in one standard physical activity 
program, but programs should be discussed and chosen together with the patient. A 
clinician or physical therapist may discuss all options together with the patient, particular 
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in those patients with a limited activity history, taking potential barriers in account like 
financial constraints and shame to exercise with healthy people or shame of using a 
walking aid. Additionally, the possible influences of weather on adherence to regular 
physical activity should be discussed with the patient. This could include talking about 
back-up activities in case of poor weather, e.g. the possibility of exercising at home.
Improvement of self-efficacy Increasing self-efficacy in physical activity means improving 
the patient’s own judgment on the ability to perform certain physical activities. Factors 
that have shown to increase self-efficacy and that could be incorporated in physical 
activity programs are performance experience, vicarious experience (modelling), social 
persuasion and physiological and emotional arousal.27 Improving physical activity 
performance experiences, could be accomplished during physical activity programs 
for example with help of a physical therapist. Starting with easy to perform physical 
exercises will be attractive because patients will first experience success instead of failure. 
During these programs social modelling and social persuasion is important, which 
could be achieved by group-orientated physical activity programs, physical activity with 
friends or family, or encouragement of a physician or physical therapist. The decrease of 
physiological and emotional arousal could be achieved by monitoring certain parameters 
during physical activity like blood oxygen saturation, blood pressure or Borg score, or, if 
warranted, teaching the patient stress management techniques. 
In conclusion, this study using a qualitative approach, shows for the first time the 
personal reasons of COPD patients to be physically active or sedentary and the relation 
with the actual measured physical activity level. Furthermore, we identified 3 important 
recommendations for enhancing physical activity in COPD patients. The results increase 
our knowledge on the facilitators and barriers in physical activity, which could be very 
useful for enhancing physical activity in this patient group with a very high percentage 
of physical inactivity.
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ABSTRACT
Background: Various physical activity recommendations exist, but those are hardly 
studied in COPD. This study compared different recommendations and investigated their 
suitability for COPD patients. 
Methods: We compared 7 different physical activity recommendations. The 
recommendations differed in frequency, intensity and time and were measured with an 
accelerometer, pedometer or questionnaire in 115 mild to very severe COPD patients 
(68% male, mean age 65 years, mean FEV1 57.5%predicted). 
Results: The percentage of patients that met the different recommendations ranged from 
22 to 86% and only 8 patients met all 7 recommendations. The agreement between the 
different recommendations was poor (ICC: 0.28). Individualizing the recommendations 
by adopting the intensity to a patient’s aerobic fitness level resulted into a higher number 
of GOLD stage III and IV patients meeting the relative recommendations compared to the 
absolute recommendations. In contrast, GOLD stage I and II patients less frequently met 
the relative recommendations.
 
Conclusions: Our study showed that applying various physical activity recommendations 
with small differences in frequency, intensity or time led to large differences in the 
classification of COPD patients into sufficiently physically active or not. Consequently, 
the used recommendation will highly affect the proposed physical activity advice to the 
patient.
Keywords: COPD • health benefits • physical activity 




Regular physical activity is known to have important health benefits and may limit the 
development and progression of chronic disease.1 As a sedentary lifestyle is frequently 
present in all severity stages of Chronic Obstructive Pulmonary Disease (COPD), 
increasing physical activity has become an important treatment target in these patients.2 
However, once adopting the fact that physical activity should be enhanced in sedentary 
COPD patients, the question rises how much physical activity is needed to obtain health 
benefits, in order to be able to give a tailored advice to the patient.
Approximately 40 years ago the first physical activity recommendation was published.3 
Currently, the physical activity recommendations of the American College of Sports 
Medicine (ACSM) for adults, which are in line with the recommendations of the World 
Health Organization (WHO), are often used.4-6 The ACSM guidelines recommend that 
adults should engage in moderate-intensity aerobic physical activity for a minimum 
of 30 minutes on 5 days each week or vigorous-intensity aerobic physical activity for a 
minimum of 20 minutes on 3 days each week, or an equivalent combination of both.4,5 
Apart from aerobic exercises, resistance, neuromotor and flexibility exercises are also 
recommended. However, the focus of our current study is on aerobic physical activity.
The recommendations are hard to apply as it is difficult to discriminate light, moderate 
or vigorous-intensity physical activity from another. A frequently used measure in this 
perspective is metabolic equivalent of task (MET), of which 1 MET is the rate of energy 
expenditure while sitting at rest. An extensive compendium of physical activities has 
been created in which MET values are measured for various activities.7 However, the 
intensity estimations in this compendium are absolute and do not take into account 
individual determinants of physical activity like body weight, gender and fitness level. 
The latest ACSM guidelines also describe several relative estimations of intensity, which 
can be used to discriminate between intensities for the individual. These individualized 
physical activity recommendations could be more appropriate, particularly for elderly 
and deconditioned persons.8 
In general, physical activity recommendations are mainly based on healthy adults, while 
recommendations for adults with a chronic illness are less clear. The WHO states e.g. those 
adults who cannot reach the recommendations due to health problems, should be ‘as 
physically active as their abilities and conditions allow’.6 The ACSM advocates adjusting 
the recommended intensity of physical activity to the adult’s aerobic fitness level and to 
use the relative estimations of intensity for elderly with a chronic illness.8 
So far, physical activity recommendations are hardly studied in COPD patients. It would 
be interesting to know if the various recommendations using different instruments are 
applicable in COPD patients in all stages of the disease. 
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The aim of this study is to compare various physical activity recommendations, using 
both absolute and relative estimations of intensity, in mild to very severe COPD patients. 
Furthermore, to investigate whether these recommendations are associated with 
measures of functional capacity.
METHODS
Mild to very severe COPD patients were recruited from general practitioners and 
outpatient clinics of general hospitals. Patients were included if their post bronchodilator 
FEV1/FVC ratio was below 0.7. Comorbidity was allowed, but patients were excluded if 
they had a serious active disease that needed medical treatment (e.g. carcinoma, recent 
myocardial infarction), or were treated for a COPD exacerbation in the past 2 months. All 
patients gave written informed consent, and the study was approved by the local ethics 
committee.
We compared 7 different forms of physical activity recommendations described in 
the literature. The recommendations differed in frequency, intensity and time of 
the recommended amount of physical activity and were measured with 3 different 
instruments (table 1). Three recommendations were based on absolute estimates of 
intensity and 4 on relative estimates of intensity. 
*2 minutes interruption duration was allowed in the 10 minute bout. 1measured by an accelerometer; 2measured by 
the SQUASH-questionnaire; 3measured by a pedometer. VO2: oxygen uptake; HR: heart rate.
TABLE 1. Overview of the different recommendations






1 MET absolute1 ≥ 5 days ≥ 3 MET moderate ≥ 30 minutes (in ≥10 min bouts*)
or ≥ 3 days ≥ 6 MET vigorous ≥ 20 minutes (in ≥10 min bouts*)
2 Questionnaire-based2 ≥ 5 days ≥ 3 MET moderate ≥ 30 minutes 






1 ≥ 5 days ≥ 40% moderate ≥ 30 minutes (in ≥10 min bouts*)
or ≥ 3 days ≥ 60% vigorous ≥ 20 minutes (in ≥10 min bouts*)
5 VO2 max
1 ≥ 5 days ≥ 46% moderate ≥ 30 minutes (in ≥10 min bouts*)
or ≥ 3 days ≥ 64% vigorous ≥ 20 minutes (in ≥10 min bouts*)
6 HR reserve1 ≥ 5 days ≥ 40% moderate ≥ 30 minutes (in ≥10 min bouts*)
or ≥ 3 days ≥ 60% vigorous ≥ 20 minutes (in ≥10 min bouts*)
7 HR max1 ≥ 5 days ≥ 64% moderate ≥ 30 minutes (in ≥10 min bouts*)
or ≥ 3 days ≥ 77% vigorous ≥ 20 minutes (in ≥10 min bouts*)
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Recommendations based on absolute measures of intensity
1. MET-absolute
This recommendation described in the ACSM guideline, was met if patients engaged in 
at least 30 minutes of moderate-intensity physical activity (≥3 MET) on ≥5 days per week, 
or at least 20 minutes of vigorous-intensity physical activity (≥6 MET) ≥3 days per week, 
or a combination of both.4 Resting energy expenditure was estimated with the Mifflin-St. 
Jeor equation.9 Furthermore, physical activity had to be accumulated in bouts of at least 
10 minutes, with maximal 2 minute interruption time within the bout.10
2. Step-based 
The step-based recommendation was met if patients took on average at least 7000 steps 
per day during the week. Although the evidence for step-based recommendations is 
less extensive, a recent review and the ACSM have set this threshold measured with a 
pedometer for older adults.4, 11 
3. Questionnaire-based
The recommendation according to the questionnaire was met if patients engaged in at 
least 30 minutes of moderate-intensity physical activity (≥3 MET) on ≥5 days per week. 
Intensity of activities was based on the physical activities compendium.7 
Recommendations based on relative measures of intensity
These recommendations are described in the ACSM guideline and have the same 
instructions on frequency and time as the MET-absolute recommendation. To distinguish 
moderate and vigorous intensity we used the lowest thresholds described by the ACSM4, 
based on:
4.Oxygen uptake (VO2) reserve
5. VO2 max
6. Heart rate (HR) reserve
7. HR max
The intensity thresholds are shown in table 1. 
Patient perception
The questionnaire also determines how many days per week the patients themselves 
reported to be physically active for ≥30 minutes at moderate intensity, which we used as 
an indication of the patients’ perception on meeting the recommendation.
Measurements
Meeting the recommendations was measured by an accelerometer (5x), pedometer (1x) 
and questionnaire (1x).
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Physical activity 
Accelerometer The Dynaport (McRoberts, The Netherlands) is a validated triaxial 
accelerometer, that is worn around the waist and detects postures, measures steps and 
estimates energy expenditure.12-14 Patients were instructed to wear the accelerometer day 
and night for one week.
Pedometer The Yamax Digi-walker SW-200 is an accurate and reliable pedometer.15,16 
Patients were instructed to wear the pedometer for 2 weeks. The patients also reported in 
a diary if they performed other non-ambulatory activities, and these were translated into 
steps by using step equivalents based on the physical activities compendium.7 
Questionnaire The short questionnaire to assess health enhancing physical activity 
(SQUASH) was administrated by an interviewer. The questionnaire has shown to be fairly 
reliable and reasonably valid.17 
Cycle ergometry
Maximal and resting VO2, HR, and energy expenditure (EE) were measured by a cycle 
ergometer test (bicycle ergometer: Jaeger ER900L: Oxygen Pro, CareFusion, Germany). 
A maximal incremental protocol was used with 3 minutes resting, 3 minutes unloaded 
cycling and approximately 10 minutes cycling with individualized incremental load of 
5-25 Watt per minute, in line with the ATS/ACCP guidelines.18 The cycle ergometry was 
used to derive the relative measures of intensity of physical activity (based on VO2reserve, 
VO2max, HRreserve and HRmax).
Functional capacity measures Functional exercise capacity was measured by a 6-minute 
walk distance test according to the ATS guidelines.19 Leg muscle function was measured 
by a 30-second chair stand test.20 Forced expiratory volume in 1 second was measured 
using a spirometer (PFT. Masterscope; Viasys) according to the ERS/ATS guidelines.21
Data analyses
Patients were included in the accelerometer-based analyses if they had worn the 
accelerometer for at least 5 full days. A day was considered a valid measurement day if the 
device was worn for ≥94% of the day.22 If a patient had worn the accelerometer for 5 or 6 days 
the patients were only included if they already reached 5 days of enough physical activity 
or if they certainly would not. Resting and maximum values of VO2, HR, and EE during the 
cycle ergometer test were obtained from the graphs in the ergometer software. The VO2 
and HR values were translated into EE measures by taking the corresponding EE value at 
that time point. Wilcoxon signed-rank test was used to test the difference between the 
absolute measure of intensity and relative measures of intensity (mean value). To assess 
agreement between the different recommendations we calculated intraclass correlation 
coefficients (ICC) with absolute agreement. Linear regression analyses were performed to 
assess if patients who met a specific recommendation had different scores on functional 
capacity tests than patients who failed the recommendation. Regression analyses were 
adjusted for FEV1, age, gender, height and weight. P-values <0.05 (tested two-sided) were 
considered statistically significant. All statistical analyses were performed using IBM-SPSS 
statistics version 20.
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Variable Total group (n=115) GOLD I+II (n=61) GOLD III+IV (n=54)
Gender, male (%) 78 (67.8) 45 (73.8) 33 (61.1)
Age, years 65 ± 8.7 66 ± 7.8 64 ± 9.5
COPD¶, A/B/C/D 54/5/19/37 54/5/0/2 0/0/19/35
FEV1, % predicted 52 (14-119) 79 (50-119) 34.5 (14-49)
BMI, kg/m2 25.1 ± 4.0 25.5 ± 3.4 24.6 ± 4.6
6MWD, meter 447 (6-646) 518 (344-646) 367 (60-600)
mMRC, score 2 (1-5) 2 (1-5) 3 (1-5)
Chair stand test, number 10.9 ± 3.2 11.6 ± 3.3 10.1 ± 2.8
VO2 max, ml/kg 18.2 (5.7-37.7) 20.2 (13.0-37.7) 13.4 (5.7-22.8)
HR rust, beat per minute 76 (56-121) 73 (56-97) 84 (58-121)
HR max, beat per minute 129 (89-166) 137 (93-166) 120 (89-161)
Steps, per day* 5552 (236-18433) 7388 (3556-18433) 3376 (236-14281)
Lying & sitting, % 79.8 ± 7.2 77.6 ± 6.3 82.3 ± 7.3
≥ 3MET, minutes per day 103 (15-298) 130 (19-298) 70 (15-177)
RESULTS
One hundred and fifteen COPD patients participated in this study (68% male, mean 
age 65 years, mean FEV1 58%predicted (table 2)). All patients wore the pedometer and 
completed the SQUASH-questionnaire, and 111 patients wore the accelerometer for at 
least 5 days. Patients were on average 103 minutes physically active per day at intensities 
above 3 MET (range 15-299).
Estimates of intensity 
The calculated estimates of intensity, based on the absolute and relative estimates of 
intensities are shown in table 3. The mean value of the relative estimates of moderate-
intensity was in GOLD stage I and II patients significantly higher than the absolute 
measure of moderate-intensity (p<0.001). In patients with GOLD stage III and IV the mean 
value of the relative estimates of moderate-intensity was significantly lower than the 
absolute measure of intensity (p<0.001).
Meeting the recommendation
Table 4 shows the minutes per day that patients met the lower threshold of the 
recommendations and the proportion of patients that met the different recommendations 
(also figure 1). The number of eligible patients per recommendation is presented in 
table E1 in the appendix. Remarkably, the recommendations based on HRmax were not 
TABLE 2. Patient characteristics
Data are presented as n(%), mean ± sd, median (range) or number/n/n/n.
¶Combined assessment COPD with use of the mMRC scale (GOLD guidelines 201126) *Steps measured by accelerometer
FEV1: forced expiratory volume in 1 second; 6MWD: 6-minute walk distance; BMI: body mass index, mMRC: modified 
Medical Research Council dyspnea index.
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Total group GOLD I+II GOLD III+IV
Moderate intensity
3 MET absolute, kcal/minute 3.1 (2.0-4.1) 3.2 (2.0-3.9) 2.9 (2.1-4.1)
40% VO2 reserve, kcal/minute 3.3 (1.2-7.6) 4.1 (2.0-7.6) 2.7 (1.2- 4.9)
46% VO2 max, kcal/minute 3.0 (0.9-7.9) 3.8 (1.7-7.9) 2.2 (0.9-4.4)
40% HR reserve, kcal/minute 3.5 (0.5-7.4) 4.2 (1.8-7.4) 2.7 (0.5-6.0)
64% HR max, kcal/minute 3.0 (0.7-6.8) 3.1 (1.0-6.8) 1.9 (0.7-5.6)
Vigorous intensity
6 MET absolute, kcal/minute 6.2 (4.1-8.3) 6.4 (4.1-7.9) 5.9 (4.3-8.3)
60% VO2 reserve, kcal/minute 4.3 (1.5-10.8) 5.5 (2.6-10.8) 3.4 (1.5-6.4)
64% VO2 max, kcal/minute 4.2 (1.2-11.0) 5.2 (2.3-11.0) 3.0 (1.2-6.1)
60% HR reserve, kcal/minute 4.9 (1.2-9.6) 5.8 (2.5-9.6) 3.2 (1.2-7.8)
77% HR max, kcal/minute 4.3 (1.6-9.8) 5.0 (1.6-9.8) 3.2 (1.6-7.7)
TABLE 3. Estimates of intensity based on the different physical activity recommendations
Data are presented as median (range). MET: metabolic equivalent of task, kcal/minute: 
kilocalorie per minute; VO2: oxygen uptake; HR: heart rate.
applicable to a large proportion of the patients (49%), due to reaching very low HRmax 
values during the cycle ergometer test (table E1).
The proportion of patients that met the different recommendations ranged from 22 to 
84% in the total group. In GOLD stage I and II patients from 36 to 90% and in GOLD stage 
III and IV from 6 to 78%. Only 8 patients (7%) met all 7 recommendations. The agreement 
between all recommendations in the total group was poor (ICC 0.28, HRmax-based 
recommendations left out).
The recommendations based on absolute measures of intensity showed poor agreement 
(ICC 0.17). Thirty-six percent of the patients met the MET-absolute recommendation, 22% 
the step-based recommendation and 84% the questionnaire-based recommendation. 
By including step-equivalents 35% of the patients met the step-based recommendation. 
Although the step-based recommendation including step equivalents seems similar to 
the MET-absolute recommendation, the agreement between the two recommendations 
was moderate (ICC 0.49), indicating that different patients met the two different 
recommendations.
In patients with GOLD stage I and II, more patients met the absolute measure of intensity 
than the relative measures of intensity. In contrast, in GOLD stage III and IV, more patients 
met the relative measures of intensity than the absolute measure of intensity.
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FIGURE 1. Proportion of patients that met the different recommendations
Patient perception
Seventy percent of all patients reported that they were physically active for at least 
30 minutes at moderate-intensity on at least 5 days per week and thus met the 
recommendation. In GOLD stage I and II this was reported by 80% of the patients and in 
GOLD stage III and IV by 59%.
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Chair stand test 6MWD Wmax VO2 max





e MET absolute -2.220 0.001 -82.799 <0.001 -21.257 <0.001 -185.255 0.002
Questionnaire-based -2.492 0.002 -97.234 <0.001 -19.741 0.004 -195.906 0.009





VO2 reserve 0.284 0.672 -37.309 0.061 -1.606 0.774 71.925 0.220
VO2 max -0.583 0.383 -28.816 0.153 1.091 0.844 94.128 0.108
HR reserve -1.002 0.130 -35.778 0.066 0.657 0.904 78.714 0.174
HR max -0.038 0.966 -12.325 0.550 0.280 0.967 62.278 0.418
Analyses were adjusted for forced expiratory volume in 1 second, age, gender, height and weight. 
Recommendations were coded as 0= met recommendation, 1= failed recommendation. 6MWD: 6-minute walk 
distance test, Wmax: maximum workload, VO2max/kg: maximum oxygen uptake/kilogram, MET: metabolic 
equivalent of task, VO2: oxygen uptake, HR: heart rate.
TABLE 5. Differences in functional capacity measures between patients that met or 
failed the different recommendations
Association with functional capacity measures
Table 5 shows the differences in functional capacity outcomes between patients that met 
or failed the different recommendations with adjustment for FEV1, age, gender, height 
and weight. Patients who met the recommendations based on absolute estimates of 
intensity (MET-absolute, questionnaire-based and step-based) had significantly higher 
functional capacity scores than patients who failed the recommendations. Contrary, 
patients who met or failed the recommendations based on relative estimates of intensity 
did not differ in functional capacity outcomes. Absolute values without adjustment are 
shown in table E2 (appendix).
CONCLUSION AND DISCUSSION
Our results showed that the percentage of COPD patients that met the different physical 
activity recommendations ranged from 22 to 86%, and that the agreement between 
the recommendations was poor. It is important to acknowledge that adapting small 
differences in frequency, intensity or time lead to different conclusions and may have 
important consequences for the individual patient. Individualizing the recommendations 
by adopting the intensity to a patient’s aerobic fitness level resulted into more patients 
with GOLD stage III and IV meting the relative recommendations than the absolute 
recommendations. In contrast, GOLD stage I and II patients less frequently met the relative 
recommendations. Seventy percent of all patients reported to be physically active at least 
5 days per week for 30 minutes at moderate intensity. 
Several factors might contribute to the low agreement between the different physical 
activity recommendations. Firstly, it is well known that subjective methods to measure 
physical activity are less accurate than performance-based methods23; usually 
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patients overestimate their physical activity level.24 Secondly, the pedometer and the 
accelerometer both mainly measure locomotion, and therefore could unjustly classify 
patients as inactive when they perform a lot of non-ambulatory activities like cycling. 
Thirdly, recommendations measured by an accelerometer include a threshold on 
‘bout duration’, periods of physical activity only count when performed in bouts of at 
least 10 minutes. To illustrate the impact of bout duration, if we had allowed 1 minute 
interruption in the 10 minute bout instead 2 minutes, 23% of the patients would have 
met the recommendation instead of the current 36%. Contrary, in the step-based and 
questionnaire-based recommendation every step or minute counts. Our results are in 
line with a study in healthy men, which also showed huge differences between various 
recommendations.25 
We investigated absolute and relative estimates of intensity in COPD patients with a 
broad range of disease severity. In GOLD stage I and II patients the relative estimates 
of moderate intensity were higher than the absolute estimate and fewer patients met 
these recommendations. As expected, the relative estimates of moderate intensity were 
lower in GOLD III and IV patients than the absolute estimates of intensity. Consequently, 
a larger number of these patients met the recommendation based on relative estimates 
of intensity compared to the absolute estimates of intensity. Furthermore, we found that 
patients who met the relative recommendations did not have better functional capacity 
scores than patients who failed the recommendation. Consequently, the question arises 
whether low recommended intensities due to adjusting the intensity of physical activity 
to the individual level of aerobic capacity still lead to health benefits. Unfortunately, 
due to the cross-sectional design, we cannot answer this question and physical activity 
patterns over time should be investigated to identify the optimal amount of physical 
activity to promote or maintain physical health.
Which physical activity recommendation should be used in COPD patients is quite 
speculative but we nevertheless comment on a few aspects. A recommendation based 
on an absolute measure of intensity like the ACSM is easy to understand and results in 
a clear advice to the patient. However, relying on subjective measures whether such a 
recommendation is met is not attractive, as patient-perception or filling in a questionnaire 
overestimates a patient’s physical activity level. Additionally, recommendations based 
on absolute estimates of intensity could be discouraging for patients with severe COPD, 
because most patients are physically not able to achieve these high physical activity 
levels. In less severe COPD patients, who are less restricted by their pulmonary condition, 
the absolute estimates of intensity might be more appropriate. Another absolute 
recommendation, the step-based recommendation has the advantage that the goal is 
easy to understand and can be easily monitored by the patient. However, the evidence of 
the efficiency of the step-based recommendation is poor and dose-response studies in 
sedentary or old individuals are lacking. 
We do agree with the ACSM guidelines that for older and deconditioned patients the 
relative estimates of intensity probably might be most suitable. An important advantage 
is that the dose of physical activity is individualized and patients do not get frustrated 
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with too high targets. However, the use of relative estimations probably demands 
frequent monitoring of aerobic capacity and should therefore not be fixed at one time 
point. Aerobic capacity could increase because of exercise benefits but also decrease due 
to disease progression or aging. Using HR-based recommendations has the advantage 
that intensity goals are easy to measure by the patients, e.g. by a heart monitor watch. 
However, a problem with using HR is that it is not suitable for a lot of patients, because 
their HR goals are difficult to define because of very low exercise capacity, sometimes also 
partly due to medication like beta-blockers. A VO2-based recommendation can only be 
applied in sophisticated exercise labs, but once a VO2max has been measured it is possible 
to define individual advises for ergometer programs. As discussed earlier, another 
problem of the relative estimates of intensity is that the recommended physical activity 
may be too low to lead to health benefits in highly deconditioned patients. 
A limitation of the present study is the cross-sectional design. Due to this design we could 
not investigate how much physical activity is sufficient to obtain health benefits. A next 
step would therefore be to investigate physical activity, dose-response relationships and 
its health benefits longitudinally. Another limitation of the study is the conversion of 
cycle ergometer data into energy expenditure and the transformation of accelerometer 
data into energy expenditure. As shown by others, the estimation of energy expenditure 
by accelerometers is still not perfect.12 However, currently the accelerometer is the 
most practical and patient-friendly tool to use, in contrast to e.g. measuring energy 
expenditure by doubly labelled water or indirect calorimetry. Furthermore, we believe 
that the conclusions of this study would not change if we had used other instruments.
In conclusion, we found that applying various physical activity recommendations with 
small differences in frequency, intensity or time led to large differences in classifying if 
COPD patients are sufficiently physically active or not. This indicates the importance to 
precisely state the used recommendation and to be cautious with comparing results of 
recommendations. Future longitudinal studies on physical activity should determine 
how much physical activity should be recommended to patients to maintain or increase 
physical and mental health in the various stages of COPD.
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Step-based, n (%) 115 (100%) 30 (100%) 31 (100%) 33 (100%) 21 (100%)
Questionnaire-based, n (%) 115 (100%) 30 (100%) 31 (100%) 33 (100%) 21 (100%)
3 MET, n (%) 111 (97%) 30 (100%) 29 (94%) 32 (97%) 20 (95%)
40% VO2 reserve, n (%) 105 (91%) 30 (100%) 29 (94%) 32 (97%) 14 (67%)
46% VO2 max, n (%) 105 (91%) 30 (100%) 29 (94%) 32 (97%) 14 (67%)
40% HR reserve, n (%) 101 (88%) 30 (100%) 28 (90%) 31 (94%) 12 (57%)
64% HR max, n (%) 59 (51%) 24 (80%) 21 (68%) 8 (24%) 3 (14%)
6 MET, n (%) 111 (97%) 30 (100%) 29 (94%) 32 (97%) 20 (95%)
60% VO2 reserve, n (%) 105 (91%) 30 (100%) 29 (94%) 32 (97%) 14 (67%)
64% VO2 max, n (%) 105 (91%) 30 (100%) 29 (94%) 32 (97%) 14 (67%)
60% HR reserve, n (%) 101 (88%) 30 (100%) 28 (90%) 31 (94%) 12 (57%)
77% HR max, n (%) 73 (63%) 29 (97%) 27 (87%) 14 (42%) 3 (14%)
SUPPLEMENTARY DATA
TABLE E1. Number of eligible patients per recommendation
Causes for non eligibility
Recommendations based on accelerometer measurements: Four patients did not wear the 
accelerometer for at least 5 full days (1 patient wore the accelerometer for 5 full days and 
12 for 6 full days).
Recommendations based on cycle ergometer measurements: Six patients did not perform a 
cycle ergometer test or did not wear the accelerometer for at least 5 full days.
Recommendations based on VO2 values: Four patients received supplemental oxygen 
during the cycle ergometer test and therefore VO2 values were not reliable.
Recommendations based on HR max: Due to low maximum HR values during the cycle 
ergometer test for some patients the estimated moderate-intensity HR value was lower 
than the HR at rest and therefore not usable. 
Recommendations based on HR reserve: In a few patients HR reserve was not measurable 
due to minimal increase in HR. This also occurred in patients with a fluctuating HR.
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ABSTRACT
We performed a pilot study on the potential beneficial effects of bronchoscopic lung 
volume reduction on the daily physical activity level of patients with severe emphysema. 
This is the first study that has measured physical activity in a performance based manner 
after (bronchoscopic) lung volume reduction. We found that bronchoscopic lung volume 
reduction significantly improved lung hyperinflation and dyspnea severity, but that this 
was not followed by an increase in physical activity 6 months later. This implies that special 
attention on physical activity enhancement is necessary after lung volume reduction in 
order to increase the physical activity level of these patients.
Keywords: COPD • dyspnea • emphysema • lung hyperinflation
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Daily physical activity is an important outcome variable in patients with chronic 
obstructive pulmonary disease (COPD) and has shown to be mainly associated with 
dynamic lung hyperinflation.1 Physical inactivity is known to cause muscle deconditioning, 
which increases the ventilatory requirements during exercise, and in turn increases lung 
hyperinflation and worsens dyspnea, thus contributing to a downward spiral.2 This is 
especially true in patients with emphysema, in which destruction of alveolar tissue can 
result in progressive static and dynamic lung hyperinflation. Moreover, physical inactivity 
is a strong predictor of mortality in COPD patients.3 Notwithstanding the beneficial effects 
of regular physical activity, physical activity levels in COPD patients are low, especially in 
those with severe COPD.4 
Lung volume reduction (LVR) by bronchoscopic techniques is an innovative and 
increasingly applied treatment method targeted at improving lung hyperinflation. 
Endobronchial devices are implanted in emphysematous parts of the lung to reduce 
hyperinflation. This may improve the mechanical properties of the remaining lung and 
the efficiency of the inspiratory muscles. Consequently, this may lead to reduction of 
dyspnea during exertion and improve functional capacity of the body. Theoretically, after 
LVR a COPD patient’s physical activity level may improve, which would be beneficial for an 
independent lifestyle of the patient and for restoration of social participation. However, 
so far physical activity has never been measured before and after LVR. We therefore 
investigated the potential beneficial effects of bronchoscopic LVR on the physical activity 
level of these severely disabled COPD patients, and investigated whether decreased lung 
hyperinflation is associated with increased physical activity.
We performed a pilot study on 16 patients with severe emphysema who participated 
between July 2009 and August 2010 in bronchoscopic LVR with coils intervention studies 
(NCT01220908 and 01328899). The studies were approved by the local ethics committee 
and all patients provided informed consent. Prior to the bronchoscopic LVR treatment, 
physical activity was examined with a triaxial accelerometer together with lung function, 
lung volumes, exercise capacity, dyspnea severity and self-efficacy. Six months after the 
bronchoscopic LVR, all measurements were repeated.
Physical activity was measured in a performance-based manner with a triaxial 
accelerometer, using the DynaPort (McRoberts, the Hague, the Netherlands). The 
Dynaport is a small device which is worn around the waist. Patients were instructed to 
wear the DynaPort continuously for a period of 1 week. The DynaPort is able to detect 
physical activity (standing, locomotion, shuffling, lying and sitting), to measure steps and 
to estimate physical activity level (PAL) based on energy expenditure. PAL is calculated as 
total energy expenditure divided by basal metabolic rate. The DynaPort has proven to be 
an accurate tool to measure postures and gait in COPD patients.5 Forced expiratory volume 
in 1 second (FEV1) and lung volumes were measured according to European Respiratory 
Society/American Thoracic Society guidelines. Exercise capacity was determined using 
the 6-minute walk distance test (6MWD).6 Dyspnea severity was determined using the 
modified Medical Research Council Dyspnea scale (mMRC).7 
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Variable Baseline 6-months follow up p-value
RV, % predicted 223 (184-267) 205 (134-223) 0.001
RV/TLC, % 61.4 (55.4-67.4) 56.7 (48.3-65.3) 0.008
FEV1, % predicted 28 (22-42) 32 (15-58) 0.35
mMRC, score 3 (2-4) 2 (2-4) 0.06
6MWD, meter 336 (200-451) 348 (140-477) 0.22
Activity, % 17.6 (8.1-27.9) 15.0 (7.7-26.4) 0.29
Steps per day, steps 2084 (374-5800) 2426 (321-5721) 0.68
Physical activity Level (PAL) 1.51 (1.33-1.61) 1.50 (1.37-1.66) 0.55
Self-efficacy, LIVAS total score 29 (13-39) 30 (20-42) 0.28
Self-efficacy in physical abilities was measured using the Dutch version of the Perceived 
Physical Activity Scale (LIVAS questionnaire).8
Of the 16 patients who were included at baseline, two were lost to follow up. Consequently, 
14 patients were included in this analysis: four males (29%), median age 62.5 years, and 
median FEV1 28% predicted. Physical activity was low at baseline: median number of steps 
per day was 2084, and median percentage activity (standing, locomotion and shuffling) 
was 17.6% (table 1).
After 6 months, no significant changes in physical activity, exercise capacity or self-efficacy 
were found (table 1). Static lung hyperinflation measurements improved significantly 
above the recently calculated minimal important difference,9 and dyspnea severity 
decreased by 1 point on the mMRC scale (p=0.06). 
 In line with our hypothesis, decreased RV%TLC was significantly associated with decreased 
dyspnea severity (rho=0.65, p=0.01). However, in contrast with our hypothesis this was 
not associated with changes in physical activity outcomes. Although exercise capacity 
(6MWD) did not improve significantly after bronchoscopic LVR, this was positively 
associated with changes in physical activity as assessed by percentage activity (rho=0.55, 
p=0.04), number of steps per day (rho=0.57 and p=0.03), and borderline significant with 
dyspnea (rho= -0.48, p=0.09).
In summary, this pilot study showed that there was no improvement in physical activity 
6 months after bronchoscopic LVR, despite significant improvements in static lung 
hyperinflation. Furthermore, decreased lung hyperinflation was not associated with 
Data are presented as median (range), unless otherwise stated. RV: residual volume; TLC: 
total lung capacity; FEV1: forced expiratory volume in 1 second; mMRC: modified Medical 
Research Council dyspnea index; 6MWD: 6-minute walk distance. Baseline and follow up 
measurements were compared with Wilcoxon signed-rank test (significant p-values are shown 
in bold). 
TABLE 1. Clinical characteristics at baseline and after 6 months
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improved physical activity or exercise capacity, in contrast to its significant association 
with reduced dyspnea severity. 
This study indicates that a new treatment method in COPD, such as bronchoscopic LVR, 
can substantially improve lung hyperinflation and dyspnea severity. The improvement in 
dyspnea could indicate that patients might perform the same activities more comfortably 
than before the treatment. However, an increase in physical activity is not automatically 
warranted. Other treatment methods that increase functional capacity in COPD patients 
have shown similar results. For example, a recent review showed that participation in 
a pulmonary rehabilitation program does not automatically result in increased physical 
activity.10 Furthermore, although lung transplantation improves lung function, physical 
activity remains below normal values and is significantly worse than in matched healthy 
controls.11 Together, this suggests that although patients have larger pulmonary reserves 
to function at higher physical activity levels, other factors are apparently more important. 
These could be physical factors like chronic deconditioning or atrophic muscles, and/or 
psychological factors, such as motivation to be physically active, anxiety or anticipated 
breathlessness. 
This study implies that it is important to provide a physical activity enhancement program 
after LVR. Such an intervention should include a structured exercise program with specific 
attention for atrophic muscles. Additionally, in our opinion, exercises should be combined 
with counselling consisting of promotion of physical activities in daily life in an attempt to 
achieve long term results. 
We are aware that the number of patients is low and that our study lacked a control group. 
A large randomized controlled trial would be useful to confirm our results.
In conclusion, despite the low number of patients, this is the first study that shows data on 
physical activity in a performance-based manner after LVR. Unexpectedly, physical activity 
did not significantly improve after the intervention, while static lung hyperinflation and 
dyspnea severity did. This suggests that the improved pulmonary capacity is actually 
not used by the COPD patients for physical activities in daily life, probably also due 
to psychological reasons. Consequently, our study indicates that a short pulmonary 
rehabilitation program with counselling on the promotion of physical activity in daily life 
should be considered after such treatments.
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ABSTRACT
Background: Residual volume (RV) measured by body plethysmography is a routine 
measurement in clinical pulmonary practice and is often an important outcome variable 
in clinical trials. However, it is not known what size of improvement can be regarded as 
being important in severe emphysema patients. Therefore, the aim of the study is to 
establish the minimal important difference (MID) for RV in severe emphysema patients 
undergoing bronchoscopic lung volume reduction.
Methods: Ninety-one severe emphysema patients were included. RV and total lung 
capacity (TLC) were measured by body plethysmography. MID estimates were calculated 
by anchor-based and distribution-based methods. Forced expiratory volume in 1 second, 
6-minute walk distance and St George’s Respiratory Questionnaire total score were used 
as anchors and Cohen’s effect size was used as distribution-based method.
Results: The calculated MID estimates according to the different anchors and methods 
ranged between -0.31 and -0.43 L for RV, -6.1 and -8.6% for percentage change in RV 
(RV%) from baseline and -2.8 and -4.0% for RV%TLC.
Conclusions: These MID estimates are useful for sample size determination in new studies 
on interventions aimed at reducing RV and for interpreting the results from clinical trials 
in severe emphysema patients.
Keywords: COPD • hyperinflation • lung volume reduction 




Lung hyperinflation is an important feature in patients with chronic obstructive 
pulmonary disease (COPD) and is the result of increased airway resistance, reduced lung 
recoil and shortened available expiratory time.1 Lung hyperinflation is strongly associated 
with important patient-centred outcomes, such as dyspnea, exercise tolerance and daily 
physical activity.1,2 As a consequence, it negatively affects patients’ daily functioning and 
their quality of life. 
In the past decade, reducing lung hyperinflation has become an important treatment 
goal in the management of severe emphysema. Several treatment methods have been 
shown to improve lung hyperinflation temporarily, such as pursed-lip breathing, exercise 
training and oxygen use, while bronchodilators or lung volume reduction surgery have 
been shown to improve lung hyperinflation in patients with COPD more definitively.1,3 
Lung volume reduction surgery has been shown to improve lung function, quality of 
life and exercise capacity.4 Lung volume reduction techniques by bronchoscope are less 
invasive, and show promising results in improving lung hyperinflation, quality of life and 
exercise capacity.5-8
Residual volume (RV) assessed by body plethysmography is commonly used to measure 
(changes in) lung hyperinflation. Body plethysmography is a routine measurement 
in clinical pulmonary practice based on Boyle’s law, with reproducible measurements 
of absolute lung volumes. In studies on methods that aim to improve hyperinflation, 
increased RV constitutes an important inclusion criterion as well as outcome variable. 
Unfortunately, to date, it is not known what size of improvement can be regarded as 
being clinically important for the severe emphysema patient. 
The concept of minimal important difference (MID) can be used to establish what 
size of effect in RV measurements after a treatment adequately reflects the perceived 
improvements by patients. MID can be defined as “a threshold value for a change that 
would be meaningful and worthwhile by the patients such that he/she would consider 
repeating the intervention if it were his/her choice to make again”.9 Any treatment effect 
above the MID is considered to be relevant. The MID for RV could, therefore, be useful 
when interpreting the significance of the results of clinical trials for patients, besides the 
statistical significance of the changes. Additionally, the MID could be used to establish 
the minimal numbers of subjects to be included in a study to be able to infer meaningful 
conclusions in future trials (i.e. power calculations). To our knowledge, the MID for RV in 
patients with severe emphysema has not yet been established.
The aim of this study was to establish the MID for RV in patients with severe emphysema 
who are being treated by bronchoscopic lung volume reduction.




A total of 91 patients with severe emphysema were included in this study. All patients 
participated in one out of three different bronchoscopic lung volume reduction 
studies, performed in one hospital in the Netherlands (University Medical Center 
Groningen, Groningen). Patients were included in this study on MID if they had body 
plethsmography measurements both from baseline and 1 month after completing the 
specific bronchoscopic lung volume reduction treatment. Twenty-nine patients with 
severe homogeneous emphysema (10 controls) were included from a randomized, 
double-blind, sham-controlled trial on bronchoscopic transbronchial airway bypass 
treatment (www.clinicaltrials.gov identifier number NCT00391612),10 33 patients with 
severe upper- or lower-lobe heterogeneous emphysema (no controls) were included from 
a bronchoscopic lung volume reduction treatment study using self-expandable nitinol 
coils (NCT01220908),6 and 29 patients with severe upper- or lower-lobe heterogeneous 
emphysema (9 controls) were included from a bronchoscopic lung volume reduction 
treatment study using one-way endobronchial valves (NCT01101958).7 All studies were 
approved by the local medical ethics committee and all patients gave written informed 
consent. 
Measurements
RV and total lung capacity (TLC) were measured by body plethysmography (Viasys, San 
Diego, CA, USA) according to the European Respiratory Society/American Thoracic Society 
guidelines.11 Furthermore, all patients performed spirometry (Masterscreen, Viasys),12 
a 6-minute walk distance test (6MWD)13 and completed the St George’s Respiratory 
Questionnaire (SGRQ).14 All measurements were performed at baseline and 1 month after 
the bronchoscopic lung volume reduction treatment. 
MID calculation methods and statistical analysis
Selected outcome variables for the statistical analyses were RV, percentage change in RV 
(RV%) from baseline and the RV/TLC ratio (RV%TLC). Various methods for estimating MIDs 
have been described in the literature.15,16 Because the combination of multiple methods is 
generally recommended, our current study included both anchor-based and distribution-
based methods to calculate the MID. 
Anchor-based methods compare the change in outcome measure with the change in 
another measure with an established MID (“the anchor”).9 The anchors chosen in this 
study were forced expiratory volume in 1 second (FEV1) (MID 100 mL
17), 6MWD (MID 26 
meter18) and SGRQ total score (MID 4 units19). An anchor is suitable to use if there is an 
appreciable association between the outcome variable and the anchor. Therefore, first 
the correlation coefficient between the change in (∆) RV, ∆RV% and ∆RV%TLC versus 
the change in the anchor were assessed. In general, there is no consensus on when a 
correlation coefficient is considered to be an appreciable association. One review 
recommends statistically significant (p<0.05) Pearson correlation coefficients of ≥0.3 as 
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Baseline Change 1 month from baseline¶
Variable Absolute % pred Absolute % change from baseline % >MID
Females/males 57/34 NA NA NA NA
Age, year 60.1 ± 8.3 NA NA NA NA
BMI, kg/m2 24.2 ± 3.3 NA 0.3 ± 0.8 1.2 ± 3.3 NA
FEV1, L 0.73 ± 0.3 26.7 ± 9.8 0.10 ± 0.17 13.1 ± 21.2 35.2
6MWD, m 319.2 ± 97.5 48.8 ± 14.7 29.7 ± 58.6 11.3 ± 23.2 52.2
SGRQ, total score 62.5 ± 11.2 NA -7.8 ± 12.9 -13.0 ± 21.5 64.0
RV, L 5.0 ± 1.1 241.0 ± 46.6 -0.43 ± 0.61 -8.7 ± 12.2 Unknown
TLC, L 7.8 ± 1.4 136.5 ± 14.2 -0.23 ± 0.43 -2.8 ± 5.5 Unknown
RV/TLC, % 64.3 ± 8.3 166.8 ± 23.5 -4.1 ± 5.7 -6.3 ± 8.8 Unknown
appreciable,16 and 2 studies in COPD patients performed the analyses when correlation 
coefficients were 0.3 or 0.5.18,20 Therefore, it is an arbitrary decision, and for the current 
study, Pearson correlation coefficients of ≥0.4 were accepted. Afterwards, linear regression 
analyses were performed with ∆RV, ∆RV% or ∆RV%TLC as dependent variables and one of 
the above-described anchors as the independent variable. Subsequently, the MID value 
of the anchor was entered into the equation derived from the linear regression analysis 
and the MID was calculated from the established equation.
Distribution-based methods compare the change in outcome measure with some 
measure of variability.9 In this study, the Cohen’s effect size was used. A moderate effect 
size was calculated of the change score of the outcome measure from baseline to 1 month 
after the bronchoscopic lung volume treatment. All statistical analyses were performed 
using PASW statistics 18 (SPSS Inc., Chicago, IL, USA).
RESULTS
Ninety-one patients with severe emphysema, who had undergone body plethysmography 
measurements at baseline and 1 month later, were included in this study (63% female; 
mean age 60 years). Population characteristics at baseline and the 1-month follow-up 
changes from baseline are shown in table 1.
Data are presented as n or mean ± sd, unless otherwise stated. % pred: % predicted; MID: minimal important 
difference; BMI: body mass index; FEV1: forced expiratory volume in 1 second; 6MWD: 6-minute walk distance; SGRQ: 
St George’s Respiratory Questionnaire; RV: residual volume; TLC: total lung capacity; NA: not applicable; ¶: placebo/
control group included.
TABLE 1. Baseline characteristics and change scores at 1-month follow-up (n=91)
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∆ RV (L) ∆ RV% ∆ RV/TLC (%)
Anchor-based method
     FEV1 -0.43 (-0.62 - -0.24) -8.6 (-9.5 - -5.7) -4.0 (-5.9 - -2.2)
     6MWD -0.41 (-0.59 - -0.23) -8.4 (-11.9 - -4.9) -3.9 (-5.5 - -2.3)
     SGRQ total score -0.35 (-0.45 - -0.24) -6.9 (-8.8 - -4.9) -3.2 (-4.2 - -2.3)
Distribution-based method -0.31 -6.1 -2.8
MID estimates according to the anchor-based method
Scatter plots and Pearson correlation coefficients between ∆RV, ∆RV% from baseline, and 
∆RV%TLC, versus ∆FEV1, ∆6MWD and ∆SGRQ total score are presented in figure 1. Pearson 
correlation coefficients ranged from 0.43 to 0.58. The highest correlations were present 
with FEV1 (range 0.47-0.58) and the lowest with SGRQ total score (range 0.43-0.47).
The MID estimates derived from the linear regression equations with use of the anchor 
MID showed that the MID estimates for the absolute change in RV according to the 
different anchors were: -0.43 L (FEV1), -0.41 L (6MWD) and -0.35 L (SGRQ total score) (table 
2). The MID estimates for RV% change from baseline according to the different anchors 
were: -8.6% (FEV1), -8.4% (6MWD), and -6.9% (SGRQ total score). The MID estimates for 
RV%TLC according to the different anchors were: -4.0% (FEV1), -3.9% (6MWD), and -3.2% 
(SGRQ total score).
 
MID estimates according to the distribution-based method
The MID estimates calculated with the distribution-based method (Cohen’s effect size) 
were: -0.31 L for RV, -6.1% for RV% change from baseline and -2.8% for RV%TLC (table 2).
DISCUSSION
This is the first study describing MID estimates for lung hyperinflation measurements. 
Our results indicate MID estimates for RV of -0.31 - -0.43 L, for RV% from baseline of -6.1 
- -8.6% and for RV%TLC of -2.8 - -4.0% in patients with severe emphysema undergoing 
bronchoscopic lung volume reduction. MID estimates were determined using both 
anchor-based and distribution-based methods. High correlations were found between 
changes in lung hyperinflation measurements and changes in patient-centred outcomes, 
such as exercise capacity and health-related quality of life, emphasising the importance 
of this clinical feature for patients with severe emphysema. 
Data are presented as MID (95% CI). ∆:change; RV: Residual volume; RV%: percentage change in 
RV from baseline; TLC: total lung capacity; FEV1: forced expiratory volume in 1 second; 6MWD: 
6-minute walk distance; SGRQ: St George’s Respiratory Questionnaire.
TABLE 2. Minimal important difference (MID) estimates for residual volume (RV)
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Anchor-based and distribution-based methods were used to determine the MID, and for 
the anchor-based method, three anchors were chosen. Therefore, four MID estimates of 
each outcome variable were generated. These ranges of MID estimates can be used for 
power calculations in future trials. Here, we critically evaluate the methods and anchors 
used for this specific intervention and study population.
For the anchor-based method, it is important that the anchor used is suitable for the 
analysis. A number of criteria can be used to establish the quality of the anchor. First, 
the MID of the anchor should be derived from multiple high-quality studies, including 
many well-characterized COPD patients, using multiple methods to establish the MID, 
and agreeing about the final MID estimate. Secondly, the anchor should be derived 
from a comparable COPD population; thus for the current study, patients with severe 
emphysema. Thirdly, the anchor should somehow reflect the perception of improved 
lung hyperinflation. Finally, the anchor should be highly correlated with changes in RV 
variables. The anchors used in the current study will be discussed here.
FEV1 seems attractive, as it is a highly reproducible measurement that is strongly 
associated with RV outcomes. The MID calculation for FEV1 is based on multiple studies, 
but establishing the MID was never the primary aim of these studies.17 In addition, the 
MID of FEV1 was based on a broad variety of COPD patients, including different treatment 
modalities and, therefore, might not be applicable to our population. Furthermore, the 
improvement in FEV1 is largely dependent on improvement in vital capacity, which is 
mainly dependent on a change in RV, so RV and FEV1 are indirectly related. However, the 
major disadvantage of this anchor is that it does not reflect the perceived improvement 
by patients1 and is not a patient-reported outcome. 
6MWD is highly correlated with RV measurements. Another advantage of this anchor 
is that the 6MWD MID estimate was calculated from a study investigating the effect of 
lung volume reduction surgery in severe COPD patients,18 and, thus, is derived from a 
comparable COPD study population that underwent a comparable, although more 
invasive, intervention. Furthermore, another study investigated the 6MWD MID using 
another treatment method and demonstrated a similar MID estimate for pulmonary 
rehabilitation.20 Also, the perceived improvement in 6MWD is thought to be a good 
reflection of the perceived improvement in lung hyperinflation after bronchoscopic lung 
volume reduction treatment.
 
SGRQ total score seems more attractive because this instrument is excellently validated 
for patient-reported outcomes in COPD. However, when using the SGRQ total score as 
an anchor, the Pearson correlation coefficients were of lowest of the three anchors in 
this study. Another disadvantage is that the MID estimate for SGRQ total score (4 units) 
is based on multiple studies, using different populations and different MID estimation 
techniques.19 
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A recent study showed that different interventions in different groups of COPD patients 
may produce different MID estimates.21 The SGRQ total score from three different lung 
volume reduction treatment studies were plotted against the change in 6MWD and 
compared with the effects after pulmonary rehabilitation. A different response pattern 
for 6MWD and a larger result for health-related quality of life were found between the 
different treatment modalities. This could indicate that a higher MID estimate for the 
SGRQ total score for studies using lung volume reduction techniques would be more 
appropriate. Furthermore, it is important to acknowledge that unblinded interventions 
can lead to larger improvements in health-related quality of life, due to the fact that 
patients are aware that they have been treated. Therefore, we advocate that the MID of 
the SGRQ should subsequently be established in a similar COPD population after a similar 
treatment, preferably, with a placebo-controlled design before using it as an anchor. 
Distribution-based methods do not comply with the primary aim of the MID concept, 
namely identifying an effect size that is meaningful in the perception of the patient. 
Therefore, we agree with the consensus that the distribution-based method should only 
be used to support estimates derived from anchor-based methods.9,16
In summary, out of the used methods and anchors in the current analyses, the anchor 
method is the best method to calculate the MID and the 6MWD appears to be the anchor 
with the highest quality for this specific patient group and intervention. 
For the current study, RV% from baseline and RV%TLC were chosen as outcome variables 
besides absolute change in RV. RV% from baseline was chosen because this adjusts for 
baseline scores, e.g. it takes sex differences into account. RV%TLC was chosen because 
it takes individuals’ lung capacity into account and has been shown to be an important 
determinant of improvement in forced vital capacity after lung volume reduction 
surgery.22 Unfortunately, most MID estimates are only expressed in absolute numbers. 
One study that did measure the MID estimate of percentage change from baseline for 
6MWD found a MID estimate of 14%.20 However, this MID estimate was based on the 
effects after a rehabilitation program and, therefore, was not chosen as anchor in our 
current study. We recommend that in addition to MID estimates for absolute variables, 
the percentage change from baseline and percentage predicted should be calculated.
A first limitation of the current study is the relative small sample size. However, all study 
measurements were performed in one specialized research hospital in the Netherlands, 
always in the same setting, using the same equipment. This led to highly standardised 
measurements with low variation, possibly explaining the rather high correlations 
between changes in lung hyperinflation and the chosen anchors. A second limitation is 
the measurement of only static lung hyperinflation and not dynamic lung hyperinflation. 
We anticipate that improved dynamic lung hyperinflation is at least as important for 
perceived dyspnea and exercise tolerance as improved static lung volume. Future 
lung volume reduction studies might, therefore, also investigate correlations between 
improved dyspnea scores and improved inspiratory capacities during exercise. A final 
limitation of the current study is the potentially low generalisability of the MID estimates 
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to other COPD populations or other treatment methods. Our study population is rather 
homogenous (predominantly female severe emphysema patients) and based on short-
term results, which strengthens the MID estimate for this population, but might limit 
the usefulness for other COPD populations or treatment methods and long-term effects. 
It is indeed known, at least for SGRQ, that different interventions can lead to different 
MID estimates in different COPD populations.21 Therefore, to be able to apply the MID 
estimates to a more heterogenic COPD population, further research in a larger, more sex-
balanced population is needed to investigate whether other interventions that reduce 
lung hyperinflation, like treatment with bronchodilators, and other COPD populations 
provide the same MID estimates for RV measurements. 
In conclusion, this is the first study that estimated the MID for change in emphysema-
related static lung hyperinflation. The calculated MID estimates according to the different 
anchors and methods ranged between -0.31 and -0.43L for RV, -6.1 and -8.6% for RV% from 
baseline and -2.8 and -4.0% for RV%TLC. These MID estimates are useful for sample size 
determination of new studies on interventions aimed at reducing RV, and for interpreting 
the results from clinical trials in patients with severe emphysema.
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The scope of this thesis was physical activity in patients with chronic obstructive 
pulmonary disease (COPD). Chapter 1 provides an introduction to the subject. The 
many health benefits of regular physical activity underline the importance of this topic, 
especially in this period of time when the occurrence of a sedentary lifestyle is increasing. 
While physical activity has many health benefits in general, the physical activity level in 
COPD patients has shown to be low, compared with a healthy population but also with 
other patient groups. Physical activity is an important modifiable risk factor and therefore 
an important treatment target in this patient group. This thesis investigated physical 
activity and its potential predictors in COPD patients in all severity stages of the disease, 
the suitability of general physical activity recommendations in COPD patients and the 
association between decreased lung hyperinflation and physical activity.
Predictors of physical activity
In Chapter 2 we identified the potential predictors of physical activity in COPD patients. 
Reviewing the literature, associations were found between physical activity and important 
disease outcomes of COPD like forced expiratory volume in 1 second (FEV1), dyspnea, 
exercise capacity, muscle function, systemic inflammation, comorbidities and health-
related quality of life (HRQL). No significant associations were described between physical 
activity and body mass index (BMI) in COPD patients, in contrast to findings in the general 
population. Furthermore, a few other cross-sectional studies separated physically active 
COPD patients from physically inactive COPD patients, giving interesting insights into 
the determinants and consequences of an inactive lifestyle. Although not consistent, an 
inactive lifestyle was associated with lower FEV1, higher levels of dyspnea, higher number 
of COPD admissions, worse exercise capacity and worse HRQL. Furthermore, only a few 
studies investigated the relationship between physical activity and psychosocial factors 
like self-efficacy or depression. In general the literature was limited and inconsistent, and 
most associations were only moderate. Figure 1 shows a theoretical framework of the role 
of physical inactivity in COPD described in chapter 2. 
Chapters 3, 4 and 5 were based on data from a cross-sectional study we performed that 
focussed on determining the predictors of physical activity in COPD. During 3 study 
visits, COPD patients performed various physical tests and completed psychosocial 
questionnaires. Physical activity was measured using a triaxial accelerometer, a pedometer 
and a questionnaire. Furthermore, patients were interviewed regarding physical activity. 
We included 115 patients with mild to very severe COPD (68% male, mean age 65 years, 
FEV1 57.5 %predicted, Global initiative for Chronic Obstructive Lung Disease (GOLD) 
severity stages: 30 stage I, 31 stage II, 33 stage III and 21 stage IV). Mean steps per day 
ranged between 236 and 18433 steps (triaxial accelerometer). 
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Chapter 3 presents a study that assessed physical activity and sitting time in COPD 
patients and investigated the potential physical and psychosocial determinants 
(that were identified in chapter 2). One hundred and thirteen COPD patients wore the 
accelerometer and were included in these analyses. Physical activity, measured by a 
triaxial accelerometer (24hours/day), showed a mean locomotion and shuffling time per 
day of 6.8% (range: 0.7-20.4). Reduced levels of physical activity were most prevalent in 
patients with GOLD stage III-IV. Predictors of physical activity were higher self-efficacy, 
sub-maximal exercise capacity and lower lung hyperinflation. In patients with GOLD 
stage I-II, higher self-efficacy and the spring/summer season were predictors, whereas in 
GOLD III-IV, worse lung hyperinflation, dyspnea severity, leg muscle function and oxygen 
use were. Predictors of sitting time in the total group were a more positive perception on 
treatment control, less autonomous motivation to exercise, not using sleep medication 
and oxygen use.
The conclusions were that both physical and psychosocial factors affected physical 
activity in COPD. The predictors of physical activity in the early stages of COPD were more 
generic, in contrast to the physical and disease-specific predictors in more severe stages. 
The predictors of sitting time were different from the predictors of physical activity.
When we compare the results of the univariate analyses in chapter 3 with the potential 
predictors we identified in chapter 2, we found, in line with the literature, that HRQL and 
health status were positively associated with physical activity. Furthermore, we found 
significant associations between higher physical activity and better lung function, lung 
volumes and leg muscle function, higher (sub)maximal exercise capacity and self-efficacy, 
less dyspnea, lower number of exacerbations and not using long term oxygen therapy. 
Furthermore, in line with the literature we found no significant association between 
physical activity and body composition. 
In contrast with the literature in chapter 2, we found a significant association between 
higher physical activity and lower depression, and no significant association between 
physical activity and comorbidities.
In addition to the literature in chapter 2, we found a significant association between better 
illness perception and motivation to exercise. Furthermore, physical activity level was 
lower in the autumn/winter season as compared to spring/summer season. Moreover, we 
did not find a significant association between physical activity and social support, sleep 
quality, use of sleep medication, work status, living status, education level, age, smoking 
status and smoking history. 
In Chapter 4 we investigated the personal reasons why COPD patients are physically 
active or sedentary using qualitative research methods, and assessed the relationship 
between those reasons and the actual measured level of physical activity. All 115 COPD 
patients underwent a semi-structured interview. The most frequently reported reason 
to be physically active was health benefits, followed by enjoyment, continuous active 
lifestyle in the past and functional reasons. The most frequently reported reason to be 
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sedentary was weather, followed by health problems and lack of intrinsic motivation. 
Furthermore, a high physical activity level was related to enjoyment and self-efficacy in 
physical activity and a low physical activity level was related to weather (health specific), 
financial constraints, health and perceived shame. In conclusion, we identified important 
facilitators and barriers to be physically active, which could be very useful for the 
enhancement of physical activity in sedentary COPD patients. 
Figure 2 shows the factors that were found to be related to physical activity in our study 
population of 115 COPD patients (chapter 3 and 4).
Physical activity recommendations
In Chapter 5 we compared 7 different physical activity recommendations and investigated 
their suitability in COPD patients. The recommendations differed in frequency, intensity 
and time and were measured with an accelerometer, pedometer or questionnaire in our 
study population of 115 COPD patients. The recommendations were based on absolute 
measures of intensity or relative individualized measures of intensity based on the patient’s 
aerobic fitness level. The proportion of patients classified as sufficient physically active by 
the different recommendations ranged from 22 to 86% and only 7% of the patients (n=8) 
met all 7 recommendations. The agreement between the different recommendations was 
poor (ICC: 0.28). Individualizing the recommendations resulted into a higher proportion 
of GOLD stage III and IV patients meeting the relative recommendations compared to the 
absolute recommendations. In contrast, GOLD stage I and II patients less frequently met 
the relative recommendations. The conclusion of this study was that applying various 
physical activity recommendations with small differences in frequency, intensity or time 
led to large differences in classifying whether COPD patients are sufficiently physically 
active or not. Consequently, the used recommendation will highly affect the proposed 
physical activity advice to the patient.
 
Lung hyperinflation and physical activity
Chapter 6 shows the results of a pilot study that investigated the potential beneficial effects 
of bronchoscopic lung volume reduction on the daily physical activity level of patients 
with severe emphysema and investigated whether decreased lung hyperinflation was 
associated with increased physical activity. Fourteen patients with severe emphysema 
who wore a triaxial accelerometer before and 6 months after the treatment were included 
in the analyses. We found that there was no improvement in physical activity 6 months 
after bronchoscopic lung volume reduction, despite significant improvements in static 
lung hyperinflation. Residual volume improved significantly above the calculated 
minimal importance difference (chapter 7). Furthermore, decreased lung hyperinflation 
was not associated with improved physical activity or exercise capacity, in contrast to 
its significant association with reduced dyspnea severity. We concluded that special 
attention on physical activity enhancement is necessary after lung volume reduction in 
order to increase the physical activity level of these patients.
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In Chapter 7 we established the minimal important difference (MID) for residual volume 
(RV) in severe emphysema patients undergoing bronchoscopic lung volume reduction. 
Ninety-one severe emphysema patients were included. RV and total lung capacity (TLC) 
were measured by body plethysmography. MID estimates were calculated with anchor-
based and distribution-based methods. FEV1, 6-minute walk distance and St Georges’s 
Respiratory Questionnaire total score were used as anchors and Cohen’s effect size was 
used as distribution-based method. The calculated MID estimates according to the 
different anchors and methods ranged between -0.31 and -0.43L for RV, -6.1 and -8.6% 
for percentage change in RV from baseline and -2.8 and -4.0% for RV%TLC. These MID 
estimates are useful for sample size determination in new studies on interventions aimed 
at reducing RV and for interpreting the results from clinical trials in severe emphysema 
patients.




We reviewed and investigated various potential predictors of physical activity. As 
expected, disease-specific physical factors, like dyspnea, exercise capacity and muscle 
function, affected the physical activity level in COPD patients. However, besides physical 
predictors we identified psychosocial, including motivational, and environmental 
factors that affected the physical activity level as well (figure 2). In patients with mild 
to moderate COPD the predictors of physical activity were found to be more generic in 
contrast to the physical and disease-specific determinants in more severe stages. Lung 
hyperinflation was found to be an important independent predictor of physical activity 
but improving lung hyperinflation with bronchoscopic lung volume reduction did not 
automatically increase physical activity in patients with severe emphysema. Furthermore, 
we found that when applying current general physical activity recommendations with 
small differences in frequency, intensity or time and measured by different instruments 
led to large differences in classifying whether COPD patients are physically active or not. 
In the following part of this thesis we will reflect on the results presented in this thesis and 
discuss the implications for clinical practice and future research.
 
Predictors of physical activity and implications
Information on factors that are related to physical activity participation, could guide 
clinicians and therapists and provide starting points for the enhancement of physical 
activity. We will discuss some identified predictors of physical activity and their possible 
implication.
Physical activity not one-dimensional
It is important to acknowledge that physical activity is part of a patient’s lifestyle and 
has a large behavioral component. Physical activity was not only affected by physical 
capabilities but we showed that psychosocial and environmental factors also play 
a role. Treating one dimension will probably not change a patient’s physical activity 
behavior. This is illustrated by our results described in chapter 7. Reducing static lung 
hyperinflation by bronchoscopic lung volume reduction (LVR) did not automatically 
lead to an improvement in physical activity, although static lung hyperinflation was an 
independent predictor of physical activity. In chapter 3 we showed that in (very) severe 
COPD patients next to lung hyperinflation, dyspnea, leg muscle function and use of long 
term oxygen therapy were independent predictors of physical activity. Therefore, besides 
improving lung hyperinflation, it may be important to also increase muscle function 
and improve dyspnea and thus a physical activity enhancement program or pulmonary 
rehabilitation after bronchoscopic LVR could be important. It would be interesting to 
investigate whether such a multi-component program after bronchoscopic LVR does 
increase physical activity. In line, another study found a weak to moderate relationship 
between change in exercise capacity and change in physical activity and concluded that 
interventions not only need to target exercise but also should target behavioral change 
with regard to physical activity.1 A final example showing that physical activity should 
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not be treated as a one-dimensional condition is derived from a study that showed that 
providing lightweight ambulatory oxygen to COPD patients using long term oxygen 
therapy (LTOT) did not increase their physical activity level.2 In our study, the use of LTOT 
was a predictor of lower physical activity in patients with (very) severe COPD as well as a 
predictor of sitting time. In order to change physical activity behaviour only diminishing 
the burden of LTOT is probably not sufficient. These examples indicate that treating one 
factor that affects physical activity will not automatically lead to an increase in physical 
activity in COPD patients. Probably, the focus should also be on physical activity itself and 
therefore behavioural change should be a target as well.
Lung hyperinflation
One of the aims of this thesis was to study the association between lung hyperinflation 
and physical activity more in depth. We found that static lung hyperinflation was an 
independent predictor of physical activity, as opposed to airway obstruction. This could 
indicate that regardless of the severity of airflow obstruction the development of static 
hyperinflation highly affects the physical activity level. This is in line with the observation 
that lung hyperinflation is more strongly associated with functional exercise capacity 
(like 6MWD) than with FEV1.
3 It would be interesting to also investigate dynamic lung 
hyperinflation next to static lung hyperinflation as demonstrated in another study.4 
Probably, dynamic lung hyperinflation is at least as important for perceived dyspnea and 
exercise tolerance as static lung volume. Therefore, it would be interesting to investigate 
if treating static and dynamic lung hyperinflation in combination with a physical 
enhancement program would lead to an increase in physical activity.
Comorbidity
It is known that many COPD patients have comorbidities5,6 and we believe that certain 
comorbidities can easily affect the level of physical activity. Unexpectedly, comorbidity 
was not associated with physical activity in our study population. The literature on the 
association with comorbidity is inconsistent: two other studies also found no association4,7, 
while six other studies did.8-13 However, in general the significant associations were based 
on surrogate markers of disease, like blood pressure or ECG readings, instead of specific 
diseases or on self-reported diseases by patients. We used a composite index-score in our 
study. Comorbidity indeces apply severity ratings for the various diseases and a COPD-
specific comorbidity index probably would have been better. Recently, a first COPD-
specific comorbidity index was developed and it would be interesting to investigate 
this index in relation to physical activity and compare it with general indices.14 However, 
this disease-specific comorbidity index, like most other indices, is based on mortality as 
outcome. We recognize that mortality is indeed an important clinical outcome. However, 
with respect to physical activity enhancement, we believe it would be of greater interest 
to identify specific comorbidities that affect physical activity or functional capacity. 
Consequently, we recommend that future research should pay more attention to the 
identification of specific diseases or combinations of diseases that affect physical activity.
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Combining quantitative and qualitative research
We investigated for the first time the relationship between physical activity and multiple 
psychosocial and environmental factors both in a quantitative and qualitative manner 
in the same study population. In the quantitative analyses, we found that physical 
activity was associated with psychosocial factors like illness perception and motivation to 
exercise. However, the associations were only moderate, which might be caused by the 
questionnaires we used. Variables like motivation or social support are difficult to measure 
and few suitable questionnaires are available. Moreover, COPD specific questionnaires 
are lacking. It would be useful to develop COPD specific questionnaire(s) that target 
these variables related to physical activity. Our qualitative analysis enabled us to gain 
more insight in these psychosocial factors. Combining these 2 methods gave use the 
opportunity to compare the results, and this strengthens our findings. In both analyses 
we found that motivation to be physically active, self-efficacy and weather significantly 
affected physical activity. We found no association between physical activity and social 
support.
Motivation to be physically active
Motivation to be physically active was related to physical activity (chapter 3 and 4). In chapter 
4 we asked the patients about their motives to be physically active or to be sedentary and 
some of these motives were also related to the actually measured physical activity level. 
Measured with a questionnaire, more autonomous motivation to be physically active was 
associated with a higher physical activity level (chapter 3). More autonomous motivation 
means that patients are more intrinsically motivated (by themselves) than extrinsically 
motivated (by others). This could indicate that for the maintenance of an active lifestyle it 
is important that COPD patients are physically active for their own reasons and not forced 
by others. An often applied technique in healthcare that addresses the patient’s own 
motivation is motivational interviewing. Motivational interviewing uses a guiding rather 
than a directing style, to engage with patients, clarifying their strengths and aspirations, 
evoke their own motivations to change, and promote autonomy of decision making.15 
Two pilot studies that combined motivational interviewing with feedback of a pedometer 
showed positive effects in increasing physical activity in COPD patients.16,17
Self-efficacy in physical activity
In both our quantitative and qualitative study, higher self-efficacy for physical activity 
was related to higher physical activity (chapter 3 and 4). Self-efficacy is someone’s belief 
in his/her capabilities to successfully execute a specific type of behavior, in this case 
physical activity. It is known that self-efficacy is a strong and consistent predictor of 
exercise adherence and that it is essential for the process of behavioral change.18-20 This 
underlines the importance of high self-efficacy for physical activity in the enhancement 
of physical activity. In chapter 4 we have described some factors that have shown to 
increase self-efficacy: performance experience, vicarious experience, social persuasion 
and physiological and emotional arousal. If necessary, such factors could easily be 
incorporated in physical activity enhancement programs. 
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Social support for physical activity  
Unexpectedly, social support for physical activity was not related to physical activity 
and thus might not affect physical activity (chapter 3 and 4). However, patients reported 
low social support (chapter 3) which could indicate that patients experience little social 
support for physical activity at all. Actually involving significant others in physical activity 
programs might be an important factor in the enhancement of physical activity. In general, 
social support has been shown to improve exercise behavior.21 But the actual effect of 
involving social support on physical activity enhancement in COPD patients needs to 
be investigated in further detail. Social support could include buddy systems, support 
or participation from family or friends, and encouragement and positive feedback from 
therapist, physicians or fellow participants. 
Weather
Physical activity level was lower in autumn and winter compared to spring and summer. 
This is confirmed in chapter 4 as weather was the most frequently reported reason to be 
sedentary. In general weather is not a disease-specific determinant of physical activity, but 
in our population it often was. A lot of patients reported that their respiratory symptoms 
increase with specific weather types and furthermore weather influencing health 
was related to a lower level of physical activity. Of course, we cannot change weather 
conditions but it is important to acknowledge the effect of weather on symptoms and 
consequently on physically activity. When composing a physical activity enhancement 
program it is probably important to discuss the influence of weather and adjust physical 
activity types to the season.
Physical activity in different severity stages of COPD
To investigate differences between patients with different COPD severity we used 
the GOLD stages, which are based on arbitrary cut off points of airflow limitation. It is 
questionable whether airflow limitation is the best method to discriminate between 
COPD patients, but currently there is no better method available. For example, in line with 
other studies, we could not demonstrate that the BODE index (containing besides lung 
function also exercise capacity, dyspnea and body mass index) was superior in detecting 
differences in physical activity of patients with COPD.4,8 Two large studies showed that 
reduced levels of physical activity were most prevalent in severe or very severe COPD 
patients (GOLD stage III or IV)22,23 and since our study confirmed this, we compared mild 
to moderate COPD (GOLD stage I and II) with severe to very severe patients (GOLD stage 
III and IV). The discussion whether severity stages based on airflow limitation alone reflect 
the differences in disease severity sufficiently, recently led to the new combined GOLD 
COPD assessment. This assessment includes besides airflow limitation also symptoms 
and exacerbation risks.24 It should be investigated if this assessment is more suitable to 
detect differences in physical activity between COPD patients.
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Mild to moderate COPD patients
Patients with mild or moderate COPD did not differ in physical activity but had 
significantly higher physical activity levels than patients with (very) severe COPD. Two 
other studies showed that the physical activity level of patients with GOLD stage I did not 
significantly differed from matched controls, whereas patients with GOLD stage II did not 
differ in some physical activity outcomes.22,23 Furthermore, we found that the predictors 
of physical activity in mild to moderate COPD patients (GOLD stage I or II) were more 
generic instead of disease-specific (self-efficacy and weather). This could indicate that, 
with regard to physical activity, patients with mild to moderate COPD might not be very 
different from the general healthy elderly population and that disease symptoms leading 
to reduced physical activity particularly play a role in more severe COPD. Unfortunately, 
our study did not have a control group, but it would of course be interesting to know 
whether the determinants of physical activity differ between COPD patients and healthy 
controls. This does not mean that enhancing physical activity is not indicated in patients 
with less severe COPD, as we showed that the ranges of physical activity within the disease 
stages were very large. In addition, many patients with mild to moderate COPD had very 
low physical activity levels. Furthermore, one frequently reported reason for patients to 
be physical active was ‘having a continuous active lifestyle in the past’, underlining the 
importance of preventing sedentary lifestyles in an early stage of the disease. Whether 
sedentary patients with mild to moderate COPD should follow a COPD-specific or general 
physical activity enhancement program remains questionable. 
Severe to very severe COPD patients
The predictors of physical activity in patients with severe to very severe COPD were 
disease-specific and physical. It is easy to understand how these factors, being lung 
hyperinflation, dyspnea, leg muscle function and LTOT, limit exercise capacity and affect 
physical activity in daily life. Some sub domains of the motivation to exercise questionnaire 
were statistically related to physical activity in these more severe patients, but probably 
the physical factors were more dominant. The identified predictors are all potential 
targets for treatment. For example, several treatment methods have been shown to 
improve lung hyperinflation temporarily, such as pursed-lip breathing, exercise training 
and oxygen use, while bronchodilators or lung volume reduction surgery have been 
shown to improve lung hyperinflation in COPD patients more definitively.3,25 However, 
physical activity did not automatically increase after successfully reducing residual 
volume (chapter 6). And also, as described earlier, increasing the portability of oxygen 
cylinders does not immediately increase physical activity. During the slow progression 
of COPD, patients may unconsciously adapt their physical activity level to avoid feelings 
of dyspnea. Usually, this will lead to a cycle of decline as physical deconditioning (cardiac 
and muscle) aggravates dyspnea even more, which in turn leads to avoiding even 
more physical activities.26 This could indicate that after successful treatment of lung 
hyperinflation, impaired muscle function and dyspnea, also specific attention should 
be paid to the enhancement of physical activity, assuming that patients are completely 
adapted to their sedentary life style.
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Other practical implications regarding physical activity
Tailoring
Our results confirm the importance of tailoring a physical activity enhancement program 
instead of a ‘one-size-fits-all’ program. The findings that enjoyment as reason to be 
physically active was related to a higher level of physical activity and the broad spectrum 
of preferred physical activity types underline this. Therefore, tailoring a program to an 
individual patient’s opportunities and preferences will probably lead to longer physical 
activity maintenance. One study that tailored physical activity advices on patients’ stage 
of readiness to change, exercise goal, motives for and perceived barriers to reaching the 
goal and preferred type of physical activity found that patients who received these 
advices were more likely to increase physical activities of daily living than patients who 
received general physical advices or no advices.27 Tailoring can be defined as ‘any 
combination of change strategies intended to reach one specific person, based on 
characteristics that are unique 
to that person, related to the 
outcome of interest and have 
been derived from an 
individual assessment’.28 Our 
study identified several factors 
that could be useful for the 
individual assessment of COPD 
patients additional to those 
mentioned in the study on 
tailored physical activity 
advices.27 Those factors are 
shown in box 1. Such an 
individual assessment should 
consequently lead to an 
individualized program for the 
patient. 
Physical activity monitoring
Subjective measures of physical activity by patients, overestimated the actual level of 
physical activity (chapter 5). Therefore measuring physical activity with performance 
based instruments is highly recommended. Triaxial and multisensory devices that 
monitor physical activity in a performance based manner were shown to be more valid.29 
Currently, these monitors are small, lightweight and thus wearable and become more and 
more affordable. We measured physical activity in our study with a highly validated triaxial 
accelerometer in COPD30, which was worn by the patients day and night for one week. Our 
patients reported a good wearability of the device. Besides measuring physical activity 
with an accurate device, using it as a feedback tool for the patient has been investigated 
and has shown promising results.31 For example, physical activity enhancement with 
 BOX 1: Factors individual assessment                                  
•	 Knowledge on health benefits of physical activity
•	 Patient’s own goal
•	 Readiness to change
•	 Reasons to be physically active
•	 Barriers in being physically active  
- weather
 - health problems    
- financial constraints   
- shame
•	 Physical activity preferences
- opportunities
- history of physical activity
•	 Self-efficacy
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feedback of a pedometer has shown to be effective in COPD patients.16,17 Currently, 
accelerometers can easily be connected to mobile phones or computers, which may lead 
to even more advanced feedback signals and makes home telemonitoring also possible.
Physical activity versus physical inactivity
An unexpected observation of our study was that the predictors of physical activity and 
sitting time were not the same. Furthermore, sitting time was not significantly different 
between patients in different severity stages (chapter 3). Interestingly, sitting time has 
been associated with an increased risk of mortality, even independent of leisure time 
physical activity.32 Furthermore, sedentary time has been shown to be an independent 
risk factor for several health outcomes, like the metabolic syndrome and cardiovascular 
risk factors, independent of physical activity.33,34 Promoting breaks in sitting time could 
be beneficial as it has been shown that a higher number of interruptions in sedentary 
time, independent of total sedentary time, was beneficially associated with metabolic 
risk variables.33,35 This indicates that, in addition to promoting physical activity, it is also 
important to reduce sedentary behaviour, for example by promoting breaks in sitting 
time.
Minimal important difference for physical activity
For interpreting the results of physical activity enhancement programs or for determining 
sample size of new studies, a minimal important difference (MID) estimation, like we 
calculated in chapter 7, would also be useful for physical activity. Such a MID could indicate 
which improvement in physical activity is meaningful and worthwhile in the perception 
of the patient. The questions arises what factor represents a meaningful and worthwhile 
change in physical activity for a patient and how this MID should be estimated. Health 
status or HRQL measured with a questionnaire are probably suitable anchors when 
using an anchor-based approach. Also patient-based anchors could be used in which the 
patients rate their own experienced change on for example a 15-point global scale.36 A 
problem with calculating a MID is that currently many different physical activity outcome 
parameters are being used, like steps, distance, activity counts, body positions, estimated 
energy expenditure and minutes at activity intensity levels. Furthermore, the duration 
of the measurement during the day or measured number of days also differs. Reaching 
consensus on the preferred outcome parameter and measurement duration would be 
helpful for the comparison of studies.
Physical activity advice and reference values
The latest GOLD guidelines state that all patients should be advised to participate in 
regular physical activity.24 What is ‘regular’ physical activity? It is important to know how 
much physical activity is necessary to obtain health benefits and to give an evidence-
based tailored advice to a COPD patient. Currently, the classification whether a patient 
is sufficiently physically active depends on the applied recommendation or used 
instrument and there is no COPD-specific physical activity recommendation yet (chapter 
5). Longitudinal studies are needed to determine how much physical activity in terms 
of frequency, intensity and time is actually sufficient in the various disease stages of 
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COPD. Additionally, COPD-specific reference values should be developed that identify 
sedentary COPD patients who need physical activity enhancement. Individualizing 
a recommendation to a patient’s body weight, sex and fitness level and thus tailoring 
a physical activity advice seems appropriate, especially in patients with (very) severe 
COPD. However, how to determine the exact dose-response relationship between 
physical activity and health benefits for the individual patient is a challenging new area 
of research. Furthermore, it is important that a patient can incorporate a physical activity 
recommendation in his/her daily life routine and therefore a recommendation should be 
clear and easy to monitor.
Unfortunately, the actual global guidelines on how to treat a patient who does not meet 
the recommendation are often vague and impractical. One important treatment modality 
for COPD patients in this perspective is pulmonary rehabilitation, that has shown to be 
effective in increasing exercise capacity, quality of life and reducing dyspnea37 and that 
consists of multi-dimensions. However, an increase in physical activity is not guaranteed 
after a rehabilitation program.38 Another problem is that not all patients have access to 
these programs, often because of the high-costs. For example the new GOLD guidelines 
state ‘all patients who get short of breath when walking on their own pace on level 
ground should be offered rehabilitation’. Unfortunately, this would exclude a lot of COPD 
patients who do in fact have a sedentary lifestyle. Besides pulmonary rehabilitation, 
structured exercise programs or physical activity counseling programs are useful tools 
in the enhancement of physical activity, but the optimal contents and setting of these 
programs are unclear. Obviously, there is a high need for more practical guidelines that 
are useful for physical therapists or physicians.
Future research in physical activity in COPD
The studies presented in this thesis have answered many research questions, but as 
research naturally generates new questions, new questions and potential research aims 
have been suggested in the discussion above. 
Overall, in research on physical activity in COPD, longitudinal studies should be performed 
more often. Our results on the predictors of physical activity were obtained from cross-
sectional data and therefore definite conclusions regarding possible cause-effect 
relationships are difficult to draw and longitudinal studies are necessary. For example, 
it would be very useful to perform follow up measurements 5 years after baseline in 
our study population. This would also provide more insight in physical activity patterns 
over time. Furthermore, longitudinal research would be helpful to determine how much 
physical activity in terms of frequency, intensity and time is actually sufficient to obtain 
health benefits. This could help to compose a more concrete physical activity advice to 
an individual patient. 
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In general, studies aiming at enhancing physical activity are necessary to optimize 
physical activity enhancement programs. It would be interesting to investigate a tailored 
multi-dimensional physical activity enhancement program that specifically targets 
physical activity as well. In these programs self-efficacy and autonomous motivation for 
physical activity should play an important role and besides promoting physical activity, 
reducing sitting time should be a target. Furthermore, the influence of involving social 
support should be investigated in new studies. Specifically in patients with mild to 
moderate COPD, it would be interesting to compare the effects of a general or COPD-
specific physical activity enhancement program. 
Future research will hopefully further improve our knowledge on optimal physical activity 
enhancement in COPD patients and consequently reduce the prevalence of sedentary 
lifestyles and its negative consequences in this patient population.
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BMI  Body mass index
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COPD  Chronic obstructive pulmonary disease
CIRS-G  Cumulative illness rating scale for geriatrics
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GOLD  Global initiative for chronic obstructive lung disease
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Chronisch obstructieve longziekte (COPD) is een chronische longaandoening die 
gekenmerkt wordt door een niet volledig reversibele luchtwegobstructie die in het 
algemeen progressief is en wordt veroorzaakt door een abnormale ontstekingsreactie 
van de longen op schadelijke deeltjes of gassen.1 Bij volwassenen vanaf 40 jaar komt 
COPD bij ongeveer 10% van de bevolking voor en in 2002 was COPD de 5e belangrijkste 
doodsoorzaak wereldwijd.2,3 De voornaamste symptomen van COPD zijn kortademigheid 
(dyspneu), hoesten en slijmproductie. COPD is niet alleen een ziekte van de longen, 
vaak zijn er ook ziekteverschijnselen buiten de long (extrapulmonaal) aanwezig en veel 
patiënten hebben ook nog andere aandoeningen (comorbiditeit).4 Vaak voorkomende 
extrapulmonale ziekteverschijnselen en comorbiditeiten zijn: spierdysfunctie, hypertensie, 
botontkalking en depressiviteit.4 De behandeling van COPD kan bestaan uit stoppen met 
roken, medicatie, revalidatie, zuurstoftherapie en chirurgische behandelingen.1,5 Verder 
wordt in de laatste COPD richtlijn van het ‘Global Initiative for Chronic Obstructive Lung 
Disease’ (GOLD) ook regelmatige lichamelijke activiteit aangeraden in de behandeling 
van alle COPD patiënten.1,5,6
Lichamelijke activiteit
Lichamelijke activiteit wordt gedefinieerd als ‘elke krachtsinspanning van skeletspieren 
die resulteert in meer energieverbruik dan in rust’.7 Lichamelijke activiteit reflecteert 
wat iemand daadwerkelijk doet en is daarmee verschillend van inspanningsvermogen 
of fitheid welke weergeven wat een persoon kan doen. Lichamelijke activiteit heeft 
dus ook een grote gedragsmatige component. Regelmatig lichamelijk actief zijn heeft 
grote voordelen. Verschillende studies hebben aangetoond dat regelmatige lichamelijke 
activiteit leidt tot verlaagde mortaliteit en verminderde kans op aandoeningen zoals 
diabetes type 2 en hart- en vaatziekten.8 Ook is aangetoond dat het kan leiden tot een 
verhoogd inspanningsvermogen en spierfitheid, gezondere lichaamssamenstelling en 
verbetering van cognitieve functies.8 Wereldwijd blijkt 1/3 van de volwassenen lichamelijk 
inactief te zijn ondanks dat lichamelijke inactiviteit door de World Health Organization in 
2004 is uitgeroepen tot de 4e grootste risicofactor voor overlijden.9,10
Lichamelijke activiteit en COPD
COPD patiënten zijn niet alleen vaker lichamelijk inactief dan gezonde volwassenen maar 
ook vaker dan andere patiëntpopulaties zoals diabetes en reumatoïde artritis.11,12 COPD 
patiënten ervaren naar mate de ziekte ernstiger wordt steeds vaker kortademigheid bij 
lichamelijke inspanning en gaan daardoor deze lichamelijke activiteiten vermijden of 
verminderen. Hierdoor kunnen ze in een neerwaartse spiraal terecht komen aangezien 
lichamelijke inactiviteit leidt tot verminderde conditie, hetgeen de kortademigheid 
juist verergert.13 Naast de eerder genoemde voordelen van regelmatige lichamelijke 
activiteit is aangetoond dat specifiek in COPD patiënten het ook leidt tot verminderde 
kortademigheid en verbeterde spierfunctie en kwaliteit van leven.14,15 Lichamelijke 
activiteit is veranderbaar en zou daarom een belangrijk behandeldoel in deze 
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patiëntpopulatie moeten zijn. Meer inzicht in de voorspellers van lichamelijke activiteit 
geeft aanknopingspunten voor het verbeteren van beweegstimuleringsprogramma’s en 
dus het verminderen van lichamelijke inactiviteit in deze patiënten.
Voorspellers van lichamelijke activiteit
In de algemene volwassen populatie is aangetoond dat lage lichamelijke activiteit 
geassocieerd is met oudere leeftijd, vrouwelijk geslacht, lager opleidingsniveau, hoger 
lichaamsgewicht, gezondheidsproblemen, lagere self-efficacy (geloof in eigen kunnen), 
ervaring met lichamelijke activiteit en weersomstandigheden.16-18 In COPD patiënten 
zijn de voorspellers van lichamelijke activiteit nauwelijks systematisch onderzocht en 
weinig studies hebben gekeken naar zowel fysieke als psychosociale voorspellers. Ook 
zijn de patiënten zelf nog nauwelijks over hun eigen gedachten en perspectieven over 
lichamelijke activiteit ondervraagd. Onderzoek naar de redenen waarom COPD patiënten 
lichamelijk actief of inactief zijn en de ervaren barrières zou nuttige informatie kunnen 
opleveren voor het stimuleren van lichamelijke activiteit in deze patiëntenpopulatie.
Beweegnormen
Regelmatige lichamelijke activiteit heeft dus vele voordelen maar een belangrijk vraag 
hierbij is wat ‘regelmatig’ lichamelijk actief zijn inhoudt en wat een patiënt dus zou moeten 
worden geadviseerd. Ongeveer 40 jaar geleden is een eerste richtlijn voor lichamelijke 
activiteit opgesteld en op dit moment worden de richtlijnen van de American College 
of Sports Medicine (ACSM) het meest gehanteerd.19-21 Deze richtlijnen adviseren dat 
volwassenen minimaal 5 dagen per week, 30 minuten op matig intensiteit lichamelijk 
actief zouden moeten zijn of 3 dagen per week 20 minuten op hoge intensiteit of een 
combinatie hiervan. Over het algemeen zijn deze richtlijnen gebaseerd op volwassenen 
zonder aandoening, terwijl de richtlijnen voor volwassenen met een chronische 
aandoening zoals COPD minder duidelijk zijn. De ACSM raadt aan om de intensiteit voor 
deze populatiegroepen aan te passen aan de individuele fitheid en dit zou ook geschikt 
kunnen zijn voor COPD patiënten.22 Maar tot nu toe zijn de beweegnormen nauwelijks 
onderzocht in deze patiëntenpopulatie.
Longhyperinflatie en lichamelijke activiteit
Een belangrijke voorspeller van lichamelijke activiteit in COPD patiënten lijkt hyperinflatie 
van de long te zijn. COPD patiënten hebben problemen met de uitademing en veel minder 
met de inademing. De lucht kan dus wel makkelijk naar binnen maar minder makkelijk naar 
buiten en sommige COPD patiënten pompen zich als het ware op. Hierdoor ademen ze op 
een hoger niveau waardoor het residuaal volume (de hoeveelheid lucht die in de longen 
achterblijft na een normale rustige uitademing) toegenomen is. Dit wordt hyperinflatie 
van de long genoemd. In het afgelopen decennium is er steeds meer onderzoek verricht 
naar behandelingen waarbij getracht wordt het longvolume te verkleinen door middel 
van bronchoscopische interventies. Hierbij worden met behulp van een kijkingreep kleine 
apparaatjes, zoals ventielen, in slecht ventilerende gebieden van de long aangebracht, die 
deze gebieden ontluchten en daardoor het longvolume verkleint. Deze technieken zijn 
weinig belastend vergeleken met een operatie, en laten goede resultaten zien wat betreft 
longhyperinflatie, kwaliteit van leven en inspanningsvermogen.23-26 In theorie leiden deze 
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behandelingen tot een verminderde kortademigheid bij inspanning en verbetering van 
de functionele capaciteit van het lichaam, waardoor het lichamelijke activiteitenniveau 
kan toenemen. Maar tot nu toe is hier nog geen onderzoek naar gedaan. Ook is nog geen 
onderzoek gedaan naar welke verbetering in residuaal volume door de patiënten zelf als 
belangrijk wordt ervaren.
Doelstellingen proefschrift
Samenvattend, lichamelijke activiteit heeft vele gezondheidsvoordelen en zou een 
belangrijk behandeldoel voor COPD patiënten moeten zijn. Maar over het algemeen is het 
lichamelijke activiteitenniveau in deze patiëntenpopulatie laag, zelfs in de mildere stadia 
van de aandoening. Het is onduidelijk wat bepaalt waarom de ene patiënt wel lichamelijk 
actief is en een andere niet. Het eerste doel van dit proefschrift was het krijgen van meer 
inzicht in het lichamelijke activiteitenniveau en voorspellers ervan in COPD patiënten 
met verschillende ernst van de ziekte, waarbij zowel fysieke als psychosociale factoren 
bestudeerd worden. Een tweede doel was onderzoeken of de huidige beweegnormen ook 
toepasbaar zijn in COPD patiënten. Een laatste doel was onderzoeken of een verbetering 
van longhyperinflatie geassocieerd is met een verbetering in lichamelijke activiteit.
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RESULTATEN
Voorspellers van lichamelijke activiteit
In hoofdstuk 2 hebben we potentiële voorspellers van lichamelijke activiteit geïdentificeerd. 
Lichamelijke activiteit bij COPD patiënten blijkt verband te houden met belangrijke 
COPD-specifieke factoren zoals longfunctie, spierfunctie, systemische inflammatie, 
comorbiditeiten en gezondheidspecifieke kwaliteit van leven. In tegenstelling tot in 
de algemene gezonde populatie, blijkt lichamelijke activiteit bij COPD patiënten niet 
samen te hangen met lichaamsamenstelling parameters (zoals BMI). Verder zijn er een 
aantal studies die actieve COPD patiënten vergeleken met inactieve COPD patiënten. 
In deze studies was een inactieve leefstijl geassocieerd met slechtere longfunctie, 
meer kortademigheid, hoger aantal ziekenhuisopnames voor COPD, slechtere 
inspanningscapaciteit en slechtere gezondheidsspecifieke kwaliteit van leven, maar de 
resultaten van de studies waren niet consistent. Verder waren er maar een paar studies 
die de relatie tussen lichamelijke activiteit en psychosociale factoren zoals self-efficacy 
(geloof in eigen kunnen) of depressiviteit hebben onderzocht. Over het algemeen was de 
literatuur beperkt en inconsistent en de meeste correlaties waren matig. Figuur 1 komt 
voort uit dit hoofdstuk en geeft een theoretisch raamwerk van de rol van lichamelijke 
inactiviteit in COPD.
Hoofdstukken 3, 4 en 5 zijn gebaseerd op data van een cross-sectionele studie die we 
hebben uitgevoerd in het UMCG en waarvan het hoofddoel was om de voorspellers 
van lichamelijke activiteit in COPD te identificeren. De deelnemende COPD patiënten 
voerden verscheidene fysieke tests uit en vulden meerdere psychosociale vragenlijsten 
in tijdens 3 studievisites. Lichamelijke activiteit werd gemeten met een accelerometer, 
een stappenteller en een vragenlijst. Ook werden alle patiënten geïnterviewd. In totaal 
hebben 115 patiënten met milde tot zeer ernstige COPD aan het onderzoek deelgenomen 
(68% man, gemiddelde leeftijd 65 jaar, FEV1 57.5% van voorspeld, ernst stadia van COPD 
(volgens GOLD): 30 stadium I (mild), 31 stadium II (matig), 33 stadium III (ernstig), 21 
stadium IV (zeer ernstig)). Het gemiddeld aantal stappen per dag varieerde van 236 tot 
18433 stappen (gemeten met de accelerometer). 
De studie in hoofdstuk 3 had als doel om lichamelijke activiteit en zitduur in COPD patiënten 
te bepalen en om de potentiële voorspellers hiervan te bestuderen (geïdentificeerd in 
hoofdstuk 2). 113 COPD patiënten hadden de accelerometer gedragen en werden in de 
analyses meegenomen. De gemiddelde duur van wandelen en schuifelen was 6.8% van de 
dag (range: 0.7-20.4%). Lage lichamelijke activiteitenniveaus waren het meest aanwezig 
in patiënten met ernstige tot zeer ernstige COPD (GOLD stadia III en IV). Voorspellers 
van hogere lichamelijke activiteit waren betere self-efficacy en inspanningscapaciteit en 
mindere longhyperinflatie. In patiënten met milde en matige COPD (GOLD stadia I en II), 
waren hogere self-efficacy en de lente/zomer seizoen voorspellers, terwijl in patiënten 
met GOLD stadia III en IV slechtere longhyperinflatie, beenspierfunctie en het gebruik 
van zuurstof voorspellers waren. Voorspellers van zitduur in de totale groep waren 
een positievere perceptie op de controle van de ziekte, minder eigen motivatie om te 
bewegen, het niet gebruiken van slaapmedicatie en het gebruik van zuurstof.
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Geconcludeerd kon worden dat zowel fysieke als psychosociale factoren het niveau van 
lichamelijke activiteit in COPD patiënten beïnvloeden. De voorspellers van lichamelijke 
activiteit in de mildere stadia van COPD waren algemeen, in tegenstelling tot de fysieke 
en COPD-specifieke voorspellers in de ernstigere stadia. De voorspellers van zitduur 
waren anders dan de voorspellers van lichamelijke activiteit.
Als we de resultaten van de analyses in hoofdstuk 3 vergelijken met de potentiële 
voorspellers die we identificeerden in hoofdstuk 2 dan vonden we in overeenstemming 
met de literatuur dat gezondheidsgerelateerde kwaliteit van leven en gezondheidsstatus 
positief geassocieerd waren met lichamelijke activiteit. Ook vonden we een 
significante associatie tussen hogere lichamelijke activiteit en de volgende variabelen: 
betere longfunctie, longvolumes en beenspierfunctie, hogere (sub)maximale 
inspanningscapaciteit en self-efficacy, minder kortademigheid, lager aantal exacerbaties 
en het niet gebruiken van zuurstof therapie. Tevens vonden we geen associatie tussen 
lichamelijke activiteit en lichaamssamenstelling.
In tegenstelling tot de literatuur vonden we geen significante associatie tussen hogere 
lichamelijke activiteit en mindere depressiviteit en tussen lichamelijke activiteit en 
comorbiditeit.
In aanvulling op de literatuur vonden we een significante associatie tussen betere 
ziekteperceptie en motivatie om te bewegen. Ook was het lichamelijke activiteitenniveau 
lager in de herfst of winter vergeleken met de lente of zomer. Verder vonden we geen 
significante associatie tussen lichamelijke activiteit en sociale steun, slaapkwaliteit, 
gebruik van slaapmedicatie, werksituatie, woonsituatie, opleidingsniveau, leeftijd, 
rookstatus en rookgeschiedenis.
In hoofdstuk 4 beschrijven we de resultaten van een studie waarin we de persoonlijke 
redenen om wel of niet lichamelijk actief te zijn hebben bestudeerd door 115 COPD 
patiënten te interviewen over lichamelijke activiteit. Ook hebben we in dit hoofdstuk de 
relatie tussen deze persoonlijke redenen en het gemeten lichamelijke activiteitenniveau 
bestudeerd. De meest genoemde reden om te bewegen was gezondheidsvoordelen, 
gevolgd door plezier in bewegen, actieve leefstijl in het verleden en functionele redenen om 
te bewegen. De meest genoemde reden om niet te bewegen was weersomstandigheden, 
gevolgd door gezondheidsproblemen en gebrek aan intrinsieke motivatie om te 
bewegen. Verder was een hoog lichamelijke activiteitenniveau gerelateerd aan plezier 
in bewegen en hoge self-efficacy in bewegen. Een laag lichamelijke activiteitenniveau 
was gerelateerd aan gezondheidsklachten door het weer, financiële beperkingen, 
gezondheidstatus en schaamte.
Concluderend hebben we belangrijke stimulerende factoren en barrières geïdentificeerd 
om lichamelijk actief te zijn, die erg bruikbaar kunnen zijn voor de stimulering van 
lichamelijke activiteit in sedentaire COPD patiënten.
Figuur 2 geeft een overzicht van de factoren die gerelateerd waren aan lichamelijke 
activiteit in onze studiepopulatie van 115 COPD patiënten (hoofdstukken 3 en 4).
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Beweegnormen
In hoofdstuk 5 hebben we 7 verschillende beweegnormen vergeleken en de bruikbaarheid 
in COPD patiënten bestudeerd. De beweegnormen verschilden in frequentie, intensiteit 
en tijd en werden gemeten met een accelerometer, stappenteller of vragenlijst in onze 
studiepopulatie van 115 COPD patiënten. De beweegnormen waren gebaseerd op 
absolute maten van intensiteit of individuele maten van intensiteit. Individuele maten 
van intensiteit waren gebaseerd op het inspanningsniveau van de patiënt (vastgesteld 
met een maximale fietstest). Het percentage patiënten dat werd geclassificeerd als 
voldoende actief volgens de verschillende beweegnormen varieerde van 22 tot 86% 
en maar 8 patiënten (7%) voldeden aan alle 7 beweegnormen. De overeenstemming 
tussen de verschillende beweegnormen was laag. Het individualiseren van de mate van 
intensiteit resulteerde in een hoger percentage patiënten met (zeer) ernstig COPD dat de 
relatieve beweegnormen haalde in vergelijking met een lager percentage dat de absolute 
beweegnormen haalde. In tegenstelling tot de patiënten met milde tot matige COPD die 
minder vaak de relatieve beweegnormen haalden. De conclusie was dat het toepassen 
van verschillende beweegnormen met kleine verschillen in frequentie, intensiteit en 
tijd in lichamelijke activiteit tot grote verschillen leidt in het bepalen of COPD patiënten 
voldoende lichamelijk actief zijn. Dit heeft als gevolg dat de beweegnorm die gebruikt 
wordt voor een groot deel het beweegadvies voor de patiënt zal bepalen.
Hyperinflatie van de long en lichamelijke activiteit
Hoofdstuk 6 beschrijft de resultaten van een pilot studie waarin we de effecten van 
bronchoscopische longvolume reductie op het lichamelijke activiteitenniveau van 
patiënten met ernstig emfyseem hebben onderzocht. Ook hebben we in deze studie 
onderzocht of verbeterde longhyperinflatie geassocieerd was met een stijging in 
lichamelijke activiteit. Emfyseem is een vorm van COPD waarbij de longblaasjes (alveoli) 
zijn beschadigd en de gaswisseling minder goed verloopt. Veertien patiënten met 
ernstige emfyseem droegen een week een accelerometer voor de behandeling en 6 
maanden na de behandeling nogmaals. Ondanks significante verbeteringen in statische 
longhyperinflatie vonden we geen stijging in het lichamelijke activiteitenniveau 6 
maanden na de bronchoscopische longvolume reductie behandeling. Verder was de 
verbeterde longhyperinflatie niet geassocieerd met een verbetering in lichamelijke 
activiteit of inspanningscapaciteit, maar wel met een vermindering in kortademigheid. 
We concludeerden dat speciale aandacht voor het stimuleren van lichamelijke activiteit 
nodig is na bronchoscopische longvolume reductie om het lichamelijke activiteitenniveau 
van deze patiënten te verhogen.
In hoofdstuk 7 hebben we de ‘minimal important difference’ (MID) bepaald voor 
veranderingen in het residuaal volume van patiënten met ernstig emfyseem die een 
bronchoscopische longvolume reductie ondergaan. Een MID kan worden gedefinieerd 
als een drempelwaarde voor een verandering die door de patiënt als zinvol en de moeite 
waard wordt ervaren en waarbij de patiënt de behandeling opnieuw zou overwegen 
als hij/zij deze keuze opnieuw zou maken. 91 patiënten met ernstig emfyseem werden 
geïncludeerd. Residuaal volume en de totale longcapaciteit werden gemeten met de 
bodybox. 
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MID schattingen werden berekend met de zogenaamde anker- en distributiemethoden. 
FEV1, 6-minuten wandelafstand en kwaliteit van leven (SGRQ totaal score) werden gebruikt 
als ankers en de Cohen’s effect size werd gebruikt als distributiemaat. De berekende MID 
schattingen volgens de verschillende methoden varieerden tussen -0.31 en -0.43 liter voor 
residuaal volume, -6.1 en -8.6% voor percentage verschil in residuaal volume van baseline 
en -2.8 en -4.0% voor residuaal volume% van totale longcapaciteit (RV%TLC). Deze MID 
schattingen zijn nuttig voor het berekenen van een steekproefomvang voor nieuwe 
studies met als doel het verminderen van residuaal volume en voor het interpreteren van 
de resultaten van klinische studies in patiënten met ernstig emfyseem. 
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INTERPRETATIE VAN DE RESULTATEN
Samenvattend hebben we verschillende potentiële voorspellers van lichamelijke 
activiteit onderzocht. Zoals verwacht beïnvloeden fysieke voorspellers, zoals dyspneu, 
inspanningscapaciteit en spierfunctie, het lichamelijke activiteitenniveau in COPD 
patiënten. Naast fysieke factoren bleken ook psychosociale factoren, inclusief motivatie- 
en omgevingsfactoren, het lichamelijke activiteitenniveau van COPD patiënten te 
beïnvloeden (figuur 2). In patiënten met milde tot matige COPD waren de voorspellers 
vergelijkbaar met de algemene populatie terwijl in (zeer) ernstige COPD patiënten de 
voorspellers fysiek en COPD specifiek waren. Longhyperinflatie was een belangrijke 
onafhankelijke voorspeller van lichamelijke activiteit maar een verbetering van 
longhyperinflatie door bronchoscopische longvolume reductie leidde niet automatisch 
tot een verbetering in lichamelijke activiteit. Verder vonden we dat het gebruik van 
verschillende beweegnormen met kleine verschillen in frequentie, intensiteit en tijd tot 
grote verschillen leidden in het classificeren of een COPD patiënt voldoende lichamelijke 
actief is.
Voorspellers van lichamelijke activiteit en de implicaties ervan
Onze resultaten laten zien dat lichamelijke activiteit niet door één factor wordt 
beïnvloed en dat dus het behandelen van één factor niet automatische leidt tot een 
stijging van het lichamelijke activiteitenniveau. Een goed voorbeeld hiervan is de in 
hoofdstuk 6 beschreven studie. Ondanks dat de bronchoscopische longvolume reductie 
behandeling wel significant de hyperinflatie van de long verminderde, wat een belangrijk 
voorspeller van lichamelijke activiteit is, verbeterde het lichamelijke activiteitenniveau 
van de patiënten niet significant. Waarschijnlijk zijn deze patiënten zo gewend aan hun 
dagelijkse activiteitenpatroon dat hier ook specifiek aandacht aan besteed zou moeten 
worden, naast andere factoren zoals verminderde spierfunctie. Verder is dit een goed 
voorbeeld van het feit dat lichamelijke activiteit naast een fysieke component ook een 
gedragsmatige component heeft en onderdeel is van de levensstijl van de patiënt. 
Combinatie kwantitatieve en kwalitatieve analyse
We hebben voor het eerst de voorspellers van lichamelijke activiteit met een kwantitatieve 
en kwalitatieve (interview) benadering onderzocht in dezelfde studiepopulatie van 
COPD patiënten. Psychosociale factoren zijn lastig te meten en de vragenlijsten zijn 
vaak van slechte kwaliteit of niet COPD-specifiek. Het combineren van de kwantitatieve 
en kwalitatieve analyses versterkt de bevindingen over de relaties tussen lichamelijke 
activiteit en psychosociale factoren. In beide analyses vonden we dat motivatie om 
lichamelijk actief te zijn, self-efficacy voor lichamelijke activiteit en weersomstandigheden 
significant lichamelijke activiteit van COPD patiënten beïnvloeden. We vonden in beide 
analyses geen verband tussen lichamelijke activiteit en sociale steun voor bewegen.
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Motivatie om lichamelijk actief te zijn
In hoofdstuk 4  bleek dat een aantal persoonlijke redenen van de patiënten om lichamelijk 
actief te zijn inderdaad geassocieerd waren met meer lichamelijke activiteit. Verder bleek 
in hoofdstuk 3 dat meer autonome motivatie om lichamelijk actief te zijn geassocieerd 
was met hogere lichamelijke activiteit. Meer autonome motivatie betekent dat patiënten 
meer intrinsiek gemotiveerd zijn om te bewegen (omdat ze er zelf van overtuigd zijn)  dan 
extrinsiek gemotiveerd (overtuigd door anderen). Oftewel dat COPD patiënten het zelf 
belangrijk vinden om lichamelijk actief te zijn. Een steeds meer gebruikte techniek in de 
gezondheidszorg die hier gebruik van maakt is ‘motivational interviewing’. Deze techniek 
gebruikt counseling die gericht is op de patiënt, waarbij getracht wordt de patiënt zelf de 
motivatie om te veranderen te laten benoemen en uit te laten voeren. Twee pilot-studies 
die deze techniek hebben toegepast in COPD patiënten lieten goede resultaten zien.27,28  
Self-efficacy om lichamelijk actief te zijn
Self-efficacy is het vertrouwen van een persoon in de eigen bekwaamheid om met 
succes invloed uit te oefenen op zijn of haar omgeving, bijvoorbeeld door een bepaalde 
lichamelijke activiteit te volbrengen. In zowel hoofdstuk 3 als 4 was self-efficacy voor 
lichamelijke activiteit gerelateerd aan een hoog lichamelijke activiteitenniveau. Het is 
bekend dat self-efficacy een belangrijk voorspeller is van het volhouden van lichamelijke 
activiteit en essentieel is voor het proces van gedragsverandering.29-31 In hoofdstuk 4 
hebben we een aantal factoren beschreven die self-efficacy kunnen verhogen, en die 
makkelijk in beweegstimuleringprogramma’s kunnen worden geïntegreerd.
Sociale steun voor lichamelijke activiteit
In tegenstelling tot wat we vooraf verwachtten was sociale steun voor lichamelijke 
activiteit niet gerelateerd aan lichamelijke activiteit. Omdat patiënten lage scores voor 
sociale steun voor lichamelijke activiteit rapporteerden, zou dit ook kunnen betekenen 
dat patiënten eigenlijk weinig sociale steun voor lichamelijke activiteit ervaren. In het 
algemeen is aangetoond dat sociale steun voor lichamelijke activiteit gedrag positief 
beïnvloedt.32 Dit zou kunnen betekenen dat het verhogen van sociale steun voor 
lichamelijke activiteit een belangrijke factor is in het stimuleren van lichamelijke activiteit 
in COPD patiënten, maar dit zou verder onderzocht moeten worden. Sociale steun 
voor bewegen kan komen van familie of vrienden maar ook van aanmoedigingen van 
therapeuten, artsen en medesporters.
Rol van het weersomstandigheden bij lichamelijke activiteit
De meest genoemde reden om niet lichamelijk actief te zijn was weersomstandigheden 
en lichamelijke activiteit was ook lager gemeten in de herfst of winter vergeleken met 
de lente of zomer. In het algemeen zijn weersomstandigheden niet een ziektespecifieke 
determinant van lichamelijke activiteit maar in onze studiepopulatie was dit meestal 
wel het geval. Veel patiënten ervaren meer longklachten bij specifieke weertypes zoals 
mist en extreme temperaturen. We kunnen het weer natuurlijk niet beïnvloeden maar 
de resultaten impliceren wel dat het belangrijk is om rekening te houden met het weer 
bij het opstellen van een lichamelijke activiteiten programma. Bijvoorbeeld door na te 
denken over back-up activiteiten. 
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Lichamelijke activiteit in verschillende ernststadia van COPD
Milde tot matige COPD
Patiënten met milde tot matige COPD hadden een significant hoger lichamelijke 
activiteitenniveau dan patiënten met ernstig tot zeer ernstig COPD. Twee studies lieten 
al eerder zien dat het lichamelijke activiteitenniveau van milde COPD patiënten niet 
significant verschilt van de algemene populatie. Voor patiënten met matige COPD gold 
dit voor bepaalde lichamelijke activiteit uitkomstmaten ook.33,34 De voorspellers van 
lichamelijke activiteit in deze mildere groep patiënten in onze studie waren gelijk aan 
die in de algemene bevolking, namelijk self-efficacy en jaargetijde. Het zou kunnen 
betekenen dat wat betreft lichamelijke activiteit milde tot matige COPD patiënten 
vergelijkbaar zijn met mensen zonder COPD. Dit zou mogelijk komen omdat deze 
patiënten nog nauwelijks fysiek beperkt worden in hun dagelijkse activiteiten door hun 
longklachten. Dit betekent echter niet dat deze mildere patiëntengroep dus uitgesloten 
zouden moeten worden van beweegstimuleringsprogramma’s aangezien er ook veel 
patiënten met milde tot matige COPD een laag lichamelijke activiteitenniveau hadden. 
Verder was een veel genoemde reden om te bewegen ‘een actieve leefstijl in het verleden’ 
wat impliceert dat het ook voor de preventie van sedentaire leefstijlen in een later stadium 
van COPD belangrijk is om lichamelijke activiteit in deze stadia al te stimuleren. Het is wel 
de vraag of patiënten met milde of matige COPD beter een COPD specifiek of algemeen 
beweegstimuleringsprogramma zouden moeten volgen. 
Ernstige tot zeer ernstige COPD
De voorspellers van lichamelijke activiteit in patiënten met ernstige tot zeer ernstige COPD 
waren ziektespecifiek en fysiek (longhyperinflatie, kortademigheid, beenspierfunctie en 
zuurstofgebruik). Al deze voorspellende factoren zijn potentiële behandeldoelen maar 
zoals we eerder beschreven leidt het aanpakken van één van deze factoren niet automatisch 
tot een verbetering van lichamelijke activiteit. Tijdens de langzame progressie van COPD 
kunnen patiënten onbewust door de ervaren kortademigheid bepaalde lichamelijke 
activiteiten gaan vermijden. Dit zal vaak leiden tot een neerwaartse spiraal omdat een 
verslechterde conditie ontstaat wat de kortademigheid bij inspanning doet toenemen, 
en daardoor het lichamelijke activiteitenniveau verder verlaagt. Succesvolle behandeling 
van één van deze factoren is waarschijnlijk onvoldoende om in een opwaartse spiraal 
te komen. Daarom zal ook aandacht besteed moeten worden aan het stimuleren van 
lichamelijke activiteit aangezien patiënten volledig zijn aangepast aan hun sedentaire 
leefstijl.
Overige praktische implicaties 
‘Tailoring’
Onze resultaten bevestigen dat het belangrijk is om een beweegstimuleringsprogramma 
op maat te maken voor een patiënt in plaats van een algemeen programma te maken 
voor alle COPD patiënten. Dit wordt bevestigd door onze waarneming dat plezier in 
bewegen was gerelateerd aan een hoger lichamelijke activiteitenniveau, en dat er een 
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grote variatie was in het soort lichamelijke activiteiten dat patiënten het liefst doen. 
Waarschijnlijk zal een voor de COPD patiënt op maat gemaakt programma ervoor zorgen 
dat ze het programma beter kunnen volhouden. Een andere studie liet zien dat een 
op maat gemaakt beweegadvies vaker leidde tot een stijging in lichamelijke activiteit 
dan algemene beweegadviezen.35 Onze studie identificeerde een aantal factoren die 
gebruikt kunnen worden voor het opstellen van een op maat gemaakt programma, naast 
algemene factoren genoemd in de eerder beschreven studie35 (Box 1).
Het meten van lichamelijke activiteit
De eigen inschatting van de patiënt van het lichamelijke activiteitenniveau bleek een 
overschatting te geven van het daadwerkelijke lichamelijke activiteitenniveau (hoofdstuk 
5). Daarom is het meten van lichamelijke activiteit met objectieve meetinstrumenten 
zoals accelerometers aan te raden. Tegenwoordig worden deze apparaten steeds kleiner, 
lichter, makkelijker draagbaar en goedkoper. In onze studie werd lichamelijke activiteit 
onder andere gemeten met een gevalideerde accelerometer.36 De patiënten droegen het 
apparaat gedurende 1 week en hadden weinig klachten over het dragen van het apparaat. 
Beweegstimulering met feedback van een stappenteller heeft goede resultaten laten 
zien in het toenemen van lichamelijke activiteit.37 Tegenwoordig kunnen accelerometers 
verbonden worden met mobiele telefoons en computers, waardoor patiënten kunnen 
worden gemonitord op afstand en stimulerende feedback signalen aan de patiënten 
gegeven kunnen worden. Dit zou gedragsverandering kunnen ondersteunen.
Lichamelijke activiteit versus lichamelijke inactiviteit
Een onverwachte observatie van onze studie was dat de voorspellers van lichamelijke 
activiteit anders zijn dan de voorspellers van zitduur. Ook was de zitduur niet verschillend 
tussen patiënten in verschillende ernststadia van COPD. Andere studies hebben laten 
zien dat zitduur een onafhankelijke risicofactor is voor verschillende aandoeningen zoals 
het metabool syndroom.38,39 Verder bleek dat het stimuleren van onderbrekingen in 
zitduur, onafhankelijk van totale zittijd, leidt tot vermindering van de risicofactoren van 
 BOX 1: Factoren individuele assessment                                            
•	 Kennis over gezondheidsvoordelen van lichamelijke activiteit
•	 Eigen doelen van de patiënt
•	 Bereidheid tot veranderen
•	 Redenen om lichamelijk actief te zijn
•	  Barrières in lichamelijke activiteit 
- weer
 - gezondheidsproblemen    
- financiële beperkingen   
- shaamte
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lichamelijke inactiviteit.38,40 Ook bij COPD patiënten kan het dus nuttig zijn om naast het 
stimuleren van lichamelijke activiteit ook het verminderen van lichamelijke inactiviteit te 
stimuleren, bijvoorbeeld door onderbrekingen in zitduur te adviseren.
Beweegadvies en referentiewaarden
De laatste GOLD richtlijn adviseert dat alle patiënten regelmatig lichamelijk actief 
zouden moeten zijn.1 Maar wat is ‘regelmatig’ lichamelijke actief zijn? Daarom is 
het belangrijk om te weten hoeveel lichamelijke activiteit nodig is om de gewenste 
gezondheidsvoordelen te behalen en om een concreet advies te kunnen geven aan een 
COPD patiënt. Op dit moment is de classificatie of een patiënt ‘genoeg’ lichamelijk actief is 
mede afhankelijk van de beweegnorm die wordt toegepast of met welk meetinstrument 
het wordt gemeten. Daarom is longitudinaal onderzoek nodig om te bepalen hoeveel 
lichamelijke activiteit in termen van frequentie, intensiteit en tijd daadwerkelijk nodig 
is in de verschillende stadia van COPD. Ook zou het nuttig zijn om referentiewaarden 
te ontwikkelen voor COPD patiënten om zo te kunnen bepalen welke COPD patiënten 
voor een beweegstimuleringsprogramma zouden moeten worden geselecteerd. Het 
individualiseren van de beweegnorm op basis van het fitheidniveau van een patiënt 
lijkt aantrekkelijk, vooral bij patiënten met (zeer) ernstig COPD. Bij het maken van een 
keuze voor een beweegnorm is het belangrijk dat patiënten een beweegnorm makkelijk 
kunnen inpassen in hun dagelijks leven en daarom zou een norm duidelijk moeten zijn 
en makkelijk navolgbaar en meetbaar.
De praktische richtlijnen hoe je een patiënt die een beweegnorm niet haalt zou moeten 
stimuleren om lichamelijk actiever te worden, zijn tot nu toe vaag en geven weinig 
praktische handvaten. Een vaak gebruikte behandelvorm waarin beweegstimulering 
plaatsvindt is longrevalidatie. Longrevalidatie is vaak multidisciplinair en er is 
aangetoond dat longrevalidatie het inspanningsvermogen, kwaliteit van leven en mate 
van kortademigheid significant verbetert.41 Maar andere studies hebben ook laten zien 
dat een verhoging in lichamelijke activiteit niet automatisch gegarandeerd is na een 
revalidatieprogramma.42 Een ander probleem is dat deze programma’s vaak erg duur zijn en 
maar een zeer beperkt aantal patiënten in aanmerking komen voor longrevalidatie. Naast 
revalidatieprogramma’s zijn gestructureerde sport- of fitnessprogramma’s of lichamelijke 
activiteit counselingprogramma’s nuttige behandelvormen, maar de optimale inhoud en 
plaatsing van deze programma’s is op dit moment niet strak vastgelegd. Concluderend, 
is er duidelijk behoefte aan meer praktische beweegrichtlijnen die bruikbaar zijn voor 
fysiotherapeuten en andere behandelaars van sedentaire COPD patiënten.
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Toekomstig onderzoek naar lichamelijke activiteit in COPD
Als eerste, raden we meer studies met een longitudinale opzet naar lichamelijke activiteit 
in COPD patiënten aan. Onze resultaten zijn verzameld op één tijdstip waardoor het 
moeilijk is om conclusies te trekken over oorzaak-gevolg verbanden. Het zou bijvoorbeeld 
heel interessant zijn om dezelfde patiënten na 5 jaar nog eens dezelfde metingen te laten 
uitvoeren. Dit geeft meer inzicht in veranderingen in lichamelijke activiteitpatronen 
van patiënten in de loop van de tijd. Longitudinaal onderzoek is ook nodig om te 
bepalen hoeveel lichamelijke activiteit daadwerkelijk nodig is om te leiden tot gewenste 
gezondheidsvoordelen, wat betreft frequentie, intensiteit en tijd in lichamelijke activiteit. 
Dit kan artsen en fysiotherapeuten helpen om concretere beweegadviezen aan een 
patiënt te geven. 
Daarnaast zijn meer studies nodig die de meest optimale vorm van beweegstimulering bij 
COPD onderzoeken. Het zou interessant zijn om een op maat gemaakt, multidimensioneel 
beweegstimuleringsprogramma te onderzoeken dat zich specifiek richt op lichamelijke 
activiteit. In deze programma’s zouden dan self-efficacy en intrinsieke motivatie een 
belangrijke rol moeten spelen. Naast het stimuleren van lichamelijke activiteit zou 
het verminderen van zitduur ook een doel moeten zijn en de rol van sociale steun 
voor lichamelijke activiteit zou verder onderzocht kunnen worden. Bij patiënten met 
milde tot matige COPD zou het interessant zijn om te onderzoeken of een algemeen 
beweegstimuleringsprogramma net zo effectief is als een COPD specifiek programma.
Toekomstig onderzoek zal hopelijk leiden tot dieper inzicht in het optimaal stimuleren 
van lichamelijke activiteit in COPD patiënten. Dit zal leiden tot een vermindering van 
sedentaire levensstijlen en de negatieve gevolgen ervan in deze patiëntpopulatie.
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DANKWOORD
Nadat de jaren zijn omgevlogen als promovenda rest dan alleen nog het dankwoord, 
want promoveren doe je zeker niet alleen. Graag wil ik daarom iedereen bedanken, die 
op welke wijze dan ook, mij heeft geholpen bij het voltooien van dit proefschrift. Een 
aantal mensen wil ik graag in het bijzonder noemen.
Zonder proefpersonen is klinisch onderzoek onmogelijk. Daarom wil ik allereerst alle 
COPD patiënten bedanken die vrijwillig hebben meegedaan aan de onderzoeken 
beschreven in dit proefschrift. Ik wil de patiënten bedanken voor hun inzet en ook het 
warme onthaal en de leuke gesprekken in hun eigen huis.
Vervolgens wil ik mijn (co)promotoren, dr. Nick ten Hacken, Prof. dr. Marike Boezen en dr. 
Mathieu de Greef, heel erg bedanken voor hun begeleiding en de prettige samenwerking 
de afgelopen jaren.
Beste Nick: Bedankt voor je enthousiasme en grote inzet voor het project en mijn 
promotie. Je was altijd beschikbaar voor vragen of het beoordelen voor weer een stukje 
tekst. Altijd als je weer kwam met ‘ik had nog eens zitten denken….’ was het maar weer 
afwachten met welk creatief idee of andere insteek je nu weer zou komen, maar samen 
met de vele inspirerende discussies leidde dit vaak zeker tot een verbetering van de 
artikelen. Bedankt voor het vertrouwen in mij als ‘onderzoeker’.
Beste Marike: Dit project was voor jou een uitstapje naar je bewegingswetenschappelijke 
roots. Door je positieve instelling, directheid en vermogen om knopen door te hakken 
bleef de vaart goed in het project. Bedankt voor je motiverende input tijdens de 
besprekingen en alle manuscripten en je hulp bij de registratie tot epidemioloog. Maar 
daarnaast vooral ook voor de plezierige samenwerking.
Beste Mathieu: Het was erg plezierig dat je na mijn afstudeerproject van 
bewegingswetenschappen ook de afgelopen 4 jaar mij hebt ondersteund in de eerste 
stappen in de wetenschap, zelfs tijdens je ziekte. Je kennis over het analyseren van 
interviews en het schrijven van een kwalitatief artikel was erg nuttig en zeer motiverend. 
Daarnaast ook bedankt voor de leuke gesprekken over de soms wondere wereld van 
wetenschap.
De leescommissie, bestaande uit Prof. dr. Rik Gosselink, Prof. dr. Tibor Hortobagyi en Prof. 
dr. Thys van der Molen, wil ik bedanken voor de bereidheid tot het lezen en beoordelen 
van dit proefschrift.
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Daarnaast hebben ook nog vele mensen geholpen bij de praktische uitvoering van het 
onderzoek.
Allereerst, wil ik alle longartsen en huisartsen bedanken die hebben meegeholpen 
door het doorzoeken van hun databases naar geschikte deelnemers en het vragen van 
patiënten voor het onderzoek.
Verder wil ik alle medewerkers van de longfunctieafdeling van het UMCG bedanken. 
Bedankt voor het uitvoeren van de vele longfunctietesten, ergo’s, bio-impedanties en de 
prettige begeleiding van de patiënten hierbij. Ook bedankt voor het inplannen van alle 
patiënten ondanks de soms onmogelijke aanvragen. 
De secretaresses van de longafdeling, Trudy, Heleen en Renée, wil ik bedanken voor alle 
hulp en ondersteuning tijdens de afgelopen jaren.
Daarnaast gaat mijn dank uit naar alle medeauteurs van de verschillende artikelen in 
dit proefschrift. Dirk-Jan Slebos, Karin Klooster, Sanne Heintzbergen, Menno Zuidema 
en Linda Bossenbroek, bedankt voor jullie aandeel in de verschillende manuscripten, 
variërend van het mogen analyseren van interessante data en het uitvoeren van analyses 
tot het hele land doorkruisen om accelerometers uit te leggen en om te hangen bij 
patiënten.
De sponsoren van het onderzoek, het Longfonds en Boehringer Ingelheim, wil ik 
bedanken voor het financieel mogelijk maken van de uitvoering van het grootse gedeelte 
van het onderzoek beschreven in dit proefschrift. Verder wil ik de sponsoren bedanken 
die het drukken van dit proefschrift mogelijk hebben gemaakt. 
Beste GRIAC-ers, de afgelopen jaren zijn termen als SNPs, Manhattan plots, het ‘sacrificen’ 
van muizen, neutrofielen en DAMPs bijna gewoon geworden. Bedankt voor alle 
interessante presentaties, inspirerende discussies en input tijdens de meetings op de 
dinsdag en de gezelligheid tijdens congressen.
Mijn paranimfen, Irene en Daan. Ik vind het hartstikke leuk dat jullie mij op deze dag 
bijstaan. Irene, nu zijn de rollen omgedraaid, erg leuk dat jij nu ook mijn paranimf bent. 
Ondanks de totaal verschillende onderwerpen van onze proefschriften waren veel 
promotie perikelen toch hetzelfde en fijn om te kunnen delen de afgelopen jaren. Daan, 
omdat maar weer bleek dat gezondheid niet iets vanzelfsprekends is vind ik het helemaal 
fijn en super ‘chill’ dat je vandaag mijn paranimf wilt zijn.
Mijn mede ‘jong’ longonderzoekers en deels kamergenoten: Susan, Erica, Wytske, Grietje, 
Maartje, Akkelies, Fransien, Eef, Anda, Linda, Karin en Ruth, bedankt voor de gezellige tijd. 
Mede door alle A4-tjes, koekjes bij alles wat maar gevierd kon worden, uurtjes bij Evert 
en op de crosstrainer en de leuke tripjes zoals curling en buitenlandse congressen zijn de 
jaren voorbij gevlogen. Ik hoop dat ik altijd zulke gezellige collega’s zal treffen.
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Zonder ontspanning, mede mogelijk gemaakt door vrienden en familie geen promotie! 
Lieve XiniX, sport, school en fysionerd vrienden, bedankt voor jullie vriendschap en 
ontspanning naast het werk en de interesse voor mijn onderzoek en promotie. Ook jullie 
heel erg bedankt; Han, Elly, Daan, Judith, Gabrielle en Marloes. Voor het er ‘gewoon’ altijd 
zijn als familie. Judith, speciaal nog bedankt voor je hulp bij de voorkant en lay-out van 
dit proefschrift. Je eerste opdracht, het was erg plezierig om dit samen met jou te doen 
en met een mooi resultaat! 
Iedereen bedankt !!!
Jorine
